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ABSTRACT
Enzootic Abortion of Ewes (EAE) is an economically important
disease of ewes, caused by the gram negative, intracellular
bacterium, Chlamydia psittaci. The disease results in lamb loss
from abortion and the perinatal death of weak lambs. Vaccines have
controlled EAE for more than thirty years, however in the last
decade vaccine efficacy has been poor.
The primary aim of this project was to examine the cell mediated
immune responses to C.psittaci in sheep and to identify potentially
immunoprotective antigens for future vaccine studies, by their
ability to stimulate both T-cell proliferation and cytokine
production.
Preliminary studies determined the parameters of an antigen
driven, ovine lymphocyte transformation assay for C.psittaci,
employing whole chlamydial elementary bodies (EB) as antigen. It
was shown that peripheral blood mononuclear cells (PBMC) from post
abortion animals would proliferate in response to chlamydial EB,
although lymphocytes from naive ewes also proliferated to a lesser
degree. Further studies in mice showed this latter response could
be caused by a cross reaction with harmless, enteric bacteria.
The development of proliferative responses of the PBMC to both
EB and mitogens was also measured during gestation. Infection at
this time led to the development of lasting T-cell responses and a
transient suppression of the response to the T-cell mitogen, Con
A. In addition, both mitogen and antigen specific responses were
disrupted in the immediate pre-parturition period. These responses
returned to control levels soon after lambing.
The T-cell proliferative response was further characterised by
probing chlamydial EB which had been separated by SDS page
electrophoresis and blotted onto nitrocellulose. Individual
antigens were then added to cultures of PBMC and T-cell lines
generated from post abortion animals. Four antigens were
identified with approximate weights of 70, 50, 38 and 30kDa which
stimulated proliferation. The ability of individual chlamydial
proteins to stimulate cytokine production in these cultures was
also tested. The four antigens above also stimulated the
production of y-IFN in the PBMC and T-cell lines from all sheep
tested.
Finally, the importance of y-IFN in a chlamydial infection was
investigated in an in vivo mouse model, where neutralising y-IFN
with a monoclonal antibody resulted in an increase in the severity
of infection in both thymic and athymic mice, when compared with
control animals. Increased numbers of viable chlamydiae were
isolated from tissues and increased pathological changes and serum
interferon levels were demonstrated.
The results presented in this thesis provide evidence for the
involvement of cell mediated responses in ovine immunity to
C.psittaci. Both T-cell proliferation and y-IFN production can be
measured, although how the responses interact with B-cells and
antibody has yet to be elucidated.
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Members of the genus Chlamydia are unique Gram-negative
bacteria. They are obligate, intracellular pathogens which lack
the ability to synthesise high energy compounds such as adenosine
tri-phosphate and guanosine tri-phosphate, leading Moulder (1974)
to coin the phrase "energy parasites". Chlamydial disease has
almost as many forms as hosts. Chlamydia infect arthropods,
molluscs, over one hundred and thirty species of birds and several
species of mammal (Ward, 1983). Avian strains can cause acute
respiratory infection in man (Macfarlane and Macrae, 1983) as well
as birds and the mammalian strains are known to cause pneumonia,
conjunctivitis, polyarthritis, synovitis, enteritis, seminal
vesiculitis, sporadic encephalomyelitis and abortion (Storz and
Krauss, 1985). Indeed, 20% of ovine abortion reported annually in
the U.K. is due to C.psittaci (Aitken, 1986a).
Taxonomy-
It is perhaps ironic that the Chlamydiae, from the Greek word
chlamys meaning a cloak, have been so named, since from the
earliest days much about them has been "cloaked" in taxonomic
confusion. In 1893, Nocard, isolated what he thought was the
agent of psittacosis from the wings of psittacine birds he had been
studying (Bedson, 1958). He named this organism Bacillus
psittacosis and although the agent described was probably
Salmonella typhimurium the name persisted until 1930. Meanwhile,
in 1907, Halberstaedter and von Prowazek isolated what they thought
was a protozoan from conjuctival scrapings, and called this
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parasite chlamydazoon. Later the chlamydiae were thought to be
viruses, since they could not be grown by normal plating
techniques. This theory continued until 1966 when Moulder showed
that the chlamydiae were in fact intracellular bacteria with no
relationship to viruses.
It was not until 1930 that at least five groups isolated the
true agent of psittacosis (Bedson, Western and Simpson, 1930;
Krumwiede, McGrath, and Oldenbusch, 1930; Lillie, 1930; Coles,
1930; Levinthal,1930), the latter three leading to inclusion
bodies being known as Lillie, Coles, Levinthal bodies or LCL
bodies. At this time Lillie proposed the name Rickettsia
psittacosis and the link with the rickettsiales was formed. This
link is perhaps not surprising since the rickettsiales are all
Gram-negative obligate intracellular, parasites (Moulder, Hatch,
Kuo, SchachteTand Storz, 1984).
However, there are differences between the two orders (Moulder
et al,1984) including the chlamydial development cycle with
alternate cell types, as well as their lack of structural muramic
acid and glutamate oxidation. Therefore in 1971, Storz and Page,
suggested that they should be classified in a separate order to be
called Chlamydiales. However, during the interim period from 1930,
many taxonomic names were proposed and the proliferation of names
used in scientific literature during the early 1960's, including
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Bedsonia, Miyagawenalla, Neorickettsia, as well as psittacosis and
ornithosis agents, prompted Page (1966) to suggest the unification
of all the members of the group in one family, Chlamydiacae with
one genus, Chlamydia .
The first division of the genus Chlamydia was based on chemical
and morphological characteristics (Gordon and Quan, 1965). It was
found that all the members of the genus could be split into two
smaller groups. Group A chlamydiae, produced compact cytoplasmic
inclusions which contained glycogen. This group was made up from
the agents associated with trachoma, inclusion conjunctivitis and
other primary human infections. Group B chlamydiae, developed
diffuse inclusions with no glycogen present and comprised all the
other chlamydiae from avian and mammalian hosts. The two distinct
groups were confirmed when it was reported that the group A
chlamydiae were inhibited by Sodium sulfadiazine and group B were
not (Lin and Moulder, 1966). It was then suggested that these
findings be formalised (Page, 1968) with the recognition of two
species within the genus to be called Chlamydia trachomatis and
Chlamydia psittaci respectively. Recently a third species has been
postulated (Grayston, Kuo, Wang, and Altman, 1986; Grayston, Kuo,
Campbell and Wang, 1989), consisting of the TWAR strains of
C.psittaci. These are respiratory pathogens which unlike the other
members of the species, seem to be restricted to human infections.
They also differ on the basis of DNA analysis, serology and
elementary body ultrastucture.
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C.trachomatis has been further subdivided using a
microimmunofluorescence technique (Wang and Grayston, 1971), which
revealed the presence of fifteen serotypes of human origin denoted
LGV 1-3 and Trachoma A-K, and also a single murine strain which
causes pneumonitis. However, C.psittaci, perhaps because of its
diverse host range is a more heterogeneous species with nine
mammalian immunotypes (Perez-Martinez and Storz, 1985), which
correlate with the 8 biotypes previously described (Spears and
Storz, 1979) and up to seven avian strains (Toyofuku, Takashima,
Arikawa and Hashimoto, 1986) . The important mammalian immunotypes
in sheep '8^61 Immunotype 1 associated with ovine abortion;
Immunotype 3 associated with polyarthritis and Immunotype 9
associated with inapparent intestinal infection. In all cases,
however, the target cells of the chlamydiae are epithelial cells
(Kuo, 1986) .
Life cycle.
The chlamydiae have a unique life cycle (Bedson, 1933 ;1936;
Bedson and Bland, 1932; 1934), which involves two specialised,
functionally distinct forms. The first of these is the infectious
Elementary Body (EB). The EB is the extracellular stage of the
chlamydial life cycle and is a rigid structure, resistant to
osmotic lysis. It is approximately 300nm in diameter and has
equivalent amounts of DNA and RNA. Unlike other Gram-negative
organisms, the chlamydial cell wall does not possess peptidoglycan
and thus the structural rigidity of the EB is thought to be due to
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the formation of disulphide bonds which cross link cysteine rich
outer membrane proteins, which appear to be produced when the
infectious EB is formed (Hatch, Allan, and Pearce, 1984; Newhall
and Jones, 1983).
The exact mode of entry of the EB into the host cell is unknown,
however in 1978 Byrne and Moulder demonstrated that invasion of
target cells and subsequent survival was possible by parasite
induced phagocytosis. This phenomenon was inhibited by heating,
suggesting a thermo-labile surface structure was involved. It was
also shown that this induction of uptake was restricted to EB,
since fewer reticulate bodies (RB) are phagocytosed in comparitive
studies (Brownridge and Moulder, 1979). More recently a surface
membrane protein has been implicated in the attachment of chlamydia
to the host cell (Hackstadt, 1986; Wenman and Meusar, 1986). The
mode of entry of the chlamydiae has been reviewed recently (Wyrick,
Choong, Davis, Knight, Royal, Maslow and Bagnell, 1989), and
parasite directed phagocytosis, microfilament dependant and
independant phagocytosis and pinocytosis via coated and non-coated
pits have all been suggested. The reasons for the many possible
modes of entry that have been reported may be due to the different
target cells used, the varied visualisation techniques employed or
the use of infectivity enhancing techniques such as centrifugation.
Once inside the cell, the chlamydiae survive by inhibiting
phagosome-lysosome fusion (Friis, 1972), perhaps in the same
manner as other intracellular pathogens such as Toxoplasma gondii
(Jones and Hirsch, 1977) and Mycobacterium tuberculosis (Lowrie,
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1983). Mycobacterium leprae, on the other hand, escapes from the
phagosome into the cytoplasm before fusion (Sibley, Franzblau and
Krahenbuhl, 1987). The exact mechanisms by which these effects are
achieved have yet to be defined. Chlamydial intracellular RBs,
however, are incapable of inhibiting phagosome-lysosome fusion
(Brownridge and Moulder, 1979) since, when compared with EBs,
more are destroyed upon uptake by macrophages. Phagosome-lysosome
fusion inhibition is thus restricted to and is triggered by EBs
(Eissenberg and Wyrick,1981). When yeast and EBs are concomitantly
phagocytosed by macrophages fusion occurs only with yeast laden
vacuoles, showing that chlamydial EBs cause specific and not
general suppression of fusion (Eissenberg and Wyrick, 1981). Later
it was shown that purified EB envelopes alone could inhibit fusion
and in this case the ability to inhibit fusion was not lost on
heating the envelopes (Eissenberg, Wyrick,Davis and Rumpp, 1983).
However, large numbers of EBs, rather than causing higher rates of
infection, actually cause reduced rates due to a phenomenon known
as immediate cytotoxicity (Moulder, Hatch, Byrne and Kellog, 197 6) .
This is thought to be caused by membrane lesions resulting from the
parasite-induced phagocytosis (Friis, 1972). Therefore, larger
numbers of EBs give rise to more ingestion, causing more lesions,
leading to irreparable membrane damage and cell death, before the
invading chlamydiae can replicate.
With survival assured the EBs remain inside a distinct vesicle
and transform into the metabolically active, reproductive form of
the organism, the RB. RBs can be up to 1600nm in diameter and due
to the protein synthesis necessary for metabolism and reproduction,
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contain three times as much RNA as DNA (Tamura and Manire, 1967).
They divide by binary fission within the confines of the endosome,
which increases in size to form a prominent inclusion.
Metabolically the chlamydiae are limited (Hatch, 1988), fragments
of various pathways are present, but they cannot generate ATP
(Moulder, 1962), and therefore possess an ATP uptake system
(Hatch, Al-Hossainy and Silverman, 1982). ATPase activity
appears to be intrinsic and is regulated by the cysteine rich outer
membrane proteins (CRP) in EB (Peeling, Peeling and Brunham,
1989). However, the chlamydiae are dependant on the host cell for
basic metabolites and other factors which enable it to synthesise
protein, DNA and RNA. The RBs, after division, mature and
condense into infectious EBs within the inclusion which then
ruptures, causing cell lysis and freeing the mature EBs into the
surrounding environment to begin the cycle again.
Persistence vs Latency?
The disease states caused by C.psittaci in ruminants fall into
two groups; chronic disease such as conjunctivitis and arthritis,
due to immunotype 2 and intestinal infection due to immunotype 9,
and the second form, acute single episode diseases such as enzootic
abortion of ewes (EAE), caused by immunotype 1. In both cases there
is a persistence or latency of infection, both in vitro (Rodolakis,
Bernard, Souriau, Layadi and Buzoni-Gatel, 1989), where avirulent
strains induced completely inapparent persistent infections, and
in vivo where following infection in ewes, C.psittaci can persist
until the following lambing season when the animals become
pregnant, at which time a proportion will abort (McEwan,
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Littlejohn and Foggie, 1951). C.psittaci can also persist in goats
as it has been isolated from them after abortion, when they are
considered to be immune (Brown, Amos, Lavin, Girjes, Tims and
Woolcock, 1988) . Further evidence of this comes from recent work
in sheep which showed that independant of the time of infection,
pathological changes did not occur in the placenta until after day
90 (Buxton, Barlow, Finlayson, Anderson and Mackellar, 1990) .
However, it has still to be demonstrated whether these phenomena
are due to a low level persistant infection existing in equilibrium
with the immune system, or are simply due to a latent form of
C.psittaci. A persistent infection in EAE suggests that EBs are
constantly released, but are held in check until the conditions
around the placenta are correct, after day 90; whereas a latent
infection would suggest a switching off of the growth cycle,
possibly an as yet undetected developmental form, which restarts
when triggered by an unknown factor, perhaps hormonal, after day
90.
Support for a latent form of C.psittaci came in 1980 when a
cryptic form of the parasite which did not stain with Giemsa was
suggested to explain an in vitro demonstration of a persistant
infection (Moulder, Levy and Schulman, 1980). Evidence for
chronic persistence comes from in vitro studies where addition of
lymphokines prevented the growth of C.psittaci in culture until the
lymphokine was removed from the culture and normal growth restarted
unaffected (Byrne and Faubion, 1982). Further in vivo studies
demonstrated the reactivation of an apparently resolved infection
when the host was immunocompromised (Yang, Kuo and Chen, 1983).
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This situation is analogous with that encountered in Toxoplasma
gondii infections, where in the immunocompetent host T.gondii form
tissue cysts containing slow growing bradyzoites (Dubey and
Beattie, 1988), which are hidden from the immune system, within
host cells (Sims, Hay and Talbot, 1988; Sims, Hay and Talbot,
1989). These tissue cysts rupture periodically and release large
numbers of infective organisms which are subsequently dealt with by
a competent immune system (Conley and Jenkins, 1981; Ferguson,
Hutchison and Petterson, 1989). However, in the
immunocompromised host, such as AIDS patients, the release of the
infective organisms can lead to recrudescence and can result in
meningoencephalitis (Luft, Conley and Remington, 1983).
Morphology and ultrastructure.
While inclusions are easily seen, single EBs are only just
visible by light microscopy, their size approaching the limit of
resolution. The EBs of C.psittaci and C.trachomatis have a coccoid
shape, whereas the EBs of the TWAR strains, the proposed species
C.pneumoniae, are pear shaped (Chi, Kuo and Grayston, 1987). All
EBs contain a single electron dense nucleoid core surrounded by
cytoplasm composed of ribosomes and amorphous material.
The higher magnification possible with electron microscopy shows
in greater detail the surface ultrastructure of the EB. The smooth
outer membrane is punctuated by a series of projections, in a
single area (Matsumoto, 1982a), which are arranged hexagonally
with a centre to centre spacing of 35-50nm (Matsumoto and Higashi,
1975). Individual projections protrude from a hole in the middle of
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a 30nm wide "flower" or "rosette" (Matsumoto, 1982b). However,
these projections break away easily from the surface of the EB and
negative staining has shown them to be 45nm in length and 6nm in
diameter. Each appears to be a tapering, hollow structure
(Matsumoto, 1988). The rosettes are made up from nine individual
subunits which are 3-5nm in size. These are arranged around a
central hole of 10-12nm from which the projection emerges
(Matsumoto, 1973).
Although the RB are larger and more flexible they possess
similar projections to those of the EB. These projections,
originating in the cytoplasm, extend through the cell wall via the
rosette and enter the host cell cytoplasm, passing through the
inclusion membrane. This further strengthens the hypothesis that
they are involved in transmembrane molecular transport (Matsumoto,
1981; Matsumoto, 1982c).
Outer membrane preparations, prepared from disrupted EBs show
that there is a further, internal, hexagonal arrangement of fine
particles, lOnm in diameter (Matsumoto and Manire, 1970). These
structures repeat every 16.7nm (Matsumoto, 1979). The outer surface
of the outer membrane also has a collection of fine particles 5-6nm
wide and 8nm from centre to centre. These structures are thought to
play a major role in the rigidity and structural integrity of the
outermost surface of the EB cell wall (Matsumoto, 1979; 1982a;
1988) .
12
ANTIGENS OF THE CHLAMYDIAE.
The chlamydiae have small genomes, of approximately lOOOKbp,
with the capacity to encode an estimated 400-600 proteins
(Stephens, 1988). This is similar to prokaryotes which live in or
on eukaryotic cells , such as the Rickettsia with 1650Kbp (Moulder,
1988), but is much smaller than typical, bacterial genomes, such as
Escherichia coli which has approximately 4000Kbp.
Of the 400-600 proteins synthesised by the chlamydiae many have
been shown to be shared by C.trachomatis and C.psittaci and recent
cross reactivity studies have shown that much of this shared
antigenicity extends to the putative C.pneumoniae strains
(Campbell, Kuo and Grayston, 1990). The most important of these
will be discussed in greater detail below and include the major
outer membrane protein (MOMP), at approximately 40Kd (Hatch,
Vance and Al-Hossainy, 1981); CRP, at 60Kd and 12Kd (Newhall,
Batteiger and Jones, 1982); a protein thought to be a heat shock
product at 57Kd (Morrison, Lyng and Caldwell, 1989); three
putative adhesins at 38Kd, 30Kd and 18Kd (Hackstadt, 1986; Wenman
and Meu.sar, 1986) and the genus specific glycoprotein
lipopolysaccharide (LPS) (Bedson, 1936; Nurminen, Leinonen, Saikku
and Makela, 1983).
Major Outer Membrane Protein (MOMP).
This protein, so called because it comprises 60% of the protein
mass in the outer membrane (Caldwell, Kromhout and Schachter, 1981;
Salari and Ward, 1981), is the most well characterised of the
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chlamydial proteins. It is a surface exposed acidic protein
(Batteiger, Newhall and Jones, 1985) containing nine cysteine
residues per polypeptide chain (Hatch et al, 1984; Stephens,
Mullenbach, Sanchez-Pescador and Agabian, 1986; Stephens,
Sanchez-Pescador, Wagar, Inouye and Urdea, 1987). These cysteine
residues are important in the formation of disulphide linked
oligomers in the outer membrane, which are necessary for the
structural integrity of the organism (Newhall and Jones, 1983;
Hatch et al, 1984). The cross linkages are also thought to be
important for the porin-like activity of MOMP (Bavoil, Ohlin and
Schachter, 1984) and as described above the developmental cycle of
the chlamydiae (Newhall and Jones, 1983; Bavoil et al, 1984; Hatch
et al, 1984).
Although antigenically cross reactive, MOMPs from different
species and strains exhibit slightly different molecular weights
(Salari and Ward, 1981; Hatch et al, 1981; Campbell et al 1990).
The variations in weight are localised in four variable domains
present in all MOMP genes where the amino acid sequence has been
deduced thus far (Stephens et al 1986, 1987; Zhang, Morrison
Caldwell and Baehr, 1989a). These variable domains, not
surprisingly, are also the location of the antigenic sites of MOMP,
including genus, species, sub-species and serotype specific
epitopes (Caldwell et al, 1981; Caldwell and Schachter, 1982;
Newhall, Terho, Wilde, Batteiger and Jones, 1986). Structural
studies of MOMPs from various serovars and biotypes of
C.trachomatis and C.psittaci, using peptide mapping, suggest that
MOMP represents a serological mosaic of antigenic determinants
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located on both the conserved and variable domains (Caldwell and
Judd, 1982; Ma, Chen and Kuo, 1987). Molecular analysis, aided by
the cloning of the MOMP gene (Allan, Cunningham and Lovett, 1984),
has confirmed these findings by looking at the MOMP sequence and
locating specific epitopes in the variable regions (Baehr, Zhang,
Joseph, Su, Nano, Everett and Caldwell, 1988; Conlan, Clarke
and Ward, 1988), and recent sequencing of the MOMP gene of the
ovine abortion strain of C.psittaci S26/3, should increase
knowledge of its role in the ovine immune response (Herring, Tan,
Baxter, Inglis and Dunbar, 1989).
Several antibody studies, described in more detail below
(Caldwell and Perry, 1982; Peeling, Maclean and Brunham, 1984),
have shown that MOMP has a role in infectivity and this is
supported by the finding that trypsin cleavage of surface exposed,
specific variable domains of C.trachomatis serovar B MOMP also
inhibit infectivity (Su, Zhang, Barrera, Watkins and Caldwell,
1988). However, despite this evidence involving MOMP in infectivity
and the fact that it is the single most predominant surface
protein, the efficacy of MOMP based vaccines has only been
partially demonstrated in C.trachomatis infections (Taylor,
Whittum-Hudson, Schachter, Caldwell and Prendergast, 1988)^
although in EAE, where vaccines have been shown to be effective in
the past (McEwan et al, 1951), stronger evidence exists for the
potential success of a C.psittaci ovine abortion strain MOMP
enriched vaccine (Tan, Herring, Anderson, and Jones, 1990) .
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Cysteine rich outer membrane proteins (CRP).
There are two further proteins of the chlamydiae which contain a
large proportion of cysteine residues and like MOMP are to be found
on the surface of the EB, although unlike MOMP are not found on
the RB. The CRP have molecular weights of approximately 12Kd and
60Kd and are found in both C.psittaci and C.trachomatis (Newhall
and Jones, 1983; Hatch et al, 1984). Again there are slight
differences among strains, C.trachomatis trachoma biovars have a
singlet protein at 60Kd, whereas the lymphogranuloma venereum
biovars have a doublet (Batteiger et al, 1985), as do C.psittaci
strains (Hatch et al, 1984). The CRP are extensively cross linked
by disulphide bonds to form macromolecular subunits with each other
and with MOMP over the surface of the chlamydial EB and this
confers the structural rigidity and osmotic stability so
characteristic of the EB which has been described above (Newhall
and Jones, 1983; Bavoil et al, 1984; Hatch et al, 1984).
The 60Kd CRP is highly antigenic and possesses genus and species
specific epitopes (Newhall et al, 1982; Newhall and Basinski,
1986). N terminus sequencing (Newhall and Basinski, 1986) and
recently, cloning and sequencing of the gene for the 60Kd protein
of C.trachomatis, has been performed (Clarke and Lambden, 1988;
Clarke, Ward and Lambden, 1988) and the results reveal the
presence of 24 cysteine residues. DNA hybridisation studies of a
C.trachomatis 60Kd CRP gene probe with C.psittaci DNA has indicated
the presence of genus conserved regions within the same gene
(Clarke et al, 1988). Further CRP gene DNA sequence analysis has
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shown a high level of homology between trachoma and lymphogranuloma
venereum strains (Watson, Lambden, Ward, Clarke, 1989). The low
molecular weight CRP of 12Kd also possesses antigenic determinants,
which are both biovar and species specific epitopes (Zhang,
Watkins, Stewart and Caldwell, 1987a).
Adhesins.
Specific binding of EBs with host receptor molecules have been
suggested as the method of endocytic uptake of the chlamydiae
(Byrne, 1976; Ward and Murray, 1984). If this is the case then the
receptor molecules would be expected to be cell wall components
(Levy and Moulder, 1982) and proteinaceous (Byrne, 1976). A
38Kd, heat labile, surface protein of C.trachomatis was recently
described (Joseph and Bose, 1991), which inhibited the binding of
EBs to HeLa cells and may be the protein responsible for the
findings of Byrne and Moulder (1978). Two putative receptors, also
termed "adhesins" have been reported by Wenman and Meusar (1986)
using a ligand blotting technique. Two proteins in C.trachomatis,
a 30-31Kd doublet and a 18Kd single protein, were shown to bind
radio-iodinated host cell membranes. The second of these was
recently shown to be a DNA binding protein, homologous to
eukaryotic histone HI (Wagar and Stephens, 1988; Tao, Kaul and
Wenman, 1991; Hackstadt, Baehr and Ying, 1991), and its ability to
bind host cell membranes was probably due to its highly basic
charge, pi 10.71 (Tao et al, 1991). Antibody to these adhesins
raised in rabbits inhibit chlamydia-host cell association.
Simultaneously, similar proteins were detected in both
C.trachomatis and C.psittaci, although in the latter case there
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was no adhesin doublet at 30-31Kd (Hackstadt, 1986) . However a
30Kd adhesin has been identified in a meningopneumonitis strain of
C.psittaci (Wenman, Kaul, and Meusar, 1986), and recently two
putative adhesins, identified by the ligand binding technique,
have been described for ovine abortion strains of C.psittaci (Tan,
1987) .
57Kd protein.
This protein is found in both C.psittaci guinea pig inclusion
conjunctivitis strains, as well as all fifteen serovars of
C.trachomatis (Watkins, Hadlow, Moos and Caldwell, 1986). It is
associated with both EBs and RBs, but does not appear to be
immunoaccessible as determined by indirect immunofluoresence and
dot immunoblot analysis of whole EBs and is therefore unlikely to
be surface exposed. The 57Kd protein has been implicated in ocular
hypersensitivity (Morrison, et al, 1989), and may be a heat shock
protein.
Lipopolysaccharide (LPS).
The LPS of the chlamydiae is a glycolipid first described by
Bedson (1936) and shown to be similar to the LPS of enteric
bacteria in 1983 (Nurminen et al, 1983) and described chemically in
1985 (Nurminen, Rietschel and Brade, 1985). LPS is present in both
EBs and RBs and is closely associated on the surface with MOMP v
(Birkelund, Lundemose and Christiansen, 1988) . It forms the basis
of the serodiagnostic complement fixation test for chlamydial
infection (Stamp, Watt and Cockburn, 1952; Schachter and Caldwell,
1980). The molecular weight of LPS is approximately 3-4Kd. The
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immunodominant group is a 2 keto-deoxy sugar (Dhir, Hakomori,
Kenny and Grayston, 1972), however D glucosamine, long chain
fatty acids and phosphate groups are also present in the molecule.
In addition, the LPS of C.psittaci strains contains D
galactosamine, not found in C.trachomatis, but it is not known if
this is a species specific characteristic.
Structurally, chlamydial LPS is divided into a lipid A moeity,
comprising the amino acids and the fatty acids, and an
oligosaccharide core constructed from the keto deoxy sugars. The
lipid A is inserted in the outer membrane while the
oligosaccharides are exposed on the exterior. Chlamydial LPS lacks
other sugars associated with bacterial LPS and appears similar to
and cross reacts with the deeply truncated forms of LPS, such as
the Salmonella Re mutants (Nurminen, Wahlstrom, Kleemola, Leinonen,
Saikku and Makela, 1983). Antigenically, LPS has genus specific
epitopes common to all Chlamydiae and epitopes which cross react
with enterobacterial LPS (Caldwell and Hitchcock, 1984). Chlamydia
specific epitopes are associated with a unique a2-8 linked keto
deoxy disaccharide, found in the core of the LPS molecule (Brade,
Brade and Kosma, 1988) and which has recently been synthesised
(Kosma, Schulz and Brade, 1988). The cross reactive epitopes have
also been characterised, and described as a terminal a-pyranoside
keto deoxy residue and a 2-4 linked keto deoxy disaccharide. A
third epitope of the cross reactive type is thought to reside in
the lipid A portion of the LPS molecule and is unmasked only after
acid hydrolysis (Brade, Nurminen, Makela and Brade, 1985). This
epitope cross reacts with enterobacterial lipid A.
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THE DISEASE.
Of all the chlamydia induced diseases of ruminants, the most
economically damaging is EAE, the commonest cause of infectious
abortion in sheep in Great Britain (Aitken, 1986a). Lamb losses
from EAE may cost the British agricultural industry as much as £10
million per annum (I.D.Aitken, personal communication). Abortions
occur in 5-10% of ewes in endemically infected flocks, but abortion
rates may be as high as 30% in flocks infected with C.psittaci for
the first time (Stamp, McEwan, Watt and Nisbett, 1950). While ewes
of all ages may abort (Linklater and Dyson, 1979), the incidence
is usually higher among young animals (Stamp et al, 1950). However
in both cases recovery is usually uneventful.
Enzootic Abortion of Ewes (EAE).
The disease was first described in 1936 (Greig, 1936) although
shepherds had recognised it as a problem for many years before
this. It is characterised by gross inflammation and necrosis of the
placenta, leading to the birth of weak or dead lambs, possibly
resulting from poor placental transfer of nutrients. Indeed, the
disease was first thought to be due to environmental factors and
dietary deficiency (Greig, 1936). However, the causative agent of
EAE was identified as psittacosis lymphogranuloma agent in 1950
(Stamp et al, 1950) and a series of studies culminated in the
development of an inactivated, whole organism vaccine (McEwan et
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al 1951; McEwan, Dow and Anderson, 1955; Littlejohn, Foggie and
McEwan, 1952; McEwan and Foggie, 1954;1956). This vaccine was
widely used and controlled the incidence of EAE without completely
eliminating it (Foggie, 1973).
Subsequently, however, the incidence of EAE has increased
again. Previously unaffected flocks have become infected, while
the abortion rate in properly vaccinated flocks has risen to 7%,
not significantly lower than in unvaccinated flocks (Linklater and
Dyson, 1979). The loss of efficacy of the vaccine was thought to
be due to either the emergence of novel, more virulent strains of
C.psittaci, which the vaccine strain (A22) no longer mimicked or a
loss of immunogenicity of the vaccine strain caused by its
prolonged laboratory passage (Linklater and Dyson, 1979; Aitken,
Anderson and Robinson, 1985). A second abortion strain of
C.psittaci, S26/3, was therefore added to the vaccine.
Despite the introduction of this bivalent vaccine, throughout
the '80s the number of cases of ovine abortion attributable to
C.psittaci was greater than 40% of all diagnosed samples
(Veterinary Investigation Diagnostic Analysis) and chlamydial
abortion remains a problem in much of Europe, particularly in those
countries with a high sheep population such as Great Britain,
France, Greece and Germany (Aitken, 1986b). Chlamydial abortion
is also a serious problem in America (Shewan, 1980) , however,
although there have been reports of it occurring in Australia, it
is not considered a problem, due to various environmental factors
and differences in sheep husbandry (Seaman, 1985) .
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Clinical signs.
The usual indicator of EAE is the discovery of dead lambs 2-3
weeks before lambing (Aitken, 1991). Earlier symptoms, including
an occasional vulval discharge, are seldom noticed or recorded
under normal farming conditions. Initial diagnosis can be made
from the gross pathology of the foetal membranes. Necrotic
placentas with oedematous thickening of the inter-cotyledonary
regions are typical of chlamydial abortions. However, despite the
obvious placental damage, aborted foetuses are well formed with
little degenerative change. After abortion ewes may have a vulval
discharge for 7-10 days, but after this dries up there are seldom
any further clinical signs and most ewes recover with no side
effects. On occasion metritis may be caused by the retention of a
placenta and this can lead to a loss of condition and even the
death of some ewes. Confirmation of diagnosis is by isolation of
C.psittaci in eggs or by tissue culture or more conveniently by the
demonstration of EBs in smears from infected tissue ( modified
Ziehl-Neelson stain- Stamp et al, 1950).
Pathogenesis
In 1950, Stamp and his co-workers were the first to isolate the
then called psittacosis-lymphogranuloma agent (now known to be
C.psittaci) from the foetal membranes of experimental animals
suffering from enzootic abortion of ewes (EAE) (Stamp et al, 1950).
They also described the appearance of a typical infected placenta,
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with the irregular thickening of the chorion due to oedema and the
severe inflammatory immune response. Necrosis of the cotyledons
associated with the presence of large numbers of infectious
chlamydia was also noted.
Understanding of the pathology involved in these gross changes
was furnished by Studdert (1968) and Novilla and Jensen (1970).
Briefly, from day 60 of gestation in normal pregnancy, haematomata
form in the arcades of the placentome. These haematomata are formed
from maternal blood from the septal capilliaries and may provide a
route whereby the chlamydial EBs in the dams circulation can infect
the foetal membranes from the maternal blood supply. However,
although the haematomata form around day 60 of gestation, it is
not until after day 90 that the first signs of chlamydial infection
can be detected (Buxton et al, 1990), irrespective of the time of
infection. In field infections clinical signs also appear to be
independant of the time of infection and are similar regardless of
when the sheep become infected (Buxton et al, 1990). This
phenomenon is unlike the situation in toxoplasmosis in sheep when
the time of infection has a direct bearing on the severity and
eventual outcome of the disease (Blewett and Watson, 1983).
In the early stages, C.psittaci replicates in the foetal
trophoblast cells adjacent to the haematomata. After continuing
cycles of infection and replication the trophoblast cells are so
badly damaged that cell debris, infectious EBs and inflammatory
exudate containing mainly neutrophils, builds up at the
maternal/foetal interphase. Infection then progresses deeper into
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the placentome and laterally into the chorionic membranes. Later in
the advanced stages of infection this can lead to extensive
necrosis of the cotyledons and the chorionic membranes with an
accumulation of exudate in the placentome and on the chorion.
Occasionally necrosis and infiltration of neutrophils and
macrophages into the maternal septa can be detected (Novilla and
Jensen, 1970) and this may lead to metritis.
In the experimental situation when infection results in the
death of the foetus before day 120 of gestation, the foetal
membranes are usually retained within the uterus for some time
before expulsion, causing severe autolysis which has prevented
worthwhile analysis from being carried out. After 120 days there is
noticeable foetal splenic and lymph node enlargement and fluid is
found in the pleural and peritoneal cavities. However,
macroscopically little foetal pathology is seen, but the
microscopic lesions which are found in foetal tissues, most
commonly in the liver, mark sites of focal inflammation with
accumulation of reticulo-endothelial cells suggesting that the
innate foetal immune system is responding to the infection.
From the wide distribution of these lesions it would appear that
entry to the foetus is through the chorionic blood vessels and from
there into the foetal circulation via the liver. Despite this,
foetal sera tested for anti-chlamydial antibody by the complement
fixation test have proved negative, although anti-chlamydial
antibody has been demonstrated by an immunoperoxidase method
employed by Buxton and colleagues (Buxton et al,1990).
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Transmi s s ioil.
The natural route of infection of C.psittaci in EAE has yet to
be identified. However, it is possible that lambs become infected
perinatally (McEwan et al, 1951), although infection can also
occur transplacentally. What is known, however, is that infection
and abortion can take place within a single lambing season
(Blewett, Gisemba, Miller, Johnson and Clarkson, 1982),
presumably from contact with infected material, highlighting the
need to immediately remove animals which have aborted from animals
still to lamb. However this finding does not rule out the
possibility of transplacental infection also occurring. In both
cases it is thought that C.psittaci enters a period of latency
until the following lambing season when pregnancy triggers the
infection of the placenta (McEwan et al., 1951; Wilsmore, Parsons
and Dawson, 1984).
Experimentally, typical EAE lesions can be reproduced by
parenteral inoculation, either sub-cutaneously or intra-venously
(Studdert and McKercher, 1968) and also by oral dosing, where
there is some evidence to suggest that the portal of entry is
tonsillar tissue (Jones and Anderson, 1988). Again, this finding
supports the view that C.psittaci infection occurs by the ingestion
of infected material or by inhalation of aerosols (Aitken, 1986b;
1991) . This may also account for the observation that EAE outbreaks
are rare in the highlands where extensive sheep farming is the
common practice, but are economically crippling in the lowlands
where the farming is more intensive.
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Another possible route is venereal transmission, but although it
has been shown that sero-conversion occurs after artificial
insemination with infected semen, intravaginal infection or
natural service, it is unlikely that this method of transmission
contributes to the epidemiology of EAE (Appleyard, Aitken and
Anderson, 1985). Finally there is little evidence of animal
vectors being involved, unlike T.gondii for example, and although
there is one report of tick borne transmission to cattle
(McKercher, Wada, Ault and Theis, 1980) this has not been repeated
and is not thought to constitute a major mode of transmission.
Treatment and Prevention.
C.psittaci is sensitive to many antibiotics such as
tetracycline, oxytetracycline, tylosine and erythromycin. However,
blanket treatment can only moderate the severity and incidence of
abortion. Treating all ewes throughout gestation is expensive and
so antibiotics are a retrospective treatment, dependant on rapid
diagnosis, which does not eliminate infection or reverse placental
damage. Therefore chemotherapy would not appear to be a practical
means of control in all flocks (Foggie, 1973; Aitken, 1986b),
however long acting tetracycline can be used to protect expensive
breeding stock in flocks known to be at risk. The first dose
(20mg/Kg) being given at or around 100 days, when the infection
will have taken hold, and repeated if necessary at 14 day
intervals.
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Good farming practices can prevent or limit infection. Animals
sero-negative for C.psittaci should be bought from flocks with no
history of EAE, although even this measure will not guarantee
infection-free animals. The problem lies in the inability of the
complement fixation test and ELISA methods to distinguish naive and
susceptible animals from those vaccinated and protected, ewes
infected and about to abort, and convalescent and protected sheep.
Therefore vigilance is necessary in detecting an outbreak of EAE
within a flock, since aborting animals may infect those which have
still to lamb (Blewett et al, 1982).
All infected material, the foetus, the placenta and contaminated
bedding and food, should be buried or destroyed and where
appropriate, lambing pens should be disinfected and if possible not
re-used. Affected ewes should be isolated for at least 7-10 days,
until the vaginal discharge dries up. After lambing, if the
number of affected ewes is small, it is advisable to cull them to
diminish the risk of transmission. However, if infection was
widespread the animals should be retained since they will be immune
to further infection and their lambing potential will not be
affected as ewes seldom abort twice.
The difficulty in distinguishing naive and susceptible sheep
from infected sheep, vaccinated sheep and convalescent sheep
highlights the need for an effective, extensive programme of
immunoprophylaxis by vaccination and at present this is the major
weapon in the control of EAE. Vaccination has been used against
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EAE since the 1950s and controlled the disease to the point where
it was no longer considered a problem. The vaccine contained a
single EAE isolate, grown in egg yolk sacs and inactivated with
formalin. In the past decade reduction in vaccine efficacy
(Linklater and Dyson, 1979) has led to many attempts to improve the
quality of the current vaccine, including the addition of a second
strain to the commercial vaccine.
A live vaccine was also demonstrated in 1973 (Yilmaz and
Mitscherlich, 1973). This tested the ability of the "P" strain of
C.psittaci to act as an attenuated vaccine and the authors claimed
that it induced protection without stimulating the complement
fixing antibodies normally detected after vaccination. Another
vaccine employed an abortion strain of C.psittaci, AB7 treated with
nitrosguanidine to form a temperature sensitive mutant (Rodolakis
and Bernard, 1984). Again this vaccine has been reported to be
effective in reducing the incidence of EAE. However, to date
neither of these vaccines have been commercially produced and
tested. More recently a purified EB vaccine (Anderson, Tan,
Jones and Herring, 1990) and a MOMP enriched vaccine (Tan,
Herring, Anderson and Jones, 1990) have also been tested and
proven successful.
Zoonosis.
As well as being of veterinary and economic importance,
C.psittaci is also an important zoonotic pathogen of humans. Avian
strains have long been known to cause respiratory disease when
transferred to humans (Schacfit<2/,v 1986), but there have also been
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reports of respiratory illness among laboratory staff (Barwell,
1955) and vaccine production workers (Baker and Cooper, 1983),
caused by ovine abortion strains of C.psittaci. There is also a
further, more serious risk from ovine abortion strains of
C.psittaci and that is their potential to cause abortion in
infected women (Buxton, 1986). The link between C.psittaci and
human abortion has only recently been confirmed (Johnson, Matheson,
Williams, Laing, Jandial, Davidson-Lamb, Halliday, Hobson, Wong,
Hadley, Moffat and Postlethwaite, 1985), but has been suspected for
some time (Roberts, Grist and Giroud, 1967) .
Clinical symptoms include fever, headache, nausea and malaise,
although photophobia, rigors and vomiting can be presented by
individual patients (Buxton, 1986). Abortion occurs within a week
of these symptoms and patients exhibit disseminated intravascular
coagulation, which may be caused by a bacterial endotoxin such as
LPS (Lester and Roth, 1977). Patients may also develop renal and
hepatic dysfunction before recovery (Buxton, 1986). The increased
danger for the mother in the human disease is thought to be due to
the direct contact between the maternal circulation and the
placenta which does not occur in sheep. Histological examination of
the placenta shows inflammation of the mesoderm and, as in the
ovine disease, there is damage to the trophoblast cells where
chlamydial inclusions can be demonstrated (Wong, Gray, Buxton,
Finlayson and Johnson, 1985) . Therefore as with the sheep
placenta, C.psittaci has a predilection for the human placenta and
pregnant women are advised to avoid working with sheep,
particularly during the lambing period.
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IMMUNE RESPONSES TO CHLAMYDIAE.
The immune responses to the Chlamydiae were reviewed recently
(McCafferty, 1990) and the main points have been highlighted and
updated below.
Humoral Immune Responses.
Of the 400-600 proteins encoded by the chlamydial genome
(Stephens, 1988) more than 100 can be resolved by SDS-PAGE (Salari
and Ward, 1981) or by two dimensional electrophoresis (Batteiger
et al, 1985). However, only a few of these are immunogenic. In a
human system, 14 protein bands from C.trachomatis were recognised,
using antisera from infected patients (Newhall et al, 1982) .
Rabbit immune sera detected eight proteins of C.pneumoniae
(Campbell et al, 1990), guinea pig sera reacted to a similar
number of bands from a guinea pig inclusion conjunctivitis strain
of C.psittaci (Batteiger and Rank, 1987) and in preliminary
immunoblotting studies in sheep, three prominent antigens from
C.psittaci ovine abortion strains were demonstrated (McClenaghan,
Herring, Aitken, and Honeycombe, 1986) . More recently 12-14
immunoreactive bands were recognised by convalescent ovine lymph
fluid (Huang, Tan, Buxton, Anderson and Herring, 1990) and nine
were identified by sera from sheep, which had been vaccinated and
challenged with C.psittaci (Anderson et al, 1990) .
Specific IgM and IgG antibodies are induced by these
immunoreactive antigens following infection (Page, Patterson,
Reopke and Glaser, 1967). Originally, Isa and co-workers (Isa,
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Linscott and Jawetz, 1968) claimed that only IgG was produced in
monkeys, even in a primary infection. However this was later
shown not to be the case and the earlier lack of IgM activity was
due to either inapparent previous infections or cross-reacting
antigens (Isa, 1973). The ability of the immunofluorescence test,
used to detect IgM, in primates has also been questioned (Juchau,
Linscott, Schachter and Jawetz, 1972), since high affinity IgG may
affect the ability of low affinity IgM to bind to chlamydial
antigen.
In several antibody studies epitopes present on MOMP have been
shown to be important in chlamydial infectivity. The neutralising
ability of anti MOMP IgG has been demonstrated, when surface cross
linking of the EB interfered with the development cycle of the
organism after internalisation (Caldwell and Perry, 1982), lending
weight to the hypothesis that the reduction of disulphide bonds and
general "loosening" of the rigid EB structure is important in the
chlamydial life cycle (Newhall and Jones, 1983; Hatch et al, 1984;
Newhall, 1987). This effect has also been demonstrated using an
anti MOMP species specific monoclonal antibody, which was effective
against more than one serovar of C.trachomatis (Peeling et al,
1984). Zhang and his co-workers have also obtained similar results,
demonstrating neutralisation (Zhang, Stewart, Joseph, Taylor and
Caldwell, 1987b; Zhang, Stewart and Caldwell, 1989b).
Neutralisation studies with monoclonal antibodies against other
chlamydial proteins recognised by immunoblot techniques have not
been as successful. While the CRP role in the structure and
31
function of the chlamydiae is pivotal and they contain biovar and
species specific epitopes, studies indicate that the epitopes are
not immunoaccessible (Zhang et al, 1987a) and neutralisation tests
have not been done. There have also been no successful attempts at
neutralisation of infectivity with monoclonal antibody reacting
with LPS. The adhesins, with a putative role in host cell
attachment, would be candidates for neutralising antibody studies
and indeed polyclonal rabbit serum raised against these proteins
was capable of inhibiting attachment in vitro (Wenman and Meusar,
1986). These results take on further significance in light of
studies by Russell and Alexander (1988) which demonstrated
prophylaxis in cutaneous leishmaniasis using two antigens known to
be involved in the attachment of another intracellular parasite,
Leishmania mexicana, to its host cell, the macrophage.
Following infection in ewes, CF antibody is produced against
epitopes found on chlamydial LPS. Titres rise to a peak at about
fourteen days after abortion and remain high for several weeks
(Stamp et al, 1952). Neutralising antibody appears later, and
titres remain higher for longer (McEwen and Foggie, 1954), but
neither CF nor neutralising antibody titres correlate with immunity
(Storz and Krauss, 1985) .
Recent work has concentrated on which subclass of IgG is
produced in the humoral response. This interest was stimulated when
Schnorr
it was shown by ELISA (Schffleer,^ Perez-Martinez and Storz, 1987),
that IgG2 was the dominant subclass in bovine chlamydial
infections. However, similar work with sheep and goat antibodies
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showed that IgGl is dominant (Krauss, Semler, Schmeer and Somner,
1985; Schmeer, Krauss, Apel, Adami, Muller and Schnfeuder, 1987).
The significance of this is unknown at present but work on how
antigens stimulate different subclasses of antibody may prove
useful, particularly in light of the fact that gamma-interferon
enhances murine IgG2 production and decreases IgGl production in
vitro (O'Gara, Umland, De France and Christiansen, 1988) .
However laboratory animal studies dealing with passive transfer
of antibodies have produced conflicting results. Passively
transferred serum antibody in non-immune guinea pigs resulted in
titres higher than those associated with natural immunity to the
guinea pig inclusion conjunctivitis strain used (Watson, Mull,
McDonald, Thompson and Bear, 1973). However on subsequent challenge
the disease was neither prevented nor slowed. Buzoni-Gatel and
co-workers (Buzoni-Gatel, Rodolakis and Plommet, 1987) found that
immune sera transferred to mice infected with C.psittaci led to
eradication of the organism from liver and spleen within 6 days, at
which stage the liver and spleen of control mice were still
infected. Recently polyclonal and monoclonal antibodies have been
shown to protect mice from abortion caused by infection with
C.psittaci ovine abortion strains (Buzoni-Gatel, Bernard,
Anderson and Rodolakis, 1990), but to date the monoclonal
antibodies used have not been characterised and their chlamydial
protein specificity is not known. In sheep however, passive
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transfer of hyperimmune sera has failed to protect ewes from
subsequent abortion, after experimental infection with ovine
abortion strains of C.psittaci (G.E.Jones, personnal
communication).
Whether these conflicting reports are due to the different
host animals used is uncertain, but they and other research
showing that B cell deficient mice can resolve chlamydial genital
infection and remain immune (Ramsey, Soderberg and Rank, 1988) and
that guinea pigs treated with anti thymocyte serum to remove their
cell mediated immune mechanisms cannot resolve infection (Rank,
Soderberg, Sanders and Batteiger, 1989), suggest that cell mediated
immune mechanisms may play an important role in chlamydial
immunity.
Cell-mediated immunity.
Cell-mediated immunity (CMI) is a function of specific T-cell
cytotoxicity and delayed type hypersensitivity (DTH) reactions, and
of natural immune mechanisms including natural killer cell activity
and phagocytosis by cytokine-activated macrophages.
Cytotoxicity attributed to both natural and T-cell mediated
mechanisms has been demonstrated in spleen cells from mice infected
with C.psittaci Cal 10 strain (Lammert, 1982). In comparison,
cytotoxicity could not be found in lymphocyte preparations taken
from the spleen, lymph nodes or peritoneal cavities of mice
infected with the LGV strains of C. trachomatis (Pavia and SchacVrtBT,
1983). Further work with human lymphocytes also failed to
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demonstrate cytotoxicity against the LGV strains of C.trachomatis
(Qvigstad and Hirschberg, 1984). The role of T-cell cytotoxicity
is therefore unresolved, although the reported differences may be
due to the different species used. It remains to be elucidated
whether these mechanisms play a role in protective immunity to
ovine C.psittaci infection.
That T-cell mediated immunity to C.psittaci occurs in sheep can
be demonstrated by DTH tests (Wilsmore, Abduljahl, Parsons and
Dawson, 1984b; Dawson, Zaghloul and Wilsmore, 1986) . After
abortion, ewes develop a positive DTH reaction; however, if
primary infection occurs outwith pregnancy no DTH response is
generated. In the latter case it is possible that the organism may
persist at too low a level to stimulate the DTH response, but may
cause abortion of the following pregnancy. Immunity is then
generated, presumably due to the higher levels of replication
within the placenta and substantial challenge of the ewe with
antigen as a result of parturition (Storz, 1971). This may explain
the earlier findings that following abortion ewes display immunity
(Stamp et al, 1950). The generation of CMI may prevent further
chlamydaemias and thereby stop subsequent placental infection even
though ewes may still harbour a low level infection.
Cytokine-activated phagocytosis by macrophages may occur as a
result of DTH responses. In 1983 Murray and colleagues (Murray,
Byrne, Rothermel and Cartelli, 1983) showed that oxygen-independent
activity of macrophages against intracellular parasites, including
C.psittaci, was enhanced by a cytokine, originally termed
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macrophage activating factor (MAF) but later shown to be interferon
gamma (IFN-y) . The same year IFN was shown to be also responsible
for oxygen dependent activation of macrophages against
intracellular parasites (Nathan, Murray, Weibe and Rubin, 1983).
However, as early as 1975 Borges and Johnson had demonstrated that
products in the supernatant of activated T-cells could effectively
reduce the intracellular replication of T.gondii.
Cytokine-activated macrophages have been associated with
restriction of chlamydial replication, possibly leading to
persistent infections (Moulder et al, 1980). Huebner and Byrne
(1988) found that while activated macrophages did not clear
infection, they were necessary if Chlamydia infected mice were to
survive, indicating that their action was bacteriostatic. This in
vivo effect of IFN-y had been described previously in a series of
in vitro experiments (Byrne and Faubion, 1982). Recently, Byrne
and colleagues (Byrne, Schobert, Williams and Kruegar, 1989) have
also demonstrated a cytotoxic effect on C.psittaci infected cells
mediated by IFN-y.
At the time that IFN-y was identified as a macrophage activator
it was also implicated as the factor in crude cytokine preparations
which induced inhibition of C.psittaci replication in macrophages
(Rothermel, Rubin and Murray, 1983; Byrne and Krueger, 1983). It
was shown that anti-IFN-y antibodies could remove this inhibition
and precipitate a recrudescence of infection. Recently, catabolism
of essential amino acids induced by IFN-y was identified as the
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mechanism for this inhibition (Byrne, Lehman and Landry, 1986) .
This is not the first time, however, that parasite and host
competition for essential amino acids has been cited as a mechanism
for inhibition of replication due to bacteriostasis (Hatch, 1975) .
Other phagocytes involved in the response to chlamydial
infection are polymorphonuclear cells or neutrophils (Register,
Davis, Wyrick, Shafer and Spitznagel, 1987). These cells are
attracted to sites of inflammation by the release of arachidonic
acid metabolites from activated macrophages. However this does not
seem to be the case with other intracellular parasites such as
T.gondii (Locksley, Fankhauser and Henderson, 1985) which appear
to affect the host cell's arachidonic acid metabolism altering the
concentrations of leucotrienes produced, thereby reducing the
inflammatory response to the infection and lowering the numbers of
neutrophils at the site of infection.
Granules from neutrophils, of patients with chronic granulocytic
leukaemia, were fractionated in order to examine which compounds
were important in the response to Chlamydia spp. The heavier
fractions, which contained lysozyme, reduced C.trachomatis
infectivity, whereas the lighter fractions, mol wt<13Kd, had a
detrimental effect on C.psittaci. Granules eluted in the lower
molecular weight fractions contain cationic proteins, but the
important individual ones are unknown at present.
37
Further in vitro techniques also show that CMI has a role to
play. These include specific antigen-induced migration inhibition
of peritoneal exudate cells from guinea pigs infected with
C.psittaci (Seynk, Kerian, Stites, Schanzlin, Ostler, Hanna,
Keshishyan and Jawetz, 1981) and the proliferation of lymphocytes
from lymph nodes of sheep (Russo and Giauffret, 1978), and also
from guinea pigs with C.psittaci antigens (Seynk et al, 1981), and
in human T-cell clones using C.trachomatis antigens (Qvigstad and
Hirschberg, 1984). In each case migration inhibition and
lymphocyte proliferation were demonstrated, indicating that
T-cells had been exposed to and had recognised chlamydial antigen.
Lammert and Wyrick (1982), using a similar mouse lymphocyte
proliferation assay, found that responses to the T cell mitogens
concanavalin A and phytohaemagglutinin were reduced 1-2 weeks after
infection and that proliferation in response to chlamydial antigen
was suppressed. Chlamydiae-induced proliferation occurred only 4
weeks after infection, by which time mitogen responses had
returned to normal.
Treatment of guinea pigs with compounds known to be selectively
immunosuppressive has shown that CMI is not the only important
immune response to C.psittaci. When cyclophosphamide is
administered at levels which deplete humoral responses, but have no
effect on CMI, there is no resolution of disease (Modabber, Bear
and Cerny, 1976) . There is therefore cooperation between the
humoral and the cell-mediated systems, although the exact
mechanism by which this occurs is not yet known (Buzoni-Gatel et
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al, 1987; Rank et al, 1989). Two possibilities are suggested;
antibody-dependent cell cytotoxicity and opsonisation. Wyrick and
colleagues (Wyrick, Brownridge and Ivens, 1978) demonstrated that
opsonised EB were taken up and destroyed in macrophages, presumably
because they could no longer prevent phagosome-lysosome fusion,
while it has also been shown that although immune sera can transfer
immunity the effect is increased by T-cell transfer (Buzoni-Gatel,
1985) .
Immunomodulation by C.psittaci.
Of importance in any review on immunity is the consideration of
modulation of the host immune response following invasion by the
pathogen. With relevance to C.psittaci infection this may occur by
pathogen-induced cytokine release, hormonal alterations and direct
suppression of the immune system.
One such example, the restrictive effects of IFN-y, has been
discussed above. However IFN-y also has profound effects upon the
immune system, particularly leading to the expression of Class II
major histocompatibility complex (MHC class II) antigens on a
variety of cell types. It is the presence of processed peptides
from foreign antigens in association with MHC class II molecules on
cell surfaces that is recognised by T-cells and thus initiates
specific immune responses. In mice infected with C.psittaci
increased expression of MHC II antigens has been described on
macrophages (Paulnock, Huebnar, Guagliardi, Leitzke, Albrecht and
Byrne, 1986). This may well play a role in the generation of immune
responses at sites of infection.
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C.psittaci may also have a direct modulatory effect on the
immune system by inducing immunosuppression through infection of
macrophages, which are important in the presentation of antigen to
the T-cell and also important phagocytic cells. Thus, while not
killing the macrophages, chlamydial infection may alter their
ability to perform their normal functions and interfere with the
immune system on many different levels. It has also been shown that
antigen from C.psittaci can directly inhibit lymphocyte
proliferation in vitro (Lammert, 1982). This is similar to the
immunosuppressive substance recently shown to be released by
Mycobacterium leprae (Liew, 1988) .
In addition, hormones have been shown to enhance C.trachomatis
infections in many animal models (Kuo, 1988) and in EAE it seems
reasonable to suggest that hormones may stimulate the infection of
the placenta which only occurs after 90 days into gestation (Buxton
et al, 1990). Alteration in the levels of many hormones affect
many functions of the immune system and immunosuppression
associated with pregnancy is a well recognised phenomenon (Tomasi,
1983) .
AIMS :
It is clear, therefore, that little is known about the cellular
mechanisms which may be important in chlamydial immunity. In
addition our understanding of ovine immunity to C. psittaci is even
more limited. This thesis is designed to further our knowledge of
ovine cell mediated immunity to C. psittaci by investigating the
development of proliferative responses to EB after an initial
infection during gestation. In addition, T-cell lines will be
generated in order that the individual proteins from the EB which
stimulate this proliferation in vaccinated and post-abortion
animals can be examined. The importance of Y -IFN in the cell
mediated response to C. psittaci will also be investigated both in
vitro and in vivo. T cell lines will be used to determine which
individual proteins from C. psittaci stimulate the production of
Y -IFN in vitro. Finally, an in vivo model will be used to







BHK-21 growth medium: A 10X solution of BHK-21 medium (Gibco Ltd,
Paisley, Scotland) was used to prepare the growth medium. It was
prepared by adding 20 mis of lOx BHK-21 medium to 20 mis of newborn
calf serum (Gibco Ltd, Scotland), 20 mis of Tryptose, Phosphate
Broth, 4 mis of sodium bicarbonate, 0.4 ml streptomycin and 1 ml
Mycostatin. Finally this was made up to 200 mis with distilled
water.
BHK-21 maintenance medium was prepared as above except that the
newborn calf serum concentration was reduced to 2%.
BHK-21 treatment medium was prepared as the maintenance medium
above except that 20 ml of the IDU solution was added before making
up the final volume to 200 ml.
BHK-21 infection medium was prepared as the maintenance medium
above except that Chlamydial Transport Medium containing a live
inoculum of C. psittaci was added before the final volume was made
to 200 ml.
Chlamydial Transport Medium was prepared by adding 7 4.6g of
Sucrose, 0.512g of Potassium di-hydrogen orthophosphate, 1.237g of
di sodium hydrogen orthophosphate and 0.721g of L-glutamic acid to
1000 ml of distilled water. In addition, 100 ml of foetal calf
serum (Gibco Ltd, Paisley), 30 ml of mycostatin and 10 ml of
Streptomycin were added before the medium was filter sterilised and
dispensed in 4 ml amounts and stored at 4°C.
Sucrose Phosphate Glutamate was prepared by adding 75g of
Sucrose, 0.52g of Potassium di hydrogen orthophosphate, 1.22g of
Di-sodium hydrogen orthophosphate and 0.72g of glutamic acid to
1000 mis of distilled water. After membrane filtration this
solution was dispensed in 20 ml amounts and stored at 4°C.
T Cell Lines and Proliferation Assays
All T cell lines were generated by using tissue culture grown
elementary bodies of C. psittaci at a final concentration of 10
ug/ml (see page 56). In addition, while a minimum of two cell lines
were raised from each animal, all graphs in Chapters 5 and 6 are
from single T cell lines from single animals which are
representative both of others in their group and the data
discussed. All proliferation assays discussed in the thesis were
after five days of culture and used 3H thymidine with a specific
activity of 2 ci/mmol.
Preparation of Uninfected BHK-21 and ST-6 cells (see page 89)
Uninfected cells were prepared by harvesting monolayers using
glass beads to disrupt the cells. After centrifugation (7 mins,
450xg), pellets were weighed and cell suspensions were prepared at
0.001%, 0.01%, 0.1% and 1% weight/volume.
Data Handling
The results of proliferation assays discussed in this thesis are




Mean Stimulation Indices ± Standard error (as calculated by
minitab) are presneted in table of porliferative response where
animals are grouped. In these tables the symbol refers to an SI
<;1. In tables of #-IFN production in Chapter 6 this symbol refers
to production of X-IFN equal to or below background.
All statistical analysis was carried out using a students t-test on
logarithmically transformed counts per minute.
The following table is presented to clarify the calculation of SI
used in this thesis. It corresponds to the results from
conventially raised mice in table 3.10 on page 94 of the thesis.
DATA IN COUNTS PER MINUTE
MEDIUM CONTROL lug/ml 5 10 20
antigen
251 872 595 2525 2817
MOUSE 1 138 910 463 902 2731
211 411 922 1048 1652
243 495 1099 367 1327
MOUSE 2 226 242 867 851 1701
161 158 244 1007 1872
131 274 399 1741 1667
MOUSE 3 145 220 537 632 1231
176 150 494 717 1502
141 142 260 1405 757
MOUSE 4 172 193 182 702 1342
122 93 297 675 901
MEANjtSE 176±45 3 4 6±81 529±84 1047±170 1625±:




Three Dorset ewe lambs, originally born by caesarean section and
kept in gnotobiotic conditions in a positive pressure isolator, for
8wk before being transferred to a clean loose box, were used as a
source of non-infected control sheep for use in lymphocyte
transformation assays and western blot analysis.
Scottish Blackface ewes from the breeding flocks of the Moredun
Research Institute were used in all peripheral blood and T cell
line studies. They were divided into three groups;
(i) 8 sero-negative ewes were challenged with a mixture of the
S26/3 and A22 abortion strains of C.psittaci and subsequently
aborted. Four were used 6 months after abortion and four 18
months after abortion.
(ii) 3 non pregnant ewes were given one injection of a
commercial vaccine and lymphocytes were used in assays after 2-4
weeks.
(iii) 9 sero-negative pregnant ewes were left unchallenged and
were allowed to lamb normally.
b) Mice.
Inbred Balb-C and minimally inbred Porton mice were supplied
from the breeding colony maintained at the Moredun Research
Institute.
Both athymic nude (Nu/Nu) and their thymic hairy (Nu/+) litter
mates with an MF1 background were supplied by Harlan-Olac Ltd
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(Oxford, England.) and maintained under sterile conditions in
positive pressure isolators in the gnotobiotic unit at the Moredun
Research Institute. The mice were fed on irradiated food and given
distilled water and sterile litter.
BACTERIA.
a) Chlamydia psittaci.
The S26/3 isolate was derived from an outbreak of abortion in a
fully vaccinated flock in 1979. It was suggested that due to
antigenic drift the organism had managed to evade the immune
response generated by the vaccine and so it was included in the new
commercial vaccine.
b) Escherichia coli.
The X215A isolate was recovered from a sheep rectal swab at the
Moredun Research Institute, in 1990. Since the sheep was clinically
normal and the isolate was negative for the adhesin K99, it was
assumed to be non-pathogenic.
c) Salmonella tvphimurium.
The SW15/A strain, an avirulent Aro A mutant with a smooth LPS
mutation, was constructed at the Moredun Research Institute by Dr
J.Oliver.
GROWTH OF C.PSTTTACT.
The growing of C.psittaci, in eggs and in tissue culture (TC),
is described below. The TC method is that developed by Anderson
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(1984). Egg grown inoculum was used to infect all experimental
animals while in vitro assays incorporated TC grown C.psittaci to
lessen the possibility of inducing cellular proliferation due to
contaminating egg derived proteins.
a) The growth of C.psittaci in hens' eggs.
(i) Inoculation of eggs.
Six day old embryonated hens' eggs were obtained from a specific
pathogen free flock, raised on an antibiotic free diet at the
Poultry Research Centre, Roslin, Midlothian, Scotland. The eggs
were incubated overnight and candled to determine viability. At
this time the air space was marked, the eggs were numbered and the
outer shell was disinfected by washing in absolute alcohol. A 21G
1.5in needle was used to punch a hole into the air space and 0.2ml
of the inoculum was injected into the yolk sac cavity. The punched
hole was again disinfected and sealed. The eggs were then placed
on their sides in a humidified incubator at 37°C.
(ii) Harvesting the yolk sacs.
Infected eggs were candled daily and any which died up to four
days later were discarded. Embryos which died up to twelve days
after inoculation were disinfected with absolute alcohol and the
outer shell was removed from the air space. Sterile instruments
were used to cut away the shell membrane and the chorioallantoic
membrane. The contents of the egg were emptied into a petri dish
and the surrounding membranes removed. A small piece of the yolk
sac membrane was cut and placed on a precleaned slide where it was
smeared using a scalpel. The smear was air dried, heat fixed and
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stained using a Modified Ziehl Neelsen method. Smears were examined
microscopically using the xlOO oil immersion objective and only
those yolk sacs which produced smears containing several hundred
elementary bodies per field of vision were harvested. Harvesting
was completed by cutting the membrane from the embryo and allowing
excess yolk to drain away before transferring the yolk sac to a
numbered bijou before storing at -70°C.
(iii) Preparation of inoculum.
Infected yolk sacs were pooled in a plastic universal bottle and
the weight was determined before transferring into a mortar. The
yolk sacs were then ground with a pestle and sterile sand and
resuspended with an equal volume of sucrose phosphate glutamate to
give a 1:2 dilution of the original yolk sac material. This was
partially purified using centrifugation at 200g for lOmin which
caused the suspension to become separated into three layers. The
middle layer was collected and stored in 1ml amounts at -70°C.
(iv) Modified Ziehl Neelsen staining.
Air dried membrane smears were heat fixed and stained in a 10%
solution of strong carbol fuchsin (BDH Chemicals Ltd, Poole,
Dorset) for 15min. The smears were then washed in tap water and
decolourised with 1% acetic acid. They were then washed again in
tap water and counterstained with 0.8% malachite green (BDH
Chemicals Ltd, Dorset) until the smear appeared blue-green, when it
was given a final wash in tap water and blotted dry. Smears were
then examined with a light microscope, using the xlOO oil
immersion objective lens.
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b) The growth of C.psittaci in tissue culture.
(i) Seeding of flasks and TRAC bottles.
The Baby Hamster Kidney Cells (BHK-21) used in this study were a
mycoplasma free heteroploid cell line obtained from the Wellcome
Research Laboratories and were used at pass levels of between 25
2
and 35. Both the 80cm falcon flasks (Flow laboratories,
Rickmansworth, England.) and the TRAC bottles (Bibby Sterilin Ltd,
Stone, Staffordshire, England) and coverslips were seeded at a
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concentration of 1.5x10 BHK-21 cells/ml in growth medium and were
allowed to grow to confluence for 24hr at 37°C. Flasks were seeded
with 20ml of cells and coverslips with 2ml.
(ii) Treatment of BHK-21 cell monolayers.
Flasks and coverslips were placed in a sterile air hood and the
growth medium removed and replaced by an equal volume of treatment
medium containing 10% 5-iodo-2-deoxyuridine (IDU). IDU, an
analogue of thymidine, is incorporated into the DNA/RNA of BHK
cells during replication, causing faulty protein synthesis and an
increased susceptibility to chlamydial infection. After the medium
was replaced the flasks and coverslips were returned to the
incubator for 3 days at 37°C.
(iii) Infection of the monolayers with C.psittaci.
The treatment medium was decanted from the flasks and TRAC
bottles and 20ml of fresh maintenance medium, containing viable
chlamydial elementary bodies, was added. The flasks were then
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centrifuged at 2,500g at 4°C for 30min on a Coolspin. to ensure
good contact of the Chlamydia with the cell monolayer and so
optimise chlamydial infection of the cells. The flasks were then
placed in an incubator set at 37°C, for a further three days.
(iv) Harvesting of C.psittaci from cell monolayers.
The maintenance medium was again removed from the flasks under
aseptic conditions and 4ml of chlamydial transport medium was added
to each flask along with sterile glass beads. The flasks were then
shaken so that the cells were both removed from the bottom of the
flask and disrupted to free the chlamydia. The chlamydial
transport medium was then aspirated off using a pipette and stored
in a sterile bijou, at -70°C until required.
(v) Titration of C.psittaci for inoculation.
The relative strength of each aliquot of inoculum was calculated
by adding serial dilutions of each to TRAC bottles and coverslips
in triplicate as described above. The coverslips were then treated
with Giemsa's stain (BDH Chemicals Ltd, Dorset.) and the number of
inclusions present on the monolayer at the lower dilutions counted
using a light microscope. Typically inclusions were counted at
-4 -9
dilutions of between 10 and 10 , since above this the monolayer
was too badly damaged and inclusions too numerous to allow accurate
counting and below this there were too few inclusions to count.
Results were recorded as the number of inclusion forming units/ml
of inoculum.
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(vi) Giemsa staining of C.psittaci infected monolayers.
As well as being used to calculate the relative strength of each
aliquot of inoculum, TRAC bottles and coverslips were also used to
monitor the percentage of infected cells. They were infected with
2ml of the infection medium at the same time as the flasks and were
stained prior to harvesting of the flasks. The coverslips were
removed from the TRAC bottles and were placed on a rack in methanol
for 5min in order to fix the monolayer. The rack was then placed
in 2.5% Giemsa stain for 20min. The coverslips were then washed in
water to remove excess stain and dehydrated in the following series
of acetone and xylene solutions, for lOsec. (acetone, 2:1
acetone/xylene, 1:1 acetone/xylene, 1:2 acetone/xylene, xylene).
The coverslips were then mounted on glass slides with DPX (BDH Ltd)
and examined at a magnification of 400 under a light microscope.
Chlamydial inclusions stained dark purple in the blue cytoplasm of
the BHK cells.
PURIFICATION OF CHLAMYDIAL ELEMENTARY BODIES.
Both egg grown and tissue culture grown C.psittaci were purified
in the same way, using the method described by McClenaghan and
colleagues in 1984.
(i) Removal of gross cell debris.
When the elementary bodies were to be purified from the BHK cell
monolayer the harvested suspension was further disrupted by
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sonication for lmin on ice, decanted into 50ml tubes and
centrifuged for 5min at l,000g at 4°C. This low speed spin removed
the largest of the cell debris while leaving the elementary bodies
free in the supernatant.
(ii) Purification of C.psittaci over 30% urografin cushion.
Urografin (Schering Health Care Ltd, West Sussex, U.K.) is the
trade name of a mixture of sodium diatrizoate and meglumine
diatrizoate and is used to prepare cell density gradients of
varying concentrations. The urografin was supplied at a density of
370mg/ml and was diluted with 20mM Tris/50mM KC1 buffer (pH 7.4)
until the desired concentration was obtained. For the first stage
of elementary body purification this was 30%. This was then poured
into the bottom of a polypropylene tube suitable for use with the
SW28 rotor of an L8 Beckman ultracentrifuge (Beckman Instruments
Ltd, High Wycombe, England.). These tubes held 36ml and so 25ml
of supernatant was carefully layered on top of the 10ml cushion.
Each tube was then balanced to within O.Olg with Tris/KCl buffer.
The SW28 rotor and swing out buckets were removed from the cold
room and the tubes were placed inside. The rotor was placed on the
ultracentrifuge and the supernatants were centrifuged at 53,000g
for 45min at 4°C. The supernatants were discarded and the pellets
were resuspended in 1ml of sucrose phosphate glutamate and stored
at -70°C until they were required for purification through a 30-60%
density gradient.
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(iii) Purification of C.psittaci through a 30-60% density gradient.
The gradients were prepared with a Gibson minipulse 2 gradient
maker. Firstly, 10ml of each of a 30% and a 60% solution of
urografin were prepared, in 2 sterile universals. A tube was run
from the 30% solution into the 60% solution via the pump and the
former was almost allowed to enter the latter before the run was
started. Two tubes were then run from the 60% solution to
individual test tubes, suitable for use in the SW40 rotor of a
Beckman ultracentrifuge (Beckman Instruments Ltd), into which the
gradients were poured at a steady pump rate of 300 units on the
minipulse dial. The semipurified elementary bodies were removed
from the freezer and thawed on a waterbath at 37°C and carefully
layered onto the gradients. The tubes were again balanced to
within O.Olg and placed into the buckets of the SW40 rotor and
centrifuged for 120min at 53,000g at 4°C. After centrifugation two
distinct bands were seen, the upper layer a mixture of elementary
and reticulate bodies and the lower solely elementary bodies. For
the purposes of this thesis both bands were collected and washed 3
times in Tris/KCl buffer, using the SW28 buckets and rotor at a
relative centrifugal force of 53,OOOg for 45min at 4°C. The
pellets were resuspended and then frozen at -70°C after the protein
concentration had been calculated.
PREPARATION OF SOLID PHASE ANTIGEN.
Antigen that had been transferred to a solid support, usually
nitrocellulose (Bio-Rad laboratories Ltd, Watford, England), was
required to enable a more sensitive investigation of the
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proliferative responses -to individual proteins from C.psittaci.
Polyacrylamide gels were run, using the Laemmli method (1970), to
separate the chlamydial proteins before they were blotted onto
nitrocellulose by the method of Towbin and his colleagues (1979)
and prepared for proliferation assays by the method of Young and
Lamb (1986) adapted by Abou-Zeid and his co-workers (1987).
(i) Sodium dodecyl sulphate polyacrylamide gel electrophoresis.
Preparing the gel.
Chlamydial proteins were separated using the Bio-Rad mini-gel
system (Bio-Rad Laboratories, England). Glass plates were cleaned
by wiping with alcohol to precipitate any contaminating proteins
and assembled according to the manufacturers instructions. Various
concentrations of polyacrylamide gels were prepared, depending on
which proteins were required to be resolved. The resolving gel
solution was then transferred to the gel mould, formed by the
assembled glass plates, until the upper layer was approximately 1cm
from the top of the smaller glass plate. Water saturated butanol
was then layered on top to prevent an air meniscus forming. The
gel was left to set for 30-45min. The water saturated butanol was
then poured off and the stacking gel was layered on top and a
perspex comb for moulding the desired wells for the samples and the
standards was inserted. Once set the comb was removed and the
prepared gel transferred to the running tank. Electrophoresis
running buffer was added to the upper and lower reservoirs and




Samples and standards were diluted 1:2 with sample buffer and
boiled for 5min in a capped tube. Different concentrations were
added, again dependant on the eventual use of the gel (200|ig were
added for T-Cell blotting; 20(ig were added for western blotting) .
20|j.l of standards (Dalton mark VII L, Biorad) were added to the
outside wells. A constant voltage of 100V was applied across the
gel and electrophoretic separation was carried out until the dye
front was approaching the bottom of the gel. The power was then
switched off and the gel was removed from the glass plates for
staining or blotting.
Coomassie Brilliant Blue staining of separated proteins.
The resolved proteins were fixed in the gel for 2-3hr using the
fixative solution. After fixation the gel was placed in Coomassie
Brilliant Blue (BDH Chemicals Ltd, Poole, Dorset, England) for
lhr before being destained with the destain solution until the
required degree of visualisation was achieved. The destaining
process was more efficient with frequent changes of destain
solution and gentle agitation.
(ii) Immunoblot transfer of proteins to nitrocellulose.
This transfer was performed using a Bio-Rad electrophoresis
unit. A plastic grid was placed on the bench and a sponge soaked
in transfer buffer was placed on top. Next a square of blotting
paper cut to the size of the gel was soaked in transfer buffer and





placed on the filter paper before being covered with a sheet of
Bio-Rad 0.45|xm nitrocellulose membrane also soaked in transfer
buffer. Care was taken at this point to ensure that there were no
bubbles breaking the contact of the nitrocellulose with the gel. A
further sheet of blotting paper was added before a second sponge
and plastic grid completed the "sandwich" effect. The "sandwich"
was then placed into the transfer unit and covered with transfer
buffer. The proteins were transferred overnight at 30V or for at
least 3hr at 40V.
WESTERN BLOTTING.
The nitrocellulose containing the transferred proteins was
stained with ponceau red (Sigma Chemical Company, Poole, Dorset.)
for 30sec at room temperature before the dye was poured off and the
nitrocellulose was washed in running tap water until the red
stained protein bands appeared. The position of the standards were
marked as were the limits of the sample. The standard strip was
removed and the nitrocellulose was washed in PBS with 0.05% TWEEN
20 and 10% horse serum for lhr at 37°C to remove the remaining
ponceau red and to lower background colouring by acting as a
blocking agent. The nitrocellulose was cut into 4mm strips with a
scalpel blade and placed in individual sections of a blotting tray
(Bio-Rad Laboratories Ltd, England ). Test sera were diluted to
1:40 and positive serum, a pool of sera from recently aborted
ewes, was added at a dilution of 1:1000. Each serum was added to
the strips in a 2ml amount and the strips were incubated for lhr at
37°C. After 3 washes in PBS with 0.05% TWEEN 20, 2ml of horse
radish peroxidase (HRP) conjugated to a donkey anti sheep
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immunoglobulin antibody (Scottish Antibody Production Unit) was
added to each strip which were then incubated for lhr at 37°C.
After a further 3 washes the strips were placed in a dish and
covered with 3,3 diaminobenzidine (DAB) (Sigma) substrate until the
colour was sufficient to visualise the reactive proteins. The
strips were then washed in water to prevent any further enzyme
substrate reaction, placed between two sheets of blotting paper
and allowed to dry.
PREPARATION OF NITROCELLULOSE BOUND ANTIGENS FOR
PROLIFERATION ASSAYS.
(i) Visualising transferred proteins.
Transferred proteins were visualised by staining with Ponceau
Red, which is not permanent and can be removed by washing. The
nitrocellulose membrane was submerged in the stain for lmin and was
then washed in running water until the bands became visible. At
this stage the major bands were marked or cut completely from the
nitrocellulose. The standards were also marked to allow
measurement of distance travelled and the calculation of Rf values,
a measure of the distance travelled by each protein divided by it's
molecular weight, at a later date.
(ii) Dissolving the nitrocellulose.
The nitrocellulose was then placed on a large sheet of filter
paper, to support the membrane when it was to be cut. A scalpel
blade and a rule were thoroughly cleaned in alcohol and used to
measure and cut the remaining nitrocellulose membrane into 2mm
54
strips. Each strip was placed in a numbered glass bijou for
identification and 0.5ml of dimethyl sulfoxide (DMSO) (BDH
Chemicals Ltd) was added. The bijoux were then left at room
temperature for lhr to ensure all the nitrocellulose had dissolved.
(iii) Resolubilising the nitrocellulose.
After lhr, 1ml of sterile 0.05M bicarbonate buffer at pH 9.6,
also used as a coating buffer for ELISA plates to aid protein
binding, was added dropwise to the bijoux during vigourous mixing
on a vortex mixer. Time and care was taken when adding the buffer,
especially with the first few drops, since large clumps of
nitrocellulose will resolubilise if it is added too quickly. The
nitrocellulose suspension was then left for lhr at room temperature
and then transferred to sterile 1.5ml eppendorfs. DMSO was removed
from the nitrocellulose, since it is toxic to cells, by washing 3
times, in Hanks Balanced Salt Solution (HBSS) containing 5% foetal
calf serum (Sigma) 2% penicillin/streptomycin and 8% bicarbonate,
on a microcentaur at ll,000g for 7min. The nitrocellulose was then
resuspended in 1ml of Iscoves Modified Dulbecco's Medium containing
5% foetal calf serum, 2% penicillin/streptomycin, 8% bicarbonate
and 2-mercapto ethanol (IMDM) and frozen at -20°C until it was
required for use in a lymphocyte transformation assay.
PREPARATION OF LYMPHOCYTES FOR IN VITRO ASSAYS.
Lymphocytes were prepared for in vitro assays in the three ways
described below depending on the donor animal. T-cell lines were
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also developed from post abortion sheep by the method of Kurnick
and his colleagues (1979) for human T-cells and Louis and
colleagues (1982) for murine cells and adapted for sheep by Haig
and his co-workers (1990).
a) Peripheral blood lymphocytes.
Blood was collected in 20ml evacuated tubes (Becton Dickinson UK
Ltd, Oxford, England.) containing 10 units/ml of preservative
free heparin (Evans Ltd, Dunstable, England.). After thorough
mixing the blood was placed in plastic universal bottles and
centrifuged in an MSE Centaur at 450g for 30min, after which the
"buffy coat" was collected from the interface of the red blood
cells and the plasma. It was diluted 1:2 with autologous plasma to
a volume of 4ml and passed over 5ml of lymphoprep (Nycomed UK Ltd,
Birmingham, England.) in a sterile 10ml centrifuge tube at 650g for
40 min. Cells at the interface were collected and washed 3 times
at 450g for 7min in HBSS. The cells were then resuspended in IMDM
and counted, by taking 10(il of cell suspension and adding it to
10|j.l of 0.1% nigrosin and counting in an improved Neubauer (Weber
Scientific International Ltd, Teddington, Middlesex) counting
chamber. The cells were then adjusted to 2xl06/ml in IMDM.
b) Spleen cells.
Mice were killed and their spleens removed with sterile instruments
under aseptic conditions. The spleens were placed in sterile petri
dishes (Nunc Gibco Ltd, Paisley, Scotland.) and the cells were
flushed from them using HBSS in two 5ml syringes with 26G3/8in
hypodermic needles. The collected cells were then transferred to
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10ml tubes and centrifuged at 450g for 7min to pellet them. The
cells were resuspended and passed over lymphoprep, as previously
described, to remove contaminating red blood cells and washed 3
times in HBSS. The cells were then resuspended at 2xl0^cells/ml in
IMDM and used in proliferation assays as described below.
c) Mesenteric lymph node cells.
Rats were killed with CC^ gas and their mesenteric lymph nodes
were removed aseptically with sterile instruments and placed in
sterile HBSS. The nodes were transferred to sterile petri dishes
where the fat was removed before the nodes were cut into small
pieces and placed in a stomacher bag. After stomaching for lOsec
to break up the nodes and free the cells, the contents of the bag
were filtered into a 10ml centrifuge tube, to remove the gross
cell debris. The cells were pelleted as before, washed 3 times in
HBSS and resuspended to 2X106cells/ml in IMDM and used in assays
described below.
d) T-cell lines.
(i) Generation of T-cell lines.
PBL were prepared as described previously for specific antigen
driven proliferation assays. They were then adjusted to
2xl0®cells/ml in IMDM. A supraoptimal concentration of antigen
(lC|j.g/ml) was added and the cells were incubated in 2ml volumes in
24 well plates (Costar Northumbria Biologicals Ltd, Northumberland,
England.) in a humid incubator for 3-5 days. After this time the
cells were centrifuged at 450g for 7min and resuspended in 3ml of
HBSS. The resuspended cells were passed over 5ml of lymphoprep in
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a 10ml sterile centrifuge tube at 650g for 30min to remove dead
cells. Viable blast cells were seen at the interface and were
collected. These were then washed 3 times in HBSS at 450g for 7min
and resuspended in IMDM. The blasts were then counted as before in
an equal volume of 0.1% nigrosin and resuspended at a concentration
of 2xl05cells/ml in IMDM containing 15 units/ml of human
recombinant interleukin 2 (IL-2) (Biogen Ltd, Switzerland.) and
incubated for 3-5 days. Fresh IL-2 was added after 3-4 days. After
this time, washing over lymphoprep was possible if the amount of
cell debris required it and the cells were rested in IMDM without
IL-2 for 48hr. The donor animal was then bled again in order to
produce an autologous source of antigen presenting cells with which
to feed the T-cell line. PBL were prepared as before from the
collected blood and were irradiated with 4,000 rads from a caesium
source, a dose calculated to allow antigen processing by the cells,
but to prevent further cell proliferation. After washing the
irradiated cells were resuspended to a concentration of 2xl0^/ml.
Dead cells were removed from the viable blast cells as before by
passing over lymphoprep and after washing 3 times, the blasts were
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readjusted to 2x10 cells/ml. 1ml of blast cells was then added to
lml of irradiated antigen presenting cells and the total of 2ml
added to each well of a 24 well plate and incubated for a week with
a supraoptimal dose of antigen. Again IL-2 was added to expand the
blasts for 3-7 days with fresh IL-2 being added after 3-4 days.
This cycle was repeated 3-4 times to generate a homogeneous T-cell
line. Larger quantities of cells were produced when necessary by
expanding the blasts for longer in IL-2 and splitting back to
2x105/ml when required.
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(ii) Phenotypic analysis of T-cell lines.
When T-cell lines had been produced, it was necessary to
phenotype the cells in order to show that the T-cells present were
in fact CD4+ helper cells. This analysis was carried out by flow
cytometry using the fluorescence activated cell scanner (FACscan,
Becton Dickinson, Oxford, England.).
Labelling.
After 3 cycles of antigen stimulation and IL-2 expansion, and
before the cells were used in a proliferation assay 5x10^ cells
were added to each of 5 tubes and washed 3 times in Earles Balanced
Salt Solution (EBSS). The first stage antibodies were mouse
monoclonal antibodies raised against sheep leucocyte markers
(supplied by Dr M.R.Brandon, University of Melbourne.). Following
washing, the cells were pelleted and resuspended in 50(il of tissue
culture supernatant containing one of the monoclonal antibodies or
a control antibody. The tubes were then incubated for 40min at 4°C
with occasional agitation. Unbound antibody was removed by washing
3 times in EBSS. The second stage antibody, a rabbit anti mouse
immunoglobulin conjugated to fluorscein isothiocyanate (FITC)
(Dakopatts, Glostrup, Denmark), was then added as 50|j,l of a 1:50
dilution. The tubes were again incubated for 40min at 4°C with
occasional agitation. Unbound antibody was removed by further
washing in EBSS and the cells were resuspended in 0.5ml of 2%
paraformaldehyde in EBSS for fixing.
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Analysis.
The Becton Dickinson FACscan utilises an argon ion laser beam
(15mA, 488nm), through which the cells pass. Scattered light caused
by the passage of the labelled cells is then detected and converted
by the "consort 30" software package (Becton Dickinson) In this way
labelled cells were detected and counted with the result given as a
percentage of labelled cells in the counted population.
(iii) Freezing T-cell Lines.
A stock of prepared T-cell lines were frozen after expansion in
IL-2 when sufficient numbers of blast cells allowed. Cells were
pelleted at 4°C in a refrigerated centrifuge and resuspended to
2xl07cells/ml in IMDM containing 40% FCS and 10% fresh DMSO.
Working on ice, 1ml aliquots were added to cryotubes which were
immediately sealed and subjected to controlled freezing (-l°C/min).
Cells were then frozen under liquid nitrogen for storage.
(iv) Thawing of T-cell Lines.
Cryotubes containing 1ml of frozen blast cells at a
concentration of 2xl07/ml were thawed rapidly in 37°C waterbath.
Then, as the last ice crystals were melting, the cells were
transferred to a sterile centrifuge tube. IMDM containing 50% FCS
was added dropwise slowly to give a final total of 3ml and the
cells centrifuged at 450g for 7min. The cells were then
resuspended to 3ml in IMDM containing 30% FCS and centrifuged again
before finally resuspending them in IMDM containing 5% FCS. The
5
viable blasts were counted and adjusted to 2x10 cells/ml as
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described before. These were incubated in a 5% CC^ incubator with
irradiated antigen presenting cells prepared as described, a supra
optimal dose of antigen and IL-2 at 5U/ml. After one week the cell
line was continued as before beginning with expansion in IL-2.
LYMPHOCYTE PROLIFERATION ASSAYS.
These assays were used to determine the proliferative response
of lymphocytes taken from experimental animals to specific antigen
in the form of whole chlamydial EBs and non-specific mitogens of
T-cells and B-cells. The solid phase assays were based on the
technique of Lamb and Young (1986) as adapted by Abou-zeid and his
colleagues (1987).
a) Soluble antigen specific lymphocyte proliferation assays.
Peripheral blood lymphocytes prepared as described were added to
the wells of a 96 well microtitre plate (Nunc, Gibco Ltd, Paisley,
Scotland.) in 0.1ml amounts and incubated with 0.1ml of varying
concentrations of chlamydial antigen preparations in triplicate
wells. Also added were different concentrations of the B cell
mitogen, bacterial lipopolysaccharide (LPS) from Salmonella
minnesota Re (Sigma Chemical Company Ltd) and a T cell mitogen,
Concanavalin A (Con A) again at varying concentrations (Calbiochem
Ltd, La Jolla, California.) all in triplicate wells. A medium
control was incorporated by adding 0.1ml of IMDM again to
triplicate wells. Plates were incubated for 3-5 days in a humid
incubator and were pulsed for the final 18hr with tritiated
thymidine (3H) (Amersham International PLC, Amersham, England.)
which was added at a concentration of 0. 5|iC/well. The plates were
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then harvested using the Skatron system (Skatron Ltd, Suffolk,
U.K.) and the filter mats were dried before the discs were removed
and placed in scintillation vials. 1ml of scintillant was added to
each vial which was then capped. The collected vials were read on
a beta-scintillation counter (Canberra Packard) using lmin counts
and the mean counts from triplicate wells were calculated.
b) Solid phase antigen proliferation assays.
Peripheral blood lymphocytes were incubated in triplicate wells
of a 96 well microtitre plate by adding 100^.1 of a 2xl06/ml
solution as previously described. Medium, B-cell and T-cell
controls were added to the blood cells (as previously described)
and further controls, nitrocellulose only and nitrocellulose
blotted with BSA (Sigma Chemical Company Ltd, Poole, England.),
were added. 50(0.1 of resolubilised nitrocellulose bound antigen
fractions were added to triplicate wells along with 50(ol of medium.
The plates were then incubated and harvested as before.
COMPLEMENT FIXATION TEST.
The complement fixation test (CFT) used was that routinely
employed for the serological diagnosis of chlamydial infection in
sheep. The CFT is based on the complement fixing properties of heat
stable antibodies to LPS, which are produced early in a chlamydial
infection, and was developed at the Moredun Research Institute
(Stamp et al, 1951). Briefly, the test relies on the ability of the
anti-LPS antibody binding the chlamydial antigen and fixing
complement. Therefore if there is no antibody present no
complement is fixed and the red blood cells are lysed. If antibody
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is present the complement is fixed and no lysis occurs. The test
was carried out in round bottomed, 96 well microtitre plates.
Serum samples were heat inactivated at 56°C for lhr and were then
diluted 1:8 in complement fixation buffer (CFT buffer). 25[il of
CFT buffer was added to all rows of the plate except the top row A,
then, 2 5p.l of each heat inactivated sample was added to the top
two rows of a column and the final well of the column. After
mixing, 251 from row B was transferred to row C and again
thoroughly mixed. This process was repeated to dilute each test
sample from 1:8 in row A to 1:512 in row G. Standard sera pooled
from positive and negative ewes were also added to columns and
treated in the same way as the test sera. Batches of chlamydial
antigen, grown in yolk sacs, were standardised before being added
in 25|j.l volumes to all wells, except the bottom row of each column.
This row was used as a control for the serum to ensure that it was
not fixing complement in a non-specific way. Guinea pig complement
(Wellcome research laboratories, England) was diluted in CFT
buffer, to a standard dilution pre-titrated, when required. It
was kept on ice ar4 25|il was added to all wells on the plate. A
complement control was added to the final column on the plate.
This involved a serial dilution of complement from row A to row H
in the same way as the test serum was diluted, to ensure that the
standard dilution of complement used was correct and did not cause
non specific lysis of the cells. CFT buffer was added to each well
in this column to replace the serum and the antigen. The plates
were then stored overnight at 4°C. The next day the plates were
incubated for 30min at 37°C while sensitised red blood cells were
prepared. Briefly, sheep red blood cells, stored at 4°C in
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Alseviers solution, were diluted to 4% v/v and mixed 1:2 with
haemolytic serum. The cells were placed in a water bath and mixed
frequently to ensure maximum sensitisation over a 30 min period.
When sensitised, 25|0.1 of the red blood cell mixture was added to
each well of the plate, which was then shaken to thoroughly mix
the complement, antigen and serum with the blood cells. The plate
was then placed in an incubator for 15min at 37°C, after which
time it was shaken again and replaced in the incubator for a
further 15min. When finally removed from the incubator the plate
was shaken once more and the contents were left to settle on the
work bench for 2hr at room temperature. After first checking the
results of the incorporated controls the plates were ready to be
read and the titres of the test samples calculated. A full pellet
with no lysis was scored as a 4 for that dilution, and no pellet




These assays are based on the anti-viral effects of the
interferons (IFN) in protecting normal fibroblasts from infection.
The target cells selected depended on the species of interferon
that was being investigated. The virus used was Semliki Forest
Virus (SFV), which has a wide host range and also has the advantage




Assays for murine interferon were carried out using the murine
L929 fibroblast cell line, as target cells. Ovine interferons
were investigated using ST-6 cells, originally cultured from an
ovine adenocarcinoma of the small intestine, as target cells.
(ii) Assay protocol.
The target cells were plated out in flat bottomed, 96well
microtitre plates (Costar, Northumbria Biologicals Ltd,
Northumberland, England.). Cell densities differed between assays,
3
5x10 cells/well in 100^.1 of growth medium (IMDM supplemented with
3
5% serum) for ST-6 cells and 2.5x10 cells/well in 100)1.1 of medium
for L929 cells. The lower density used in the latter case was
necessary, because it was found that if the L929 cells were
allowed to become confluent they were unaffected by the addition of
the virus and showed no cytopathic effect (CPE). After 24hr, in a
humid incubator, the test samples were serially diluted in
serumless medium, so that any interferon present would be titrated
and a final titre of interferon units/ml calculated. These samples
were added to duplicate, triplicate or quadruplicate wells of the
96 well plate in 100|il volumes. Following a further 24hr
incubation, the medium was removed from the plate and replaced with
200|il of medium supplemented with 2% FCS and containing SFV
(supplied by Dr A.G.Morris, University of Warwick). The SFV had
been titrated on ST-6 cells and stored at -70°C as a stock solution
5
of 10 tissue culture infectious doses (TCID) and was used in the
2
assay at 10 TCID^q. The plate was replaced in the incubator for
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48hr when the degree of CPE was read, using an inverted
microscope. Titres were given as the inverse of the lowest dilution
which reduced the CPE by 50%. A positive control was incorporated
by the addition of various titrated dilutions of recombinant human
a-interferon (supplied by Dr M.Scott, Wellcome Laboratories,
Beckenham, Kent) to the cells. This interferon was known to be
protective to the ST-6 cells to a level of lU/ml in ovine assays.
Recombinant murine y-interferon, produced in the supernatant of
transfected Chinese hamster ovary cells (supplied by Dr A.G.Morris,
University of Warwick.) was used for the same purpose in murine
assays. Both controls also served to standardise results between
assays performed at different times.
b) y-Interferon neutralisation assays.
In order to determine whether the interferon present in the test
sample was in fact y-IFN or was a/P IFN it was necessary to first
of all incubate the test samples for 3hr at room temperature (RT)
with a monoclonal antibody known to neutralise the activity of
y-IFN, after which the assay was carried out as before. A rat IgG
monoclonal antibody, was used to neutralise murine y-IFN and a
murine monoclonal IFN 9 (supplied by Dr P.R.Wood, Parkville,
Australia ), originally raised against bovine y-IFN but which was
shown to cross react with and neutralise ovine y-IFN, was used in
ovine assays. A random monoclonal antibody was added as a control
and the difference between the titres of the respective samples was
taken as being due to y-IFN.
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ASCITES PRODUCTION.
High titre murine y-IFN neutralising antibody was produced in
the form of ascitic fluid from the cell line R46A2 (supplied by Dr
A.Mowatt, University of Glasgow.). Athymic nude mice were kept in
aseptic conditions in a positive pressure isolator and were primed
with an intraperitoneal injection of pristane (Sigma Chemical
Company Ltd), an immunosuppressant. 7 days later this was followed
by an injection of 5xl0^cells intraperitoneally to each mouse. As
tumours developed the ascitic fluid produced was drained, using a
23G 3/8in hypodermic needle, collected in 10ml centrifuge tubes
and clarified by centrifugation at 450g for 15min. This removed
gross cell debris. The titre of the pooled ascitic fluid was
calculated against a known level of y-IFN activity, aliquoted and
stored at -20°C.
MICROSCOPIC EXAMINATION OF TISSUES.
Small blocks of tissue were cut and were fixed for 2-4hr in cold
modified bouin (Finlayson, Buxton, Anderson and Donald, 1985),
before being processed by the St Marie method at 4°C. Briefly,
this involved leaving the tissue in 70% ethanol overnight before
dehydrating through alcohols. The tissue was then rinsed in a 2:1
alcohol/xylene solution and then a 1:2 alcohol/xylene solution for
lOmin and finally washed 3 times in xylene for 20min each time
before embedding in paraffin wax. Sections 4|Jm thick were cut and
placed on poly-L-lysine coated slides and dried overnight at 37°C
and stained with haemotoxylin and eosin (Stevens, 1977).
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IMMUNOPEROXIDASE STAINING.
The immunoperoxidase method described below was a direct
staining method which employed the IgG fraction of pooled ovine
hyperimmune antisera against the A22 abortion strain, directly
conjugated to the marker enzyme HRP (Finlayson et al, 1985).
Tissues were fixed and processed using the St Marie method
described above. Sections 4|im thick were cut and dewaxed in
xylene, rinsed in alcohol and endogenous peroxidase blocked with
1% ^O^/methanol for 30min. The slides were rinsed twice, in PBS
containing 2% egg albumin for lOmin to reduce non-specific binding
of the antibody. The conjugated antiserum was diluted 1:10 with a
solution of 1% BSA in PBS, was layered onto the section and left
in a humidity chamber at RT for 90min. Sections were then rinsed in
PBS/2% egg albumin, washed twice in Tris/HCl buffer (pH 7.6), and
substrate, 4|j.g of DAB in 10ml Tris/HCL, added for lOmin at RT
before being dehydrated through alcohol and mounted in xylene with
DPX.
IN SITU HYBRIDISATION.
This method utilises the ability of DNA and RNA to bind to
complementary strands of DNA and RNA. In the method used in this
thesis an RNA probe was used to detect strands of chlamydial RNA.
For in situ hybridisation tissues were fixed in 4% paraformaldehyde
rather than cold bouin as previously stated.
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(i) Preparation of slides.
The slides were prepared by the method of Tourtellotte and his
co-workers (Tourtellotte, Verity, Schmid, Martinez and Shapshak,
1987). Briefly, slides were washed in IN HCL for 20min and then
soaked in tap water for l-2hr, rinsed in absolute alcohol and wiped
dry. When dry, the slides were placed in a solution of Denhardts in
0.15% Standard Saline Citrate (SSC), allowed to incubate overnight
at RT and fixed in a solution of 3:1 ethanol/acetic acid for 20min
again at RT. The slides were then acetylated by exposing them to a
solution of triethanolamine (pH 8.0) and acetic anhydride, and
agitating gently for lOmin. After dehydrating through alcohols the
slides incubated overnight at 70°C in a 1% (v/v) solution of the
organosilane y-aminopropyltriethoxysilane, which covalently bonds
the section to the slide without affecting the specificity or
sensitivity of the hybridisation. The next day they were washed in
tap water and baked overnight at 100°C. At this stage the slides
could be stored in dust free boxes for up to 6 months at RT. When
required the slides were activated by first rinsing in a 10%
gluteraldehyde in PBS solution (pH 7.0) for 30min at RT. Then the
slides were stabilised in a 0.1% sodium periodate solution for
15min and rinsed in PBS. Activated slides could be stored at RT
for 2 weeks.
(ii) Preparation of coverslips.
Coverslips were first cleaned in 1M HCL for 30min and rinsed in
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distilled water. After washing in 95% alcohol for 30min the
coverslips were dried on gauze and immersed in sigmacote (Sigma
Chemical Company) and again dried on gauze. They were then baked
for 2hr at 180°C in a covered glass dish.
(iii) Preparation of sections.
Sections 6jxm thick were cut from tissue blocks, processed by the
St Marie method described above, mounted on the prepared slides
using poly-L-lysine and dried overnight at 37°C. The sections were
dewaxed in xylene which in turn was removed by washing in alcohol
and the sections were air dried. They were then washed in graded
alcohols, rinsed 3 times in PBS and placed in a 2x SSC solution for
lOmin.
(iv) Staining.
The prepared sections were incubated in pre-hybridisation buffer
for 2hr at RT. In order to save reagents sections were not immersed
in the buffer instead 300(il of buffer was layered on each section.
Similarly, only 30|i.l of hybridisation buffer containing the probe
conjugated to digoxigenin was added to to the sections, which were
mounted with the prepared coverslips and then incubated overnight
at 42°C. The sections were then washed in 2x SSC for lhr and then
in lxSSC for lhr. At this stage RNase was added to remove any
unhybridised, conjugated probe in order to lessen the background
staining. This was carried out for 30min at 37°C. The RNase was
removed when the sections were rinsed in 0.5xSSC for 30min at RT.
The sections were stained by placing them in a lOOmM Tris/HCL 150mM
sodium chloride buffer (pH 7.5) (buffer 1) for lmin and then
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immersing them in buffer 1 containing 2% normal sheep serum and
0.3% Triton X-100 for 30min. The detecting antibody was an
anti-digoxigenin antibody conjugated to alkaline phosphatase
diluted 1:500 in buffer 1, containing 1% normal sheep serum and
0.3% Triton X-100 and 100|il was layered onto the sections which
were incubated overnight at 4°C. The following day the sections
were placed in buffer 1 containing 1.5% (W/V) levamisole for lOmin
after which the buffer was replaced with a lOOmM Tris/HCL lOOmM
sodium chloride 50mM magnesium chloride solution (buffer 2)
containing 1.5% (W/V) levamisole for lOmin. The colour was
developed with a phosphatase substrate made in buffer 2 and 500|j.l
were layered on each section for 2-4hr. Colour development was
stopped with a solution of lOmM Tris/HCL ImM EDTA pH 8.0. Finally
the sections were counterstained in 0.25% light green in 70%
alcohol, dehydrated and mounted in DPX.
MEDIA AND SOLUTIONS.
These media and solutions were used in all the methods described
above unless otherwise stated.
a) Growth of C.psittacl.
Tryptose. phosphate broth (TPB) was prepared by dissolving 29.5g
of powdered medium (Difco Laboratories Ltd, Surrey, England.) in
500ml of distilled water and making the resultant solution up to
1000ml. The solution was dispensed in 20ml amounts and autoclaved.
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Sodium bicarbonate solution was prepared by dissolving 80g of
sodium bicarbonate (BDH Ltd) in 995ml of distilled water and adding
5ml of 0.4% phenol red as an indicator. This solution was
sterilised by membrane filtration.
5-iodo-2-deoxyuridine (IDU) powder (Sigma) was dissolved in
200ml of BHK-21 maintenance medium to give a final concentration of
800(ig/ml and then filter sterilised.
Streptomycin. One vial of streptomycin sulphate (Evans medical
Ltd, Greenford, England.) was dissolved in 10ml of HBSS, giving a
final concentration of 100, 000|ig/ml.
Gentimycin was supplied by Nicholas Laboratories (Slough,
England.) in the form of gentimycin sulphate in lg vials, which
were then dissolved in 100ml of distilled water to give a
concentration of 10 , 000(j.g/ml.
Mycostatin was obtained from E.R.Squibb and sons (Hounslow,
England.). The contents of a lg vial was resuspended in 100ml of
distilled water, to give a final concentration of 5000 units/ml.
BHK-21 maintenance medium was prepared as described appendix 1
except that the newborn calf serum concentration was reduced to 2%.
BHK-21 treatment medium prepared as for the maintenance medium
above except that 20ml of the IDU solution was added before making
up the final volume to 200ml.
BHK-21 infection medium was prepared as for the maintenance
medium except that CTM containing live inoculum was added before
the final volume was made.
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b) Purification of chlamydial elementary bodies.
2OmM Tris 5 0mM KC1. 1.21g of Tris(hydroxymethyl) amino methane
(BDH Ltd) and 7.26g of KC1 (BDH Ltd) was dissolved in 400ml of
distilled water and the pH was then adjusted to 7.4 with
concentrated HC1. The volume was then made up to 500ml.
Urografin. A 30% urografin cushion was prepared by adding 8.76g
of urografin (Schering) to 14g of Tris/KCl to give a final volume
of 20ml. A solution of 60% urografin for the density gradient was
prepared by adding 17.52g of urografin to 8g of Tris/KCl buffer to
produce 20ml.
c) Preparation of solid phase antigen.
Acrylamide. A solution of 30% acrylamide was prepared by
dissolving 29.2g of acrylamide (Bio-Rad laboratories, Watford,
England.) and 0.8g of N'N' methylene bis acrylamide (Bio-Rad
laboratories) in 80ml of distilled water. When fully dissolved the
solution was adjusted to 100ml.
As acrylamide is a potent neurotoxin great care was taken when
handling it. Gloves were worn at all times.
Tris buffer. A 1.0M solution of Tris was prepared by dissolving
12.lg of Tris in 80ml of distilled water. The pH was adjusted to
6.8 with concentrated HC1 and the final volume adjusted to 100ml
with distilled water. A 1.5M Tris buffer was prepared by adding
18.2g of Tris to distilled water as before. After dissolving the
pH was adjusted to 8.8 with concentrated HC1 and the volume was
corrected to 100ml.
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Sample buffer. 20g of glycerol (BDH Ltd), 4g of sodium dodecyl
sulphate (SDS) (BDH Ltd) and 2mg of bromophenol blue (BDH Ltd) were
i
added to 25ml of 1M Tris pH 6.8 and 5ml of mercaptoethanol (BDH
Ltd). The pH was adjusted with concentrated HC1 and distilled water
was added to give a final volume of 100ml.
Running buffer was prepared in 51itre volumes by adding 5g of
SDS and 72g of Glycine (BDH Ltd) to 51itre of distilled water. The
pH of this solution was approximately 8.2.
Immunoblot Transfer Buffer. Proteins were transferred from the
gel to the 0.45|im nitrocellulose membrane (Bio-Rad laboratories)
using an immunoblot transfer buffer prepared by dissolving 2.9g of
Tris and 14.5g of glycine in 200ml of methanol before making the
final volume up to 1000ml by adding distilled water.
d) Complement Fixation Test (CFT).
CFT buffer was obtained from Oxoid in tablet form. A tablet was
dissolved in 1000ml of PBS.
Sheep red blood eel 1s were collected in a 3.7% sodium citrate
solution to prevent clotting. They were washed in PBS and stored
in Alseviers solution.
Complement was obtained freeze dried from the Wellcome
Foundation, Beckenham, Kent England. Each vial was reconstituted
in distilled water before being stored immediately at -70°C.
Haemolysin in the form of rabbit haemolytic serum for sheep red
blood cells was also obtained from the Wellcome Foundation. It was
stored at 4°C.
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e) Microscopic examination of tissues.
Scott' s tap water substitnt.fi was made up from llitre of
distilled water 3.5g of sodium bicarbonate and 20g of magnesium
sulphate.
Mayer's haemotoxylin was lg of haemotoxylin, 0.2g of sodium
iodate and 50g of potassium alum which were dissolved overnight in
llitre of distilled water. The next day 50g of chloral hydrate and
lg of citric acid was added and the solution was boiled for 5min
and allowed to cool before being filtered.
Eosin was prepared by dissolving 4g of eosin yellowish in 20ml
of alcohol and making up to 400ml with distilled water.
f) In situ hybridisation.
5Ox Denhardts is a solution of 1% Ficoll, 1%
polyvinylpyrrolidine, 1% BSA in distilled water.
The acetylatlon solution was 350ml of a 0.1% triethanolamine
(18.6g/l) in distilled water (pH 8.0) and 0.88ml (0.25% v/v) of
acetic anhydride.
Pre-hybridisat 1 on buffer was prepared in 2.5ml amounts to save




Herring sperm DNA (lOmg/ml) 0.125ml
Yeast tRNA (lOmg/ml) 0.0625ml
Dextran sulphate (50% W/V) 0.5ml
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The hybridisation buffer differed from the pre-hybridisation
buffer in that l(og of probe was diluted in 10(il of lOmM Tris/lmM
EDTA/ 600mM Sodium chloride. This solution was diluted 1:200 in the
pre-hybridisation buffer.
RNase was added as a l|og/ml solution in lx SSC with 500mM Sodium
chloride and lOmM Tris (pH 7.5).
Buffer 1 was prepared by dissolving 12.lg of Tris and 8.76g of
sodium chloride in 1000ml of distilled water (pH 7.5).
Buffer 2 was again 12.lg of Tris with 5.8g sodium chloride and
10.16g of magnesium chloride dissolved in 1000ml of distilled
water.
The buffer 3 used to stop the colour development was a solution
of 1.21g of Tris and 67mg of EDTA dissolved in 200ml of distilled
water (pH 8.0).
The alkaline phosphatase substrate was prepared by adding 45(0.1
of NBT solution (Boerhinger Mannheim) , 35jol of x-phosphatase




THE PROLIFERATIVE RESPONSES OF OVINE PERIPHERAL BLOOD




After chlamydial abortion sheep are considered to be solidly
immune and do not abort again (Stamp et al, 1950) . Cell mediated
mechanisms have been implicated in immunity to C.psittaci (Ramsey
et al, 1988; Rank et al, 1989). In other studies delayed type
hypersensitivity reactions (DTH) have been used as a measure of
cell mediated immune (CMI) responses to C.psittaci in sheep
(Wilsmore et al, 1984; Wilsmore et al, 1986; Dawson et al,
1986). Another method of assessing CMI is to measure antigen
stimulated proliferation of lymphocytes in previously infected
animals. In order to achieve the aims of this thesis by
investigating the ovine cell mediated response to C.psittaci, it
was first of all necessary to look for specific proliferation in
response to the extracellular EB of C.psittaci in the peripheral
blood mononuclear cells (PBMC) of animals which had been infected
and which subsequently aborted. As well as measuring CMI by
lymphocyte proliferation to C.psittaci antigen , a second aim of
the study outlined below was to determine the optimum conditions
for the in vitro proliferation assay which was to be used and to
investigate the concentrations of mitogens and antigen which would
give optimum responses in the assay. This should allow a
measurement of the degree of reactivity to chlamydial antigen
within a population of infected sheep.
Experimgntal procedure.
PBMC were collected in vacutainers containing preservative-free
heparin from 6 blackface ewes. Group 1 contained 3 ewes which had
been infected with C.psittaci and had aborted in the previous
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lambing season and group 2 contained 3 ewes, sero-negative for
C.psittaci by CFT, which had been obtained from a farm known to
have been free from chlamydial abortion for the previous three
years (see table 3.1). The PBMC were used in an in vitro
proliferation assay and were stimulated with various doses of Con
A, LPS and a purified preparation of EBs grown in BHK-21 cells.
Concentrations ranged from 0.5/ig/ml-10jUg/ml for Con A,
1/ig/ml-100)1g/ml for LPS and 1/ig/ml-lOOjUg/ml for the EBs.
Table 3.1: Experimental design for the determination of the optimum
conditions for in vitro proliferation assays.
Group (n) Sero-converted Aborted PBMC
13+ + +
2 3 - +
Results.
All concentrations of antigen and mitogen quoted in the results
section are the final concentrations in the wells of the 96 well
plates.
PBMC responses to LPS.
There was no significant difference in the level of response the
cells from the animals, in both the uninfected and the post
abortion groups gave, when stimulated by LPS, in the dose range
tested (see table 3.2, figure 3.1). The peak response was given by
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a final concentration of lOOjUg/ml, which was the highest
concentration tested. For the purpose of this thesis the optimum
concentration was considered to be 20/ig/ml, which gave Sis of 10
and 9 in groups 1 and 2 respectively.
Table 3.2: Proliferative response to LPS of the peripheral blood
mononuclear cells from group 1 post abortion ewes and
group 2 uninfected ewes. Results expressed as Sl+se.
Background counts per minute (cpm) ranged between
683+132 and 1239±150.
Response to LPS (fJLg/ml)
Group 1 5 10 20 40 60
1 1±0 3±.5 6±la 10±2a 9±la 12±2a
2 - 2±.5 4±la 9±la 10±2a 12±3a
P<0.05 when compared with medium controls.
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.1: Proliferative response to LPS of the peripheral blood
mononuclear cells from group 1 post abortion ewes (+-+)
and group 2 uninfected ewes (o-o).
1 5 10 20 40 60
Cone (ug/ml)
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PBMC responses to Cori A.
The PBMC from both groups 1 and 2 were stimulated by Con A in
the dose range that was tested (see table 3.3, figure 3.2). The
response peaked at a final concentration in the well of 5jUg/ml in
both groups and the magnitude of the proliferation was the same in
both groups at all concentrations tested. The peak response gave a
stimulation index (SI) of 60 in group 1 and 65 in group 2 and for
the purposes of this thesis this was considered the optimum dose.
Table 3.3: Proliferative response to Con A of peripheral blood
mononuclear cells from group 1 post abortion ewes and
group 2 uninfected ewes. Results expressed as
Stimulation Index (SI) + standard error (se).
Response to Con A (/Ig/ml)
Group 1.25 2.5 5 10 15
1 25±3a 35±2a 65±5.5a 40±3.5a 23±3a
2 24±2a 38±3a 60±4a 38±2a 21±3a
P<0.05 when compared with medium controls.
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3.2: Proliferative response to Con A of peripheral blood
mononuclear cells from group 1 post abortion ewes ( + -+)
and group 2 uninfected ewes (o-o).
83
PBMC response to EBs.
At the lower concentrations of purified EBs (<40jUg/ml),
lymphocytes from both groups of animals gave responses which were
significantly above background (P<0.05) (see table 3.4, figure
3.3). A concentration of 20/ig/ml stimulated the peak response, with
cells from group 1 giving a SI of 24 and cells from group 2 giving
a lower, but still significant SI of 13. At concentrations
greater than this level there was little or no response in either
group.
Table 3.4: Proliferative response to chlamydial elementary bodies
of the peripheral blood mononuclear cells from group 1
post abortion ewes (+-+) and group 2 uninfected ewes
(o-o).
Response to chlamydial EBs (Hg/ml)
Group 1 5 10 20 40 60
1 4±1 10±2a 17±2a 24±3a 8±1.5a
2 2±.5 7±2a ll±2a 13±2a 8±la
a
P<0.05 when compared with medium controls.
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3.3: Proliferative response to chlamydial elementary bodies
of the peripheral blood mononuclear cells of group 1







The stimulation of the PBMC by LPS and Con A mitogens was
similar in both uninfected and post abortion ewes. The optimum
concentration for each mitogen was the same for each group of sheep
and the level of the response at this dose did not differ
between the groups.
The PBMC from post abortion animals gave a strong proliferative
response to EBs, whereas the cells from uninfected animals were
less reactive. The PBMC used in the assay were collected
approximately 6 months after the animals had aborted, showing that
the cell mediated proliferative responses induced by infection with
C.psittaci are long lasting. Whether this effect is due to a memory
T-cell population or is brought about by the immune system
constantly being boosted by a low level persistant infection, or a
Chlamydia infected environment is not clear. There is no recorded
evidence for a persistant infection continuing in sheep after
abortion, but this may be due to the difficulty of isolating
C.psittaci at this stage, rather than being because persistance
does not occur. It is known that Chlamydia can lie dormant from one
lambing season to the next (Stamp et al, 1950) and that it is
seldom isolated from sheep even days after infection (Huang et al,
1990). However, reisolation has been achieved after abortion in
goats (Brown et al, 1989).
The PBMC from the control sheep also mounted a proliferative
response to the EB antigen preparation, which although lower than
post abortion PBMC responses was still significantly above medium
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control background levels. It is unclear whether this is due to a
mitogenic effect of chlamydial LPS, known to be contained in the EB
preparation, or whether it is the result of a cross reaction, since
C .psittaci is known to cross react serologically with other enteric
bacteria such as Salmonella (Nurminen et al, 1984). Reactions to
inoculum components are unlikely to have been a problem, since the
inoculum used for in vivo challenge was grown in egg yolk sacs and
the purified EBs used in the in vitro proliferation assay were
tissue culture grown.
Further study is required to examine this question of cross
reaction in greater detail and also to determine why there was a
virtual absence of proliferation in response to EBs at
concentrations above 20p.g/ml. One possibility is that it was due to
a toxic component in the preparation, since the antigen
preparation also contains BHK-21 cell debris and possibly traces of
the gradient medium, Urografin.
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Chapter 3b:
THE PROLIFERATIVE RESPONSES OF OVINE PERIPHERAL BLOOD




In the preceding experiments, two apparent problems arose with
the preparation of EBs used as a specific stimulus for the in vitro
lymphocyte transformation assays employed in this work. The first
was the reduced responsiveness of the cells stimulated by the
higher concentrations of EBs and the second was the unforseen
proliferation of naive cells from uninfected sheep which, although
it was at a lower level than that of the primed cells, was
significantly above the background response. In the first instance
it was decided to investigate whether the antigen preparation was
toxic for living cells. Secondly, an investigation was undertaken
to determine whether the EB preparation used was inducing a
non-specific proliferation in naive cells, by acting as a mitogen,
or if the response seen was due to a cross reaction between the EBs
and other antigens, probably bacterial, that the animals had been
exposed to.
Experimsnhal Procedure■
Experiment 1:1s there a toxic component in the EB preparation ?
PBMC from the post abortion animals and the uninfected animals
used previously were collected and set up in duplicate, in vitro
lymphocyte transformation assays. The cells were stimulated with
various concentrations of the individual components of the purified
EB preparation grown in BHK-21 cells, including uninfected BHK-21
cells and Urografin, and a control EB preparation grown in ST-6
cells, a sheep fibroblast cell line (Norval et al, 1981) . One of
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the duplicate assays was treated as a transformation assay and was
harvested and read as normal. The cells from the other assay were
removed at day 5 and were counted (see table 3.5). Nigrosine was
used to assess cell viability.
Table 3.5: Design of experiment to determine the toxic factor
present in the chlamydial elementary body (EBs)
preparation.
PBMC tested against PBMC tested for
Cell viability % Proliferation
BHK-21/EB + +
ST-6 /EB + +
BHK-21 only + +
ST-6 only + +
Urografin + +
Experiment 2a: Is the EB preparation mitogenic or is there cross
reaction with other bacteria ?
In order to determine whether or not C.psittaci has non-specific
mitogenic properties for PBMC, 8 Wistar rats and 8 Balb-C mice
were used (see table 3.6). Group 1 contained 4 rats and 4 mice
which were raised conventionally while group 2 contained 4 rats and
4 mice raised in a positive pressure isolator and were given
distilled water and irradiated food and bedding. Neither group
recognised chlamydial antigen as determined by CFT. At 8 weeks old
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the mice and the rats were killed and the spleens of the mice and
the mesenteric lymph nodes of the rats were aseptically removed.
Single cell preparations of these tissues were set up in an in
vitro proliferation assay and stimulated as before with Con A, LPS
and EBs from the S26/3 strain of C.psittaci.
Table 3.6: Design for experiment to determine whether the EB
preparation is a mitogen or whether there is cross
reactivity with other enteric bacteria.
Group Species (n) Housed Infection Cells used
la Mouse 4 Conventional3 0Uninfected Spleen
lb Rat 4 tt tt Lymph node
2a Mouse 4 Isolator^ tt Spleen
2b Rat 4 tt tt Lymph node
3 Mouse 4 tt C.psittaci^ Spleen
4 It 4 S,.typhimuriume tt
5 tt 4 tt E.coli^ II
0
conventional small animal cages. C.psittaci given i.p.
cages placed in positive pressure ^ S. typhimurium given i.p.
0
isolator. E.coli given i.p.
Experiment 3: What are the possible sources of a cross reaction ?
Possible sources of the cross reaction were investigated using
12 Balb-C mice. Group 3 contained 4 mice, which were raised in a
positive pressure isolator in the same way as group 1 above, but
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these mice were infected with 10 inclusion forming units of
C.psittaci at 4 weeks old. Group 4 again contained 4 mice raised
7
in an isolater, but were infected with 10 avirulent
S.typhimurium. A further 4 mice, group 5, were also raised in an
7
isolator, but were infected at 4 weeks with 10 avirulent E.coli
(see table 3.6). Again, after four weeks the mice were killed,
their spleens were removed aseptically and single cell suspensions
were prepared and used to set up a proliferation assay. As well as
stimulation with Con A and LPS the cells were also given a
homologous challenge with the bacteria they had been infected with
and a heterologous challenge with the other two bacteria, all at
concentrations of 1, 5, 10 and 20|j,g/ml.
Results.
Toxicity.
At higher concentrations of EB (40|ig/ml) , whether grown in
BHK-21 cells or in ST-6 cells, proliferative responses were
significantly diminished (p<0.05) when compared to those of lower
doses. However, proliferation was significantly higher (P<0.05) and
the percentage viability of the stimulated lymphocytes was greater
in ST-6 grown EB preparations, than in BHK-21 grown EBs, when used
at this concentration (see table 3.7). There was no significant
difference between the preparations at any other concentration
tested (P>0.05). The proliferation induced in response to the
non-EB, cellular components of the preparations and to Urografin
was negligible with a SI of 1 and this was not significantly above
background (P>0.05).
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The percentage viability of the cells cultured with the higher
concentrations of both ST-6 and BHK-21 EB preparations and the
cells stimulated by preparations of uninfected BHK-21 cells and
ST-6 cells could not be calculated, since there were few live
cells present and most fields under the microscope contained a
large amount of cell debris (see table 3.8). The cell debris was
present in the 1:10 and the 1:100 dilution of the uninfected BHK-21
cells, however in the ST-6 cells it was only present in the 1:10
dilution and a viability of 30% was recorded at the 1:100 dilution.
The viability of cells cultured with Urografin, LPS and Con A
remained constant for all dilutions and was between 75% and 85%.
These findings are summarised in table 3.9.
Table 3.7: Proliferative response of peripheral blood mononuclear
cells (PBMC) when stimulated by individual components
of the EB preparation (SI). Background cpm ranged
between 203+21 and 301+25.
Component Concentration
5/Xg/ml 10 20 40 60
BHK-21+EB 3±1 7±la ll±2a 4±.5a -
ST-6 +EB z i 3. 0 - cl4+1 8+1 12±la 8±la -
0.001%(w/v) 0.01% 0.1% 1%
BHK-21 only - - - -
ST-6 only - - - -
0.001%(v/v) 0.01% 0.1% 1%
Urografin - - - -
P<0.05 when compared with medium control cpm.
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Table 3.8: Cell viability (%) of PBMC when stimulated by individual
components of the EB preparation.
Component Concentration
5/ig/ml 10 20 40 60
BHK-21+EB 70 65 40 cd cd
ST-6 +EB 75 70 55 30 cd
0.. 001%(w/v) 0.01% 0.1% 1%
BHK-21 only 55 40 cd cd
ST-6 only 75 50 30 cd
0..001%(v/v) 0.01% 0.1% 1%
Urografin 70 75 70 70
cd: cell debris
Table 3.9: Summary of the toxicity and the proliferation induced by








Mitogenicitv vs high dose suppression.
The cells of the mice and rats of group 1, which had been raised
conventionally, all responded to Con A and LPS (P<0.05) with SI of
78 and 30 respectively. Mouse spleen cells also responded to EBs
with a SI of 6, as did the rat lymph node cells with a SI of 9
(p<0.05) when compared with medium controls. However, the cells
from the mice and rats in group 2, which were raised under aseptic
conditions in a positive pressure isolator, while responding to
Con A and LPS (P<0.05) did not respond to the EB preparation (see
tables 3.10 and 3.11, figures 3.4 and 3.5). The responses of the
cells in this group treated with the mitogens Con A and LPS were
similar to those of their conventionally raised litter mates in
group 1 (P>0.05). The response to the EB preparation in both mice
and rats in group 2 did not rise above a SI of 1.
Table 3.10: Proliferative response to EBs of the mesenteric lymph
node cells of rats raised conventionally and raised in
isolators expressed as stimulation index (SI)+se
Housed Conc(/ig/ml)
1 5 10 20
Conventional 2+.5 3+.5 6+l& 9+la
Isolator - - - -
P<0.05 when compared with medium control cpm.
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Table 3.11: Proliferative response to EBs of the spleen cells of
mice raised conventionally and raised in isolators
expressed as Sl+se
Housed Conc(/ig/ml)
1 5 10 20
Conventional 2+.5 3+1 4+la 7+la
Isolator - - -
P<0.05 when compared with medium control cpm.
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.4 : Proliferative response to EBs of the mesenteric lymph
node cells of rats raised conventionally (+-+) and







1 5 10 20
Cone (log Kg/ml)
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Fig 3.5 : Proliferative response to EBs of the spleen cells of
















In the third experiment the spleen cells from the mice in all
three groups gave a proliferative response when given a homologous
challenge in vitro. The peak response to C.psittaci in the
chlamydia infected group 3 was a SI of 27 (P<0.05) (see table 3.12,
figure 3.6), in group 4, the Salmonella infected mice gave a SI of
19 (P<0.05) in response to S.typhimurium (see table 3.13, figure
3.7) and for group 5 the peak response to E.coli was a SI of 16
(P<0.05) (see table 3.14, figure 3.8). In addition, each group
also gave significant, but lesser responses, to heterologous
stimulation with the other two bacteria (P<0.05).
Table 3.12: Proliferative response to EBs, S.typhimurium and E.coli
of the spleen cells of mice infected with C.psittaci.
Background cpm ranged between 261+32 and 345+37.
Concentration (/Lig/ml)
1 5 10 20
C.psittaci 20±1.5a 26±2a 27±1.5a 15±la
S.typhimurium 7±la 9±2a 10±2a 6±1.5a
E.coli 3±1 3±1 5±1.5a 7±la
P<0.05 when compared with medium control cpm.
99
Table 3.13: Proliferative response to EBs, S.typhimurium and E.coli
of the spleen cells of mice infected with
S.typhimurium.
Concentration (/ig/ml)
1 5 10 20
C.psittaci 2+.2 3+.2 7+la 3+.5
S.typhimurium ll±2a 12±1.5a 18+1.5a 19±la
E.coli 5±la 7±la 9±la ll±3a
P<0.05 when compared with medium control cpm.
Table 3.14: Proliferative response to EBs, S.typhimurium and E.coli
of the spleen cells of mice infected with E.coli.
Concentration (jLtg/ml)
1 5 10 20
C.psittaci 3±. 5 3±. 2 5±.5a 7±la
S.typhimurium
/ i a
4±1 4±la 8±1.5a 12+2a
E.coli 3+. 5 4+.5a 9+2a 16+1.5
3.
P<0.05 when compared with medium control cpm
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Fig 3.6 : Proliferative response to EBs (+-+), S.typhimurium
























7 : Proliferative response to EBs (+-+), S.typhimurium














Fig 3.8 : Proliferative response to EBs (+-+), S.typhimurium




















It is clear from the cell counts presented above that the
decrease in the proliferative response at higher concentrations of
EB preparations is the result of toxicity. Toxicity would appear to
be present in both the EBs grown in ST-6 cells and BHK-21 cells,
although it is not known if the toxicity is due to the same
component. The toxin(s) which is present in the preparation is
also present in uninfected BHK-21 cells and ST-6 cells and may be
released from the cells when they are disrupted during purification
to release the EBs. In any purified preparation of EBs there is a
degree of host cell contamination which is carried over due to the
apparent "stickiness" of the EBs themselves. This makes further
purification difficult although an extra washing stage in the
purification process does appear to alleviate the problem without
removing it. Urografin was shown to be neither toxic for living
cells nor mitogenic.
Mitogenicity vs cross reaction.
It was decided to use mice and rats for the study to examine the
question of mitogenicity in EBs for two reasons. Firstly, one can
achieve greater control of the environmental conditions in which
they are raised than is possible with sheep. Also as the mitogens
LPS and Con A act by cross linking sugar residues on lymphocyte
receptors and are therefore cross species reactive, the mitogenic
effect could still be detected. The initial experiment, involving
the mice and rats from group 1 and group 2 showed conclusively that
the response to C.psittaci in uninfected animals is a cross
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reaction with other factors derived from the environment rather
than a mitogenic effect. The cells from the isolator reared
animals, and therefore derived from a protected environment,
displayed normal mitogenic responses when compared with the cells
from conventionally reared animals. However they did not mount a
proliferative response to the EB preparation used to stimulate the
cells. Conventionally raised animals, which would normally be
exposed to a very much greater range of antigens in the form of
bacteria and other organisms in non-sterile food, water and
bedding, did mount a significant response to the EB preparation.
The most obvious candidates for this cross reaction are
commensal enterobacteria, since they readily become established
when animals are raised conventionally. Two of the most common were
therefore included in the second experiment. As C.psittaci is known
to cross react serologically with the LPS of Salmonella (Nurminen
et al, 1984), S.Cyphimurium was used in the study along with an
E.coli, isolated from the faeces of a sheep at the Moredun
Research Institute. It is not suggested that the strains selected
were those strains that caused the proliferative response in the
uninfected sheep, mice and rats, they were merely intended to be
representative of normal gut flora and thus examine the possibility
that enterobacteria might be the cause of the cross reaction.
Infection with any of the three bacteria used would seem to
cause a marked cross reaction with the others and would explain the
responses seen in cells from conventionally reared, uninfected
animals. Stimulation by cross reacting antigens may even be
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responsible for maintaining long term memory lymphocyte populations
against Chlamydia, in vivo (Beverly, 1990) . However, a
homogeneous challenge results in a higher SI than a heterogeneous
challenge and this again is seen when sero-negative ewes are
compared with infected animals. These experiments show that care
should be taken to ensure that uninfected control animals used in
any experiment are of a known background and are free of
C.psittaci, since the cross reactions may lead to ambiguous
results.
Conclusions.
The evidence indicates that sheep can become infected in one
lambing season, carry the infection for a year, abort and are
then immune to further chlamydial challenge (Stamp et al, 1950).
However, it is as yet unknown when these mechanisms develop.
Antibody responses to C.psittaci do not develop until just before
abortion, as measured by the CFT (Stamp et al, 1952) and western
blot analysis (Tan, 1989), and it may be that proliferative
mechanisms do not occur until this time. A knowledge of this could
go some way to explaining the mechanism behind the ability of
C.psittaci to cause latent infection and subsequent immunity.
However, further study must be undertaken with great care, as it
has been shown that purified preparations of EB can be toxic and




THE DEVELOPMENT OF PROLIFERATIVE RESPONSES OF OVINE PERIPHERAL
BLOOD MONONUCLEAR CELLS TO C.PSITTACI DURING PREGNANCY.
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Introduction.
In the previous chapter proliferative responses were
demonstrated in the PBMC of post abortion animals. In other
published studies, in vitro proliferation of ovine PBMC to
chlamydial EBs has also been demonstrated in infected, pregnant
sheep 42 and 50 days after infection (Dawson et al, 1986). The
following study sought to examine the development of these
proliferative responses in the PBMC of infected animals through the
later stages of gestation and up until lambing/abortion, employing
an in vitro lymphocyte transformation assay. The effects of both
pregnancy and infection on the lymphocyte proliferative responses,
as defined by their reactivity to B and T cell mitogens, were also
measured. In addition cytospin smears of the peripheral blood
preparations were examined for C.psittaci organisms by an
immunoperoxidase method, in an attempt to determine whether the
chlamydaemia described by Storz (1971) occurred late in gestation
allowing C.psittaci to travel from the site of latency to the
placenta via the peripheral blood system.
Experimental Procedure.
Twelve ewes (5-6 years old) were obtained from a farm known to
have been free from EAE for at least three years. Oestrus was
synchronised and the ewes were tupped. After 8 weeks the sheep were
examined with an ultrasound scanner to confirm that they were
pregnant. The animals were then split into two groups of 6 (see
table 4.1).
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Table 4.1: Experimental design monitoring the development of
proliferative responses of peripheral blood mononuclear
cell (PBMC) to C.psittaci in pregnant sheep.
Infected PBMC
Group (n) day 90 sampled Aborted
16+ + 4/6
2 6 + 0/6
Group 1 were infected with C.psittaci on day 90 of gestation.
Each animal was given a 1ml suspension of the S26/3 strain,
cultured in egg yolk sacs and stored in liquid nitrogen until
required. The material was diluted in PBS to give a dose of
10~*' ^ELD^Q/ml and was injected subcutaneously over the left
shoulder. Separate needles and syringes were used for each animal.
Group 2 were retained as unchallenged control ewes and were housed
separately in a clean, high security animal house. All animals
were screened for antibody to T.gondii and were found to be
negative. After abortion/lambing the extent of any macroscopic
chlamydial lesions in each placenta was estimated visually and
recorded as a percentage of the total area of the placental sample.
Vaginal swabs and samples of placenta were collected for culture.
The length of gestation from tupping to lambing/abortion was also
noted as was the birth weight of live lambs. Any lamb which did
not survive 48hr was deemed to be non-viable and the loss was
attributed to C.psittaci, for the purpose of this experiment.
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Before infection of group 1 PBMC were collected from all 12
animals and this was repeated thereafter every 14 days, one group
being bled one week and the other group being bled the following
week, until after abortion/lambing. Further samples were collected
4 weeks after abortion/lambing. The blood was collected in
evacuated test tubes containing preservative-free heparin. Using
an in vitro lymphocyte transformation assay the proliferative
response of each ewe was measured against the B cell mitogen LPS,
the T cell mitogen Con A and a purified preparation of chlamydial
EBs grown in cultured BHK cells. Cytospin smears of the peripheral
blood were also prepared on each occasion and were tested for the




A summary of the clinical differences described below is
presented in table 4.2.
Table 4.2: Summary of the clinical differences between infected
sheep (Gp 1) and uninfected sheep (Gp 2).
Length of Viable Average Weight viable Infected
Group Gestation (d) Lambs Weight (kg) lamb/ewe (kg) placenta
1 134±5a 3/8 3.9+0.5 1.95 5/5
2 143±3a 8/8 4.3+1.2 5.7 0/6
P<0.05 when groups are compared.
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I) Length of Gestation.
All lambs/foetuses were recovered from both groups and placentas
were collected for isolation studies from eleven of the twelve
animals. Animals in group 1 which had been infected at day 90 had
a significantly shorter gestation period, 134±5 days as compared
with 146±3 days for the uninfected animals in group 2 (p<0.05).
II) Lamb Weight.
Two of the 6 infected ewes in group 1 produced live lambs
whereas in group 2 all 6 animals produced live lambs. In group 1,
only 3 of the 8 lambs produced, were born live (37.5%) with a mean
weight of 3.9±0.5kg. All 8 lambs in group 2, were born live and
they had a mean birthweight of 4.3±1.2kg. The latter lambs
although born with a greater birthweight were not significantly
heavier. However, when the weight of viable lamb produced per ewe
was calculated for each group the uninfected animals in group 2,
produced 5.7kg of lamb per ewe and the infected animals produced
only 1.95kg.
III) Isolation of C.psittaci from placental tissue.
Placentas were recovered from 5 of the 6 infected ewes and all
had macroscopically visible areas of typical chlamydial lesions.
The areas affected ranged from an estimated 5% of one placenta, up
to 90% of the placenta in another case. C.psittaci was isolated
from all 5 placentas and from the vaginal swabs taken from all 6
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animals in group 1. In group 2 no macroscopic signs of chlamydial
infection were found on any of the placentas and all attempts at




The responses of the PBMC to the B cell mitogen LPS, from both
groups remained similar throughout the duration of the experiment
(see table 4.3, figure 4.1). Both groups showed increased activity
from a mean stimulation index (SI) of 2 at day 90 to one of 10 just
before parturition, after which levels dropped again to a SI of 2
where they remained. Although the responses between the groups did
not differ significantly, there were significant increases in the
magnitude of the mean response in both groups between day 90 and
day 132 just before parturition (p<0.05). Similarly the drop in
response in both groups between day 132 and parturition was also
significant (p<0.05).
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Table 4.3: Proliferative response of ovine PBMC to 20/ig/ml LPS,
during gestation, at lambing and 30 days after
lambing of infected and uninfected sheep. Results are
expressed as Sl+se. Background cpm ranged between
1,172+131 and 1,537±162.
day gestation day post lambing
Group 90 104 118 132 lambing 14 30
1 2±.5 4±.4a 4+la 10±lab 3±.4ac 2±.3 3±.2a
2 2±.5 nd 6±la 8±lab 3±.5ac 3±.5a 3±.7a
£
P<0.05 compared with medium control cpm
b
P<0.05 compared with pre-infection cpm
P<0.05 compared with previous bleed cpm
nd: not done
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Figure 4.1: Proliferative response of ovine PBMC to 20^ig/ml LPS,
during gestation, at lambing and 30 days after
lambing of infected (+-+) and uninfected (o-o) sheep.
90 104 118 132 ab/1 14 30
dys gestation dys post ab/1
- + ~ inf -°- uninf
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II) Con A.
Prior to infection of group 1 animals the PBMC from both groups
of animals responded with similar magnitude to the T cell mitogen
Con A (see table 4.4, figure 4.2). Thereafter and until
parturition the mean response in group 1 was significantly-
suppressed, decreasing from a SI of 155 pre-infection, to one of
70 at parturition (p<0.001). However, within 14 days of
parturition it rose to the pre-infection level. Group 2 responses
on the other hand showed a slight increase from a mean SI of 180 at
day 90 to one of 220 in the cells collected just before parturition
at day 132. At this point they were significantly higher than
those in group 1 (p<0.05). However, the response to Con A in
these animals also became markedly suppressed around parturition,
dropping from a SI of 220 to a SI of 120 at parturition (p<0.05).
At this time they were again slightly higher, but not
significantly different from the responses of the infected animals
(p>0.05). The level of response in these uninfected animals also
returned to normal soon after parturition, in a similar manner to
the infected ewes.
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Table 4.4: Proliferative response of ovine PBMC to 2.5/ig/ml Con A,
during gestation, at lambing and 30 days after
lambing of infected and uninfected sheep.
day gestation day post lambing
Group 90 104 118 132 lambing 14 30
1 155±25a 102±20ab 82±20abd 70±15abd 71±10ab 75±15abd 163±34a
2 180±30a nd 213±30ad 225±40ad 110±45abc 152±50ad 167±35a
P<0.05 when compared with medium control cpm
b
P<0.05 when compared with pre-infection cpm
P<0.05 when compared with previous bleed cpm
d
P<0.05 when groups are compared
nd: not done
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Figure 4.2: Proliferative response of ovine PBMC to 2. 5/Xg/ml Con A,
during gestation, at lambing and 30 days after
lambing of infected (+-+) and uninfected (o-o) sheep.
90 104 1 18 132 ab/l 14 30
dys gestation dys post ab/l
— + — inf -o- minf
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III) Specific Antigen.
Proliferative responses to crude EB preparations were again
similar and of small magnitude in both groups before infection at
day 90 (see table 4.5, figure 4.3), However, within 14 days the
responses in group 1 had risen from a mean SI of 3 to 43 (p<0.05).
The group response remained at this heightened level until day 132,
a few days before parturition. During the same period of time the
responses in group 2 also rose slightly and significantly (P<0.05),
from a mean SI of 3 to one of 10. At every comparable bleed from
day 104 the mean response in group 1 was higher than in group 2
(p<0.05). As with the mitogens the responses to specific antigen
dropped in the days prior to lambing/abortion.Xn this case in group
1 the mean SI fell from 39 to one of 11 between days 132 and
parturition (p<0.05). After this it rose again to between 13 and
20 where it remained for the duration of the experiment. Group 2
levels dropped to a mean SI of between 3 and 6 where they remained
for the remainder of the experiment.
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Table 4.5: Proliferative response of ovine PBMC to 20/ig/ml EBs,
during gestation, at lambing and 30 days after
lambing of infected and uninfected sheep.
day gestation day post lambing
Group 90 104 118 132 lambing 14 30
~ „ „ab . „abd „« ^„abd .. - ..abed , „abd „ «abd
1 2+.5 42+8 37+9 39±11 11+2 16+3 13+2
r, n ^abd ,, , ab „ab „ _ac , a2 2+1 nd 7+3 11+4 11+3 3+.5 4+1
P<0.05 when compared with medium control cpm
k
P<0.05 when compared with pre-infection cpm
0
P<0.05 when compared with previous bleed cpm
P<0.05 when groups are compared
nd: not done
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Figure 4.3: Proliferative response of ovine PBMC to 20/ig/ml EBs,
during gestation, at lambing and 30 days after
lambing of infected (+-+) and uninfected (o-o) sheep.
dys gestation dys post ab/1
~ + _ inf -o- minf
120
Detection of C.psittaci in the peripheral blood.
No C.psittaci could be detected in the cytospin preparations
taken from the peripheral blood of any ewe, in either group at any
of the time points sampled.
Discussion.
Clinical Differences.
Infection of group 1 animals at day 90 of gestation, resulted
in demonstrable clinical differences between this group and the
uninfected group with increased lamb mortality, decreased length of
gestation and reduced birth weight of live lambs. The lamb
mortality and the reduction in the length of gestation and of
birthweight were consistent with that seen regularly in field
infections (Aitken, 1991). These clinical signs almost certainly
arise from the placental damage incurred. The resulting loss in
placental function leads to the death of the foetus or the early
birth of weakly lambs (Aitken, 1991). Hormonal changes measured in
infected animals (Leaver, Howie, Aitken, Appleyard, Anderson,
Jones, Hay, Williams and Buxton, 1989; Leaver, Howie,
Appleyard, Aitken and Hay, 1987) may be due to this placental
damage and may be the cause of early births and abortions. While
the placentas from the two ewes in group 1 which produced live
lambs had fewer, smaller areas of necrotic tissue than the others
in the group this is not always the case in experimental
chlamydiosis (G.E.Jones, personal communication). It is perhaps
not surprising that there is a correlation between the
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length of pregnancy and lamb survival (G.E.Jones, personal
communication), and this was the case in group 1, since the two
ewes which produced live offspring had the longest gestation
periods.
In the field, where an initial infection will result in up to
30% of animals aborting (Stamp et al, 1950) it is not clear why
some animals abort and others do not, when presumably all are
susceptible to infection and abortion.
lymphocyte responses.
The similarity in the responses of the PBMC of both groups of
animals to the B-cell mitogen LPS throughout this study seems to
suggest that a chlamydial infection has no effect on the
non-specific proliferative responses of ovine B-cells. However,
the significant rise in response in both groups measured between
day 90 and day 132 suggests that there is possibly some pregnancy
associated factor which increases the responsiveness of lymphocytes
to this mitogen, since a similar effect was recorded in the
response of uninfected animals to the T-cell mitogen Con A. These
results do not necessarily mean that there is a heightened response
to specific antigens and the experiment, as designed, does not
answer questions about immunosuppression associated with pregnancy
(Tomasi, 1983), since the responses are those of PBMC and
therefore say nothing about local immune responses around the
developing foetus.
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Although there appears to be little difference in the response
of the two groups to LPS there is a considerable difference in the
response of the infected sheep to the T-cell mitogen Con A when
compared with uninfected animals. In the infected group a marked
suppression was identified, from 14 days after infection. Once
again the reason for this is not clear, but it has been seen
before in mice where infection with the C.psittaci Cal 10 strain,
decreased the response of spleen cells to both T and B-cell
mitogens (Lammert and Wyrick, 1982) . However, the finding in
sheep is further complicated by the fact that the antigen specific
lymphocyte response to EBs of C.psittaci at the time of the mitogen
suppression does not appear to be affected, since it remains high
until the immediate pre-parturient period. These results show that
any postulated immunosuppression associated with pregnancy does not
affect the peripheral immune system's ability to mount a strong
proliferative response to specific antigen in vitro. Despite this
strong proliferative response there has been little antibody
shown to be produced until after abortion when titres rise to reach
a maximum after 14 days (Stamp et al, 1952) as measured by the CFT
and Western blot analysis (Tan, 1990). This is further complicated
when considered beside the finding that the B-cell response to LPS
increases from day 90 until before parturition. Thus it would seem
that proliferation is intact, but that specific antibody responses
are not apparent. Although not measured in this study ovine DTH
responses to C.psittaci have been demonstrated in pregnant animals
(Dawson et al, 1986) and previously the development of DTH had
been reported as coinciding with the induction of suppression of
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humoral responses in mice (Basten, 1981) and this may possibly
explain why there is no specific antibody detected. Both pregnancy
associated immunosuppression (Tomasi, 1984) and the intracellular
nature of C.psittaci (Hahn and Kaufman, 1981) may also affect the
ability to mount an antibody response. However, in the case of
T.gondii infection of pregnant sheep neither of these prevent a
strong antibody response (McColgan, Buxton and Blewett, 1988).
A common factor in both of the groups was the sudden drop, of
the PBMC responses to the purified EBs and both mitogens in the few
days prior to lambing/abortion. A reduced responsiveness to T-cell
mitogens has been described in human pregnancy (Tomoda, Fuma,
Miwa, Saiki and Ishizuka, 1976), bovine pregnancy (Wells,
Burrells and Martin, 1977) and ovine pregnancy (Burrells, Wells
and Sutherland, 1978) . In the latter study, the response to
phytohaemagglutinin (PHA) and pokeweed mitogen (PWM) were measured.
In both cases, as with Con A, there was a decrease in response in
the immediate pre-parturient period which remained for some days
after lambing. The actual time that the suppression began differed
between the two mitogens used in the study and both differed from
the time of suppression of the Con A stimulated cells. This time
lapse may be the result of the different modes of action of the
three mitogens, but the overall effect is undoubtedly associated
with pregnancy and the onset of parturition. Similar
immunosuppressive effects have been reported in patients with
multiple trauma injury and are associated with prostaglandin E2
release, tissue damage and bacterial endotoxins (Green and Faist,
1988), all of which are associated with chlamydial abortion. In
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addition, prostaglandin E2 release is thought to play a role in
the onset of labour (Bleasdale and Johnston, 1984) and may be the
reason for the immunosuppression in uninfected animals. Defects in
the immune system brought about by these factors include diminished
DTH responses (Hansbrough, Zapata-Sirvent, Peterson, Wang,
Bender, Claman and Boswick, 1984), reduced T dependant antibody
responses (Wood, O'Mahoney, Rodrick, Eaton, Demling and Mannick,
1986) and decreased proliferative responses to mitoaens (Leguit and
Zeijlemaker, Schellekens and Eijsvoogel. 1973.
Meines, 1973), all of which are factors in the immune response of
C.psittaci infected, pregnant ewes. x
Detection of C.psittaci in the peripheral blood.
There are many reasons which could explain the failu.e to detect
C.psittaci in the peripheral blood. The first and most obvious is
that the organism may not be there. However, the possibility
should be considered that the immunoperoxidase method used was not
sensitive enough to highlight trace amounts of EBs. The method
also requires C.psittaci to have infected the PBMC, since any free
EBs would have been washed away during the preparation of the
blood.
Conclusions.
It is clear from the evidence presented above that pregnancy
alters the PBMC response to mitogens and to chlamydial antigens in
vitro immediately before parturition. What effect this has on the
outcome of a chlamydial infection is uncertain, because when this
phenomenon is apparent infection of the placenta is already
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underway. Mitogen responses of PBMC as measured by Con A are also
suppressed by chlamydial infection, but the mechanisms involved
are unknown since they do not prevent proliferation in response to
to the EBs themselves.
The effect infection with C.psittaci has on the development of
PBMC responses in pregnant sheep has been detailed. Also since the
responses are long lasting in animals following abortion, there is




PROLIFERATIVE RESPONSES OF OVINE PERIPHERAL BLOOD MONONUCLEAR
CELLS AND CD4+ T-CELLS TO ELEMENTARY BODY PROTEINS.
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Introduction.
In previous chapters, it has been shown that a proliferative
response to EBs can be demonstrated in vitro in lymphocytes from
infected pregnant animals during gestation and that this response
can still be measured at least 6 months after abortion. What is as
yet unresolved, however, is which chlamydial antigens are
responsible for stimulating this proliferative response? The
chlamydial genome encodes between 400-600 potentially antigenic
proteins (Stephens, 1988), of which more than 100 can be
visualised by SDS-PAGE eletrophoresis (Salari and Ward, 1981). Of
these proteins, 12-14 bands from the EAE strain S26/3, are
recognised by ovine convalescent sera and lymph fluid (Huang et al,
1990) and 9 bands, from the same strain, are recognised by ovine
post vaccine challenge sera (Anderson et al, 1990). This study
was designed to identify which chlamydial proteins are T-cell
reactive using antigen specific T-cell lines developed from PBMC
and the method of Young and Lamb (1986) which involves the
separation of chlamydial EBs by SDS-PAGE. The separated proteins
are then blotted onto nitrocellulose and individual proteins are
cut from the nitrocellulose and dissolved in dimethylsulphoxide
(DMSO). The dissolved nitrocellulose is then resolubilised as a
fine particle suspension which allows individual antigens to be
tested in a proliferation assay. In addition it was hoped that any
differences there may be between the responses of both vaccinated
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and post-abortion animals would also be identified and may help to
explain the finding that animals require to be revaccinated every 3
years (Aitken, 1991), while post-abortion animals do not abort
again (Aitken, 1991) .
The T-cell lines were also tested for proliferation against
recombinant MOMP and two synthetic peptides (supplied by Dr
A.J.Herring, Moredun Research Institute), based on the MOMP
sequence obtained from the S26/3 EAE strain of C.psittaci (Herring
et al, 1989). MOMP was chosen as a possible recombinant protein
vaccine, because of its importance in terms of both mass (Caldwell
et al, 1981) and function (Newhall and Jones, 1983) and, because
of the success of a MOMP enriched test vaccine (Tan et al, 1991) .
Experimental procedure.
The sheep used in the experiment were placed in 5 groups (see
table 5.1). Group 1 consisted of three sero-negative blackface ewes
from the previous lambing season. Group 2 contained three Dorset
ewes, which had been raised under gnotobiotic conditions for 8
weeks before being transferred to and maintained in a clean loose
box. The 3 blackface ewes in group 3 were given 1 dose of the
commercially available vaccine (Coopers Animal Health Ltd,
Breakspear Road, Middlesex, England) as per manufacturers
instructions. Four blackface ewes which had aborted in the
previous lambing season (6 months earlier) and another 4 which had
aborted in the season before (18 months earlier) were placed in
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group 4a and 4b respectively. Group 5, consisted of 2 blackface
ewes which were injected intra-muscularly with keyhole limpet
haemocyanin (KLH) and which were used to produce negative control
T-cell lines.
PBMC were collected from the animals and were stimulated with
whole EB as well as individual EB protein fractions in lymphocyte
transformation assays. The latter were separated on 10% or 12%
SDS-PAGE gels, blotted onto nitrocellulose and resolubilised as a
fine particle suspension. Con A and LPS were used as control
mitogens.
T-cell lines were generated from the PBMC of sheep which
responded strongly in the above PBMC proliferation assays. The
lines were phenotyped by flow cytometry and were retested in an in
vitro assay, using the same stimuli as described above. In
addition, the T-cell lines were tested against a recombinant form
of MOMP and also 2 synthetic peptides, one from variable domain 2
and one from variable domain 4. Monoclonal antibodies against MHC
class 1 and MHC class 2 molecules were also added to determine
which molecule was used in antigen presentation to the T-cell
lines. All assays included the T-cell line raised against KLH as a
control.
Finally, samples of the medium were removed from the wells of
the 96 well plates, before the addition of the tritiated
thymidine, and stored at -20°C until they could be tested for
cytokine activity.
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Table 5.1: Experimental groups used to determine the ovine
peripheral blood mononuclear cells (PBMC) and T-cell
line response to biochemically fractionated chlamydial
proteins.
Group (n) Treatment PBMC T-cell lines
1 3 - + -
2 3 - + -
3 3 vaccinated + +/-
4a 4 C.psittaci ( 6mths)k + +
4b 4
0
C.psittaci (18mths) + +
5 2 KLHd + +
Si
sheep given commercially available vaccine as per instructions
k
sheep had aborted 6 months previously
sheep had aborted 18 months previously
d
sheep had been immunised with KLH to provide control T-cell lines
*PBMC was collected at 21 days post vaccination in Gp 3 and 21 days
post injection in Gp 5.
Results.
Proliferative response of ovine PBMC to whole chlamydial EBs.
The PBMC from the seronegative ewes in group 1, the uninfected
Dorset lambs in group 2 and the KLH infected ewes in group 5,
showed similar proliferative responses to whole chlamydial EBs (see
table 5.2 and figure 5.1). The peak response gave an SI of between
8 and 10 in all groups. This was significantly higher than
background measured by unstimulated cells in medium only. Only 1
animal from group 3 developed a strong proliferative response to
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whole EBs and gave an SI of 17, the other two animals gave
responses similar to those in groups 1, 2 and 5 (Sis of 7 and 10
respectively). All responses were again significantly above
background (P<0.05). Finally, the PBMC collected from the sheep in
groups 4a and 4b all proliferated strongly in response to
stimulation by EBs (p<0.05). There was no significant difference
between groups 4a and 4b (P>0.05) and maximum responses gave Sis of
of 26 and 24 respectively.
Table 5.2: The proliferative responses (expressed as a
stimulation index (SI)) of ovine PBMC to different
concentrations of chlamydial elementary bodies (EBs).
Group EB (/ig/ml)
1 5 10 20
1 2±. 2 7±la 10±1.5a 10±l.la
2 2±. 2 5±.7a 6±la 8+1a
3 4±.5a 7±.5a 8±1.3a 11+2..9a
4a 4±.5a ll±l.la 17±2a 26+2.3a
4b r-H+1CO ll±la 16±2a 24±1.9a
5 2±. 1 6±1 a 9±la 8±la
P<0.05 when compared with medium control cpm.
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Figure 5.1: The proliferative response to whole EBs, of ovine PBMC
from the uninfected sheep of group 1 (□-□) and group 2
(A-A) , vaccinated sheep in group 3 ( + - + ), infected
sheep in group 4a (o-o) and group 4b (o-o) and group 5














Proliferative response of ovine CD4+ T-cell lines to whole
chlamydial EB.
All T-cell lines generated for these experiments were > 90% CD4+
when phenotyped by flow cytometry. There was no significant
difference in the proliferative response of the group 4a and 4b
T-cell lines when compared either with each other or with the
proliferative response of the PBMC of these groups (P>0.05).
Maximum responses were given on stimulation with 20(ig/ml of EBs and
resulted in Sis of 24 and 27 respectively (see table 5.3 and figure
5.2). There was a significant rise, however, in the proliferative
response of the T-cell lines raised from group 3 animals when
compared with the PBMC response of the same group (P<0.05). The
maximum response was given by 20|j.g/ml and resulted in an SI of 20.
There was no proliferative response to chlamydial EB by T-cell
lines generated from group 5 ewes, which had been raised against
KLH.
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Table 5.3: The proliferative responses (expressed as a
stimulation index (SI)) of ovine CD4+ T-cell lines
to different concentrations of chlamydial elementary
bodies (EB).
Group EB (Hg/ml)
1 5 10 20
3 6±la 10±l.la 14±la 20±2a
4a 6±la 11±0.8a 17±l.la 24+1.9a
4b 5±.7a 12±0.7a 15±l.la 25±1.7a
5
£
P<0.05 when compared with medium control cpm.
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Figure 5.2: The proliferative response to whole EBs, of ovine CD4+
T-cell lines from the vaccinated sheep in group 3
(+-+), infected sheep in group 4a (o-o) and group 4b









Proliferative response of ovine pbmc and T-cell lines t<2.
biochemically fractionated chlamydial proteins.
There was no significant proliferation in response to any
fractionated chlamydial protein in the PBMC of any sheep from
groups 1, 2 or 5 (p>0.05). T-cell lines generated from group 5 also
gave no significant proliferative response when stimulated by the
fractionated proteins (p>0.05). The PBMC from group 3 sheep only
gave significant proliferation, compared with unstimulated
background controls, when stimulated by a protein of approximately
38Kd (P<0.05) (see figure 5.3). However, the T-cell lines generated
from the PBMC of the sheep in this group gave a much wider range of
response (see figure 5.4). Significant proliferative responses to
fractionated proteins of approximate weights of 30, 38, 50 and
70Kd were consistently obtained (P<0.05). On occasion significant
responses to proteins of 90 and 45Kd were also seen (P<0.05). PBMC
from all the animals in groups 4a and 4b responded to many
fractionated proteins with approximate weights 30, 38, 50 and
70Kd (p<0.05) (see figure 5.5). Other antigens also stimulated
significant proliferation in the PBMC of some animals, but not in
others (p<0.05). These had approximate weights of 18, 45 and 90Kd.
T-cell lines generated from the PBMC of these animals gave similar
patterns of response when stimulated by fractionated proteins as
did the PBMC donor animal (see figure 5.6). The T-cell line
proliferative response to individual proteins was higher than the
PBMC response, but was not significantly so (P<0.05).
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Figure 5.3: The proliferative response of group 3 peripheral blood
mononuclear cells to nitrocellulose bound chlamydial
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*MOMP appears on the x-axis merely to emphasise the approximate
molecular weight of this protein. It is unknown if protein(s)
stimulating proliferation in this area is MOMP.
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Figure 5.4: The proliferative response of group 3 CD4+ T-cell lines
to nitrocellulose bound chlamydial proteins.
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Figure 5.5: The proliferative response of group 4 peripheral blood
mononuclear cells to nitrocellulose bound chlamydial
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Figure 5.6: The proliferative response of group 4 CD4+ T-cell lines
to nitrocellulose bound chlamydial proteins.
Nitrocellulose background control (cpm±se) 699±92.
S.I.
p<§.# 5
90 7 0 5 0 momp 3 0
molecular weight (kDa)
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PBMC and T-cell proliferative responses of group 5 sheep to KLH.
PBMC from the group 5 KLH infected ewes responded to whole EBs
as described above (table 5.2), they also gave significant
proliferative responses when stimulated KLH. The maximum response
was given by stimulation with 20/ig/ml and resulting in a SI of 16
(p<0.05). KLH specific T-cell lines were developed as negative
controls and did not respond to whole EBs, LPS or any individual
chlamydial protein. Also they did not proliferate in response
either to recombinant MOMP or to the synthetic peptides. The lines
did, however, respond strongly to both KLH giving a SI of 24
(p<0.05) (see table 5.4, figure 5.7) and the T-cell mitogen Con A
giving a SI of 67 (p<0.05).
Table 5.4: The proliferative response, expressed as stimulation
index (SI)+se, of group 5 PBMC and CD4+ T-cell lines to
Keyhole Limpet Haemocyanin (KLH). Background cpm
ranged between 575+21 and 1,009+123.
Cell type KLH (/ig/ml)
1 5 10 20
PBMC 6±la 8±1.3a 13±2a 16+1.5&
CD4+ T-cells 6+la 10+1.7& 16+1.5& 24+2ab
P<0.05 when compared with medium control cpm
b
P<0.05 when groups are compared.
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Figure 5.7: The proliferative response to KLH of the PBMC (+-+) and








Proliferative responses of group 4 T-cell lines to recombinant MOMP
and to two synthetic peptides from variable domain 2 and 4,
T-cell lines generated from the PBMC of sheep in group 4, were
stimulated by recombinant MOMP (rMOMP) and two synthetic peptides
VD2 and VD4 (see table 5.5 and figure 5.8 and 5.9). The T-cells
gave significant proliferative responses and a SI of 7+1.5 when
stimulated by 2.5/ig/ml of rMOMP (p<0.05). The maximum proliferative
response to the peptides were given with stimulation by 1/ig/ml and
gave Sis of 15 for VD2 and 18 for VD4 (P<0.05).
Table 5.5: Proliferative response of group 4a/4b CD4+ T-cell lines
to recombinant MOMP and to two synthetic peptides from
variable domain 2 (VD2) and variable domain 4 (VD4) of
MOMP. Background cpm ranged between 941+87 and
1,442±121.
Concentration (/lg/ml)
.6 1.2 2.5 5
rMOMP 4+0.8a 5±1.3a 7±1.5a 4±la
.25 .51 2
VD2 11+1.7a 15±1.5a 15±2a 7±0.7a
VD4 10+1.4a 15±1.7a 18±2.3a 8+1.6a
P<0.05 when compared with medium control cpm.
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Figure 5.8: The proliferative response of the group 4a/4b CD4+
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Figure 5.9: The proliferative response of the group 4a/4b CD4+
T-cell lines, to the synthetic peptides of rMOMP from
VD2 ( + - + ) and VD4 (o-o).
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Inhibition of proliferative responses of a group 4 sheep (2171) by
monoclonal antibody against MHC nlass TT moleculss.
A T-cell line, generated from the PBMC of a single sheep in
group 4, was stimulated with 2 0(ig/ml of EBs, 2. 5|j.g/ml of rMOMP and
l|ig/ml of each of the synthetic peptides. The proliferation of the
T-cells in response to the various stimulations was significantly
inhibited by the addition of a monoclonal antibody against MHC
class II molecules (p<0.05), but was unaffected by the addition of
a monoclonal antibody against MHC class I molecules (p<0.05). The
response to EBs was lowered from an SI of 18 to one of 8 (see table
5.6 and figures 5.10, 5.11, 5.12 and 5.13). The decrease in
response to rMOMP was from an SI of 7 to one of 2 and the
proliferative response to the peptides VD2 and VD4 dropped from 16
to 6 and from 17 to 7 respectively.
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Table 5.6: Inhibition of antigen driven proliferation of group 4a
sheep 2171, T-cell line in response to 20/lg/ml EB,
lflg/ml VD2 and VD4 and 2.5/ig/ml of rMOMP, by
monoclonal antibody directed against MHC class I and
class II. Background cpm ranged between 1,081+111 and
1,371±211.
Antigen antibody Concentration of antibody (%v/v)
0>5 l-O 2-5
EBs MHC class I 18±1 19±1.7 20+1.5 20+1.8
EBs MHC class II 16±2 10+1.5a 9±la 8±1.5
rMOMP MHC class I 6±1 7±1.2 6+1.3 6±1.1
rMOMP MHC class II 5+1.5 3+1.2a 2±0.8a 2+0.6
VD2 MHC class I 15±1.5 14+1.7 15+2 15±1.5
VD2 MHC class II 15±1.3 10+1.8a 8+1.3a 6±1.5
VD4 MHC class I 17±1.7 17±1.5 16±1 17+1.2
VD4 MHC class II 16+1 12+1.2a 10+1.5a 7+la
P<0.05 when compared with MHC class I control.
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Figure 5.10: The diminished proliferative response of the T-cell
line derived from group 4a sheep, 2171, to 20^g/ml of
chlamydial EB, when blocked by MHC class I and II
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Figure 5.11: The diminished proliferative response of the T-cell
line derived from group 4a sheep, 2171, to 2.5pg/ml of
rMOMP, when blocked by MHC class I and II monoclonal
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Figure 5.12: The diminished proliferative response of the T-cell
line derived from group 4a sheep, 2171, to 1.2|ig/ml of
synthetic peptide VD2, blocked by MHC class I and II
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Figure 5.13: The diminished proliferative response of the T-cell
line derived from group 4a sheep, 2171, to 1.2pg/ml of
synthetic peptide VD4, blocked by MHC class I and II










- + - VD4 MHC I
-+





Some current vaccine strategies are based on the use of
molecular biological techniques to produce recombinant proteins
representing protective antigens, which, it is hoped will confer
protective immunity against specific infectious agents encountered
in the field. (Arnon, 1984). While simple techniques, such as
western blot analysis of serum samples will identify antibody
reactive proteins, with intracellular parasites such as Chlamydia,
cell mediated immunity and T helper cell (CD4+) reactive proteins
are thought to be more important (Hahn and Kaufman, 1981) and
therefore measurement of T-cell reactivity may be more productive.
Western blot analysis of chlamydial proteins from EAE strains
has shown a number of bands that are recognised by ovine
convalescent and post vaccine sera (Huang et al, 1990; Anderson et
al, 1990). However, before immunoblotting the proteins are
separated on SDS-PAGE gels. This process involves boiling and
reducing the protein to aid separation, but this leads to
denaturation of the protein and antibodies, many of which are
directed against discontinuous, conformational epitopes, will not
generally react with them once they have been denatured (Berzofsky,
1980). Therefore some immune recognition may be lost.
However, unlike antibodies T-cells do not generally recognise
discontinuous epitopes, (Gell and Benacerraf 1959), but instead
react to non native, processed proteins in peptide form, presented
by an antigen presenting cell via MHC restriction molecules
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(Ishizaka, Okudalra and King, 1975). Denaturation of the protein
should not therefore affect the ability of such T-cells to
recognise and respond to a protein. Therefore, western blot
analysis of T-cell reactive proteins using the method of Young and
Lamb (1986) was used in this study to identify T-cell reactive
proteins which in the future could be selected as candidate
antigens for future vaccine studies.
The technique, while being a rapid method of screening proteins,
does have some disadvantages, since the unequal transfer of
different proteins to nitrocellulose, which limits the efficiency
of a Western blot, may also affect this assay (Young and Lamb,
1986) . There are also the possibilities that some epitopes may be
destroyed or that the decreased immunogenicity of the
nitrocellulose bound antigen may mean that this technique is
unsuitable for weakly antigenic proteins (Young and Lamb, 1986).
One method used in this study to overcome the problem of the
cell type specificity of the PBMC responses and to focus on CD4+
T-cell responses was the generation of CD4+ T-cell lines. The
polyclonal CD4+ cell lines raised against EBs have a greater
specificity, since only T-cells reactive to the selecting antigen
are generated (Riedlinger, Grencis and Wakelin, 1986) and, since
an increased number of cells in the line should be responsive,
sensitivity should also be increased (Chiller, Defrietas, Chesnut,
Grey and Skidmore, 1982). This phenomenon was demonstrated in the
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different results obtained with the PBMC of the vaccinated ewe and
the T cell line generated from the PBMC. The PBMC only responded to
one protein, whereas the T cell line exhibited a much wider range
of antigen response.
The reason why PBMC from animals in group 3, responded only to a
protein with a molecular weight similar to that reported for MOMP
is unclear. It may be simply that MOMP is the most abundant protein
in the vaccine preparation and other proteins do not stimulate an
in vivo response to the same degree as a natural infection because
the antigenic load in the vaccine is lower than that encountered in
a natural infection at the time of abortion. Alternatively, it may
be that the other proteins have been altered by the vaccine
production process, which includes inactivation in formaldehyde
for 14 days (McEwan et al, 1955) rendering them unrecognisable by
the T-cells. However, since the T-cell lines recognised some of
the other proteins the first explanation is the more likely.
Further evidence for this theory, comes from the fact that the
other two ewes in this group did not develop strong proliferative
responses to EBs and T-cell lines could not be generated from the
PBMC from these animals. Again this may be due to altered
immunogenicity or immunoaccessibility or simply due to the
antigenic load being too small. However, since one animal in the
group developed apparently normal immune responses antigenic
alteration is improbable. This does not mean that the commercial
vaccine offered no protection, since infection of the animal would
result in a secondary boost to the immune system and may confer
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protection. Differences between the antigens recognised by this
group and those seen by PBMC from groups 4a and 4b are again
probably due to the difference in the dose of antigen each
received.
Uninfected animals from group 1 and 2, did not show a
significant response to any fractionated protein. On many
occasions in individual animals, however, there were responses to
certain fractions, including that closest to the buffer front,
which would have contained both the low molecular weight proteins
and chlamydial LPS. Another reactive fraction was the first one,
which contained unresolved large proteins and non-reduced EBs which
had not entered the gel. Most sero-negative animals also gave
small responses to a protein of approximately 55Kd which could be
the putative heat shock protein described by Morrison et al, 1989.
All of these could be the source of the cross-reaction described in
previous chapters.
In groups 4a and 4b the antigens which stimulated proliferative
responses varied between animals, but there was little or no
variation between those which gave a response at the PBMC level and
those which responded at the T-cell level for any given animal. The
differences between individual sheep was expected as there are also
differences seen at the antibody level (Anderson et al, 1990;
Tan, 1983). In all animals there were 4 antigens which
consistently gave significant proliferative responses (P<0.05)
indicating that these may be immunodominant. These were of
approximate molecular weights 30Kd, 38Kd (MOMP), 50Kd, and 70Kd.
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However, there were other proteins which stimulated T-cell
proliferation in some animals and not others within the group. It
is unclear whether these antigens will also be important in
stimulating a protective immune response. Of the 4 putative
immunodominant antigens two have weights which are similar to two
well characterised chlamydial proteins, namely MOMP (Caldwell et
al, 1981) and the 30Kd adhesin (Hackstadt, 1984). Further study
is necessary, however, to determine whether or not these are
actually the two proteins stimulating the proliferation.
In an attempt to clarify whether T-cells recognise MOMP, the
T-cell lines raised from the post abortion animals in group 4a and
4b were also tested against recombinant MOMP and two synthetic
peptides derived from MOMP and based on the MOMP sequence obtained
from the S26/3 EAE strain of C.psittaci (Herring et al, 1989). In
a small group of 5, all animals tested responded both to
recombinant MOMP and to the peptides. In each case the
proliferation in response to the antigen was reduced by addition of
antibodies against MHC class II molecules, further emphasising
that the T cell lines were functional CD4+ T-cells. The KLH
specific T cell line was used as a negative control and did not
respond to either the recombinant protein or to the peptides. MOMP
was chosen as a possible recombinant protein vaccine, because of
its importance in terms of both mass (Caldwell et al, 1981) and
function (Newhall and Jones, 1983) and, because of the success of
a MOMP enriched test vaccine (Tan et al' 1990). Thus while
supporting the use of a recombinant MOMP vaccine by demonstrating
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post abortion immune recognition, further large scale studies are
required to determine whether a single protein vaccine will be




PRODUCTION OF GAMMA INTERFERON BY OVINE PERIPHERAL BLOOD
MONONUCLEAR CELLS AND CD4+ T-CELL LINES IN RESPONSE TO STIMUL ATION




In the previous chapter ovine PBMC and CD4+ T-cell
proliferation in response to individual antigens of C.psittaci was
demonstrated. In this study cytokine release by activated
lymphocytes will be investigated as a further indicator of ovine
cell mediated immune responses to C.psittaci. Cytokines are the
coordinators of the immune and the inflammatory responses (Arai,
Lee, Miyajima, Miyatake, Arai and Yokata, 1990) and as such are
necessary for the development of protective immune responses, since
cell to cell interactions, such as T-cell help for B-cell antibody
production, require intercellular messengers (Arai et al, 1990).
Specifically this study will investigate gamma interferon (y-IFN)
production by activated PBMC and T-cells. y-IFN was originally
identified as an anti-viral agent (Wheelock, 1965), but its role
in enhancing the killing of intracellular bacteria has also been
established (Nathan et al, 1983; Murray, 1988).
The importance of y-IFN in chlamydial immunity has been
demonstrated in vitro and in vivo. y-IFN activates macrophages
(Nathan et al, 1983; Arai et al, 1990) and activated macrophages
have been associated with the restriction of chlamydial replication
in vitro (Moulder et al, 1980) . Huebnar and Byrne (19 88) also
found that activated macrophages, while not clearing infection,
were necessary if mice were to survive an in vivo infection. A
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similar effect has been described previously in vitro (Byrne and
Faubion, 1982) . y-IFN mediated cytotoxicity has also been
demonstrated against C .psittaci infected fibroblasts in vitro
(Byrne et al, 1989).
The interferons have been shown to be distinct from each other
and have been well characterised in many species. In mouse and man
they have been classified by their biological and physiochemical
characteristics (Stewart, 1980). In sheep similar differences
exist and a biologically active molecule was identified as y-IFN on
the basis of its acid labile, antiviral activity (Entrican, Haig
and Norval, 1989). Recent cloning of the cDNA of this molecule
(Mclnnes, Logan, Redmond, Entrican and Baird, 1990) has
revealed a 96% homology with the published bovine y-IFN sequence at
both the nucleic acid level and in its predicted amino acid
structure (Cerretti, McKereghan, Larsen, Cosman, Gillis and Baker,
1986) .
The following study was designed to examine the production of
y-IFN by ovine PBMC and CD4+ T-cell lines, when stimulated by
biochemically fractionated chlamydial proteins, in order to
determine which chlamydial antigens stimulate both T-cell
proliferation and y-IFN production in an in vitro assay. The
presence of y-IFN in the samples tested was detected by a bioassay
and also by a sandwich ELISA. The latter was developed as a
diagnostic assay for detecting tuberculosis in cattle (Rothel,
161
Jones, Corner, Cox and Wood, 1990) and employs monoclonal
antibodies raised against bovine y-IFN (Wood, Rothel, McWaters
and Jones, 1990), but which cross react with ovine y-IFN (Rothel
et al, 1990) .
Experimental procedure.
Samples of conditioned media were collected from the PBMC and
the T-cell lines stimulated by fractionated antigens in experiments
carried out in the previous chapter. The samples were removed from
the wells of the 96 well plates in lOOpl volumes and triplicate
wells were pooled, prior to the addition of tritiated thymidine to
the 96 well plates. The samples were then stored at -20°C until
they were tested for interferon activity.
Activity was measured in an interferon bioassay and positive
samples were further characterised in a y-IFN neutralising bioassay
(see materials and methods). The presence of y-IFN was also
measured directly by a sandwich ELISA method (Commonwealth Serum
Labs, Parkville, Australia). Briefly this involved the addition of
conditioned medium to plates coated with an anti-y-IFN monoclonal
antibody. A second, horse radish peroxidase conjugated, antibody
was then added and a coloured substrate was added to visualise the
bound y-IFN. Conditioned medium from stimulated PBMC was added in
50jxl volumes and 2 5JJ.1 volumes were added from T-cell line
conditioned medium. Concentrations of y-IFN were assessed and
calibrated using recombinant bovine y-IFN (Ciba-Geigy, Saint
Aubin, Switzerland.) ) as a positive control. All groups, sizes,
and treatments were the same as those described in the previous
chapter (see table 6.1).
162
Table 6.1: Experimental groups used to determine the ovine
peripheral blood mononuclear cell (PBMC) and T-cell
line Y-IFN production in response to biochemically
fractionated chlamydial proteins.
Group (n) Treatment PBMC T-cell lines
1 3 - + -




4a 4 C.psittaci ( 6mth)k + +
4b 4 C.psittaci (18mth)C + +
5 2 KLHd + +
sheep were vaccinated with commercial vaccine as per instructions
k
sheep had aborted 6 months previously
sheep had aborted 18 months previously
d
sheep were immunised with KLH to provide control T-cell lines.
Results.
PBMC production of Y-IFN after stimulation by EBs. LPS and Con A.
Unstimulated background controls of the PBMC of all sheep tested
gave results below the sensitivity of the ELISA (<40pg/ml) and
titres of 32U/ml by bioassay. The PBMC of group 1, group 2 and
group 5 animals which had not been infected with C.psittaci, did
not produce Y-IFN detected by ELISA or bioassay, when stimulated
by whole EBs or LPS (see table 6.2 and figure 6.1). However, they
did produce Y-IFN when stimulated by Con A. Concentrations
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measured by ELISA were between 140 and 175pg/ml of IFN and gave
titres of between 128U/ml and 256 in the bioassay. The PBMC from
the vaccinated animals in group 3 did produce increased levels of
Y-IFN when stimulated by EBs. Concentrations were the equivalent
of 40pg/ml by ELISA and gave titres of 64U/ml in the bioassay.
There was no response to LPS, but Con A responses were similar to
the previous groups. Finally, the cells from the group 4a/4b
animals, which will be considered as a single group (see previous
chapter), produced higher levels of Y-IFN than group 3 animals in
response to EBs. Optical densities measured by ELISA were ten
times above medium controls and this corresponded to 125pg/ml and
gave titres of 256U/ml. LPS and Con A responses were as those
described for other groups.
Table 6.2: Production of Y-IFN (pg/ml+se and U/ml) by ovine PBMC
stimulated with EB (20°g/ml), LPS (20°g/ml) and Con A
(5°g/ml).
Response to
EB LPS Con A
Gp pg/ml U/ml pg U/ml pg U/ml
1 - - - - 155±20 128
2 - 170±18 256
3 40± 3 64 - - 145±32 128
4a/b 125±22 128 - - 175±12 256
5 - - - 170+24 128
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Figure 6.1: Production of y_IFN bY ovine PBMC stimulated with
20pg/ml of EBs, 20|ig/ml of LPS and 2.5pg/ml of Con A,














Gpl Gp2 Gp3 Gp4 Gp5
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T-cell line production of y-IFN after stimulation by EBs. LPS and
Con A.
The level of production of y-IFN was increased in all T-cell
lines when compared to PBMC results as measured by the
concentration present in the unstimulated controls. Unstimulated
T-cells produced background concentrations of y-IFN of between 40
and 45 pg/ml as compared with the negative results given by control
PBMC (see above). No T-cell line produced y-IFN in response to LPS.
The T-cell line generated from the best responding animal in group
3 (see previous chapter) produced y-IFN when stimulated by EBs and
Con A (see table 6.3 and figure 6.2). EB stimulation resulted in
concentrations of 475±45 pg/ml and Con A stimulated cells produced
500±42 pg/ml of y-IFN as measured by ELISA, bioassay titres were
512U/ml. Group 4a/4b responses gave similar rises in OD as the
PBMC in the group and were ten times greater than background. This
gave a concentration of 515±60pg/ml and a titre of 512U/ml in
response to EBs and Con A produced 480±55 pg/ml, but had a titre
of 1024. Group 5 T-cell lines did not respond to EBs, but gave
high readings in response to Con A similar to the other T-cell
lines described above.
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Table 6.3: Production of Y-IFN (pg/ml+se and U/ml) by ovine
T-cell lines stimulated with EB (20°g/ml), LPS
(20°g/ml) and Con A (5°g/ml).
Response to
EB LPS Con A
Gp Pg/ml U/ml pg U/ml pg U/ml
3 475±45 512 - - 500±42 512
4a/b 515±60 512 - - 480±55 1024
5 - - 490±40 512
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Figure 6.2: Production of y-IFN by ovine CD4+ T-cell lines




£BMC and T-cell line response to biochemically fractionated
chlamydial protein.
There was no response to any fractionated protein from either
the PBMC or T-cell lines generated from groups 1, 2 or 5. In group
3 PBMC from the 2 animals with a low proliferative response only
produced y-IFN when stimulated by a protein of approximately 38Kd
(see figure 6.3). The third animal gave a wider range of response
to antigens of approximately 70, 50, 38 and 30Kd (see figure
6.4). T-cell lines from this animal produced more y-IFN than the
PBMC and were also stimulated by proteins of 90 and 60Kd (see
figure 6.5). Group 4a/4b PBMC and T-cell lines produced y-IFN in
response to the same bands (see figure 6.6 and 6.7). All animals
responded to proteins of 70, 50, 38 and 30Kd and some responded to
bands of 90. 60 and 18Kd. Again concentrations of y-IFN were
greater in the T-cell lines.
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Figure 6.3: Production of y-IFN by the PBMC from the low
responding sheep in group 3, stimulated by
biochemically fractionated chlamydial proteins.
molecular weight (kDa)
*Graphs represent # -IFN production from single sheep
representative of each group and the data discussed.
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Figure 6.4: Production of y-IFN in the PBMC from the high
responding sheep in group 3, stimulated by
biochemically fractionated chlamydial proteins.
molecular weight (kDa)
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Figure 6.5: Production of y-IFN by the CD4+ T-cell lines generated




Figure 6.6: Production of y-IFN by the PBMC from the sheep in




Figure 6.7: Production of y-IFN by the CD4+ T-cell lines generated




Group 5 PBMC and T-cell line y-IFN production in response to
stimulation by KLH.
The PBMC from the sheep in group 5 produced Y-IFN in response to
stimulation by KLH (see table 6.4 and figure 6.8). Levels of Y-IFN
detected were 125pg/ml by ELISA and bioassay titres of 256U/ml.
T-cell lines generated from these PBMC again produced greater
amounts of Y-IFN in their medium controls and cells stimulated with
20°g/ml of KLH produced 520pg/ml and titres of 512U/ml.
Table 6.4: The production of Y-IFN by PBMC and CD4+ T-cell lines
from sheep in group 5 in response to 20°g/ml of KLH.








Figure 6.8: Production of Y-IFN by the PBMC and CD4+ T-cell lines
generated from the sheep in group 5, stimulated by









Group 4a/4b T-cell line production of q-IFN in response to rMOMP
and synthetic peptides.
Five T-cell lines from group 4a/4b were stimulated by rMOMP and
two synthetic peptides described in the previous chapter. All
produced Y-IFN (see table 6.5 and figure 6.9), cells stimulated
with rMOMP produced 75pg/ml+8 by ELISA and gave bioassay titres of
between 128 and 256U/ml. The cells stimulated by the synthetic
peptides gave 227pg/ml+33 and titres of 512U/ml for VD2. Results
for VD4 were 260pg/ml+48 and a titre of 256U/ml.
Table 6.5: The production of Y-IFN by T-cell lines, from sheep in
group 4a/4b, to 2.5°g/ml rMOMP and 0.5°g/ml of the
synthetic peptides VD2 and VD4.
pg/ml+se U/ml




Figure 6.9: The production of y-IFN by T-cell lines, from sheep in
group 4a/4b, to 2.5ng/ml rMOMP and 0.5ng/ml of the










The two detection systems used in this series of experiments may
not detect similar quantities of y-IFN. The bioassay will only
detect active molecules of y-IFN which can protect the target cells
from viral infection, while the monoclonal antibodies in the ELISA,
as well as detecting active molecules may also detect any
non-biologically active molecules of y-IFN which may be present in
the conditioned media. Therefore both assays were used to detect
y-IFN.
The major difference between the PBMC and T-cell line production
of y-IFN was the increased concentrations of y-IFN detected in the
conditioned medium taken from the unstimulated control cells of the
T-cell lines. This result was not unexpected, since even though
PBMC assays have more cells/well the preparations will contain many
non-y-IFN producing cells such as B-cells and monocytes, whereas
the T-cell lines contain >90% CD4+ cells (see previous chapter),
which are all capable of producing y-IFN (Watanabe, Taguche,
Iwata, Kawadi and Hanaoka, 1983). Increased production will also
result from the increased number of cells which will be sensitive
to C.psittaci and which will produce y-IFN upon stimulation by EBs.
Differences in background levels within groups also correlated with
the different proliferative backgrounds in individual sheep seen in
the previous chapter. High proliferative backgrounds resulting in
high levels of y-IFN and low proliferative backgrounds producing
low levels.
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There was very little difference between the responses of the
group 4a/4b PBMC and T-cell lines to individual proteins other than
the difference in the concentrations of y-IFN produced, which has
already been discussed. This confirms the finding of the previous
chapter where similar results were reported in the proliferative
response of the post abortion group 4 animals and would suggest
that a strong cell mediated immunity existed in the PBMC of these
animals. This may explain why animals seldom abort more than once
(Stamp et al, 1950).
The detection of y-IFN in the conditioned media of the PBMC and
T-cell lines of infected animals stimulated by EBs correlated well
with the proliferation reported in the previous chapter. However,
animals which were uninfected in groups 1, 2 and 5, and which
showed some proliferation in response to EBs did not produce
increased detectable levels of y-IFN and amounts present in EB
stimulated cells from these groups were similar to quantities in
unstimulated control cells. It is possible that the proliferation
described for these groups is due to the stimulation of non-y-IFN
producing cells, such as B-cells. Another intriguing possibility is
that the proliferation is due to T-cell subsets similar to those
described for mice (Bottomly, 1988). Murine T-helper cells have
been subdivided into 2 groups with Thl cells producing y-IFN and
IL-2 while Th2 cells produce IL-4 (Mossman and Coffman, 1987).
Obviously, if a similar differentiation occured in sheep then the
proliferation recorded when no y-IFN was detected could be due to
the stimulation of Th2 cells. However, PBMC from the high
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responding animal in group 3, while proliferating only in response
to a protein of approximately 38Kd, also produced y-IFN when
stimulated by the three other immunodominant antigens with
approximate weights of 70, 50 and 30Kd described in the previous
chapter. The reason for cells producing y-IFN when no
proliferation is present is less clear, although it has been
reported previously for T-cell lines and clones (Hecht, Longo and
Matis, 1983). It is possible that high levels of proliferation of
non-y-IFN producing cells within the unstimulated controls may
lower the stimulation index of proliferating PBMC to insignificant
levels. This would leave the background concentrations of y-IFN
unchanged and the increased amount of y-IFN produced by
proliferating cells would be detected.
These findings would suggest that the production of y-IFN by
PBMC and T-cell lines in response to stimulation by EBs was a more
specific test than the measurement of cellular proliferation, when
examining the immune status of sheep to C.psittaci. This has
already been shown to be the case in bovine tuberculosis, where
the ELISA method used in this study has been used as a diagnostic
test (Wood, La Corner, Rothel, Baldock, Jones, Cousins,
McCormick, Francis, Creeper and Tweddle, 1991). It may be that the
production of y-IFN by stimulated PBMC may prove to be a useful
diagnostic tool for other intracellular bacteria such as
C.psittaci. However, a protective role for y-IFN against ovine
abortion strains of C.psittaci has yet to be demonstrated.
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Chapter 7 s
A MOUSE MODEL OF A CHLAMYDIAL INFECTION TO INVESTIGATE THE EFFECT
OF ENDOGENOUS GAMMA INTERFERON ON THE RESOLUTION OF DISEASE.
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Introduction.
In previous chapters the in vitro cell mediated responses of
sheep to C.psittaci have been investigated and certain antigenic
proteins have been identified which stimulate both the
proliferation of T-cells and the production of y-IFN by those same
cells. Recently, a large body of evidence has been gained from
both in vitro and in vivo experiments which shows the importance of
y-IFN in the immune response to many intracellular pathogens such
as Trypanosoma cruzi, Toxoplasma gondii, Listeria monocytogenes ,
Rickettsia conorii and Vaccinia virus (Borges and Johnson, 1975;
Nakane, Numata, Asano, Kohanawa, Chen and Minagawa, 1990; Manor
and Sarov, 1990; Dunn and North, 1991; McCabe, Meagher and
Mullins, 1990; Karupiah, Blanden and Ramshaw, 1990).
In chlamydial immunity it was reported as early as 1982 that
lymphokines restricted the growth of C .psittaci in murine
macrophages in vitro (Byrne and Faubion, 1982) and that the
inhibition of growth could be suppressed by adding anti y-IFN
antibody to the culture (Byrne and Kreugar, 1983; Rothermel et al,
1983). The ability of y-IFN to activate the microbicidal activity
of host macrophages (Nathan et al, 1983) as well as cause
suicide-like cell destruction of bacteria-infected cells triggered
by bacterial LPS (Byrne et al,1988; Dijkmans, Decock, Heremans,
Van Damme and Billiau, 1989; Dijkmans, Van Damme, Cornette,
Heremans and Billiau, 1990) could well be important in in
resistance to C.psittaci.
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In order to determine the in vivo effects of endogenous y-IFN on
the resolution of a live infection of the S26/3 ovine abortion
isolate of C.psittaci a mouse model of the early stages of
infection was constructed. Normal mice and athymic nude mice were
employed, together with the in vivo use of a monoclonal antibody
which neutralised y-IFN, with the intention of altering the
pathogenesis and the severity of the infection. As activated
T-cells (Watanabe et al, 1983) and natural killer (NK) cells
(Welsh, 1984) produce y-IFN, athymic mice were used to determine
the effect of removing T-cells and their products and it was hoped
that the antibody treated groups would highlight the differences
due to the removal of y-IFN.
RypBrlmental procedure.
Athymic nude mice (nu/nu) on a MF1 background and their hairy
litter mates (nu/+) (Harlan Olac Ltd, Oxford, England) were
divided into 9 groups (see table 7.1). Group A contained 10 nu/+
mice infected intra-peritoneally (i.p.) with 106 IFU of C.psittaci
S26/3, grown in egg yolk sacs. Group B also contained 10 nu/+
mice infected with a similar dose of C.psittaci but also treated
with a murine y-IFN neutralising monoclonal antibody. The
antibody, a rat/mouse hybrid, was a gift from Dr A.Mowatt,
Glasgow University. Mice in group B were injected i.p. on day -1,
0, 1 and 3, with 200|il of PBS containing enough monoclonal
5
antibody to neutralise 10 units of murine y-IFN, as measured in a
bioassay. Group C and D were each comprised of 12 nu/nu mice and
were treated in the same way as groups A and B respectively.
184
Control groups E and F contained 6 nu/nu and 6 nu/+ mice
respectively and were not infected with C.psittaci, but were
treated with the monoclonal antibody in the same manner as groups B
and D. The 6 nu/nu mice in group G were given a control inoculum
of 450|a.l of uninfected egg yolk sac on day 0 and 200^.1 of a control
antibody of rat IgG on day -1, 0, 1 and 3. Groups H and I,
containing 6 nu/nu and 4 nu/+ mice respectively were given a
control inoculum of 450|j.l of uninfected egg yolk sac on day 0.
Within the groups, half the mice were killed on day 3 and the
other half were killed on day 5 in a chamber with C02 gas. After
killing, animals were weighed and blood was taken in order that
sera could be analysed for y-IFN activity. The mice were examined
macroscopically for visible lesions. Using aseptic precautions,
the spleen from each animal was removed and weighed before samples
of spleen, liver and lung were taken for attempted isolation of
viable C.psittaci and for histopathological studies. The latter
were immediately fixed in 10 per cent formal saline while samples
for isolation were frozen at -70°C in chlamydial transport medium
until required.
Tissue sections for histopathology were stained with
haemotoxylin and eosin (HE) while serial sections were stained with
an immunoperoxidase method to demonstrate chlamydial antigen.
Selected tissue sections were treated with an in situ hybridisation
method for the demonstration of chlamydial RNA.
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Table 7.1: The group sizes and treatments used to evaluate the role
of endogeneous gamma interferon in the resolution of a
live chlamydial infection in mice.
Group (n) Type Treatment Day killed
A 5 Nu/+b C.psittaci only 3
5 5
B 5 Nu/+ C. psittaci+Antibody^ 3
5 5
C 6 Nu/Nua C.psittaci only 3
6 5
D 6 Nu/Nu C.psittaci+Antibody 3
6 5
E 3 Nu/Nu Antibody only 3
3 5
F 3 Nu/+ Antibody only 3
3 5
G 3 Nu/Nu Yolk Sac6+ Rat IgGf 3
3 5
H 3 Nu/Nu Uninfected Yolk Sac 3
3 5
I 2 Nu/+ Uninfected Yolk Sac 3
2 5
sl b
athymic mice on a MF1 background thymic MF1 littermates
c 6
mice given 10 IFU of C.psittaci i.p.
^
mice given murine Y-IFN neutralising monoclonal antibody
0
mice given uninfected egg yolk sac as a control innoculum
f
mice given rat IgG as a control antibody
Results.
The C.psittaci infection in mice produced several histological
changes in the tissues examined. In the spleen, there was an
expansion of the periarteriolar lymphoid sheaths (PALS) associated
with an increase in overall spleen weight (Fig 1). Phagocytic
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vacuoles were also present in the red pulp and to a small extent
the white pulp and there was an increased presence of
polymorphonuclear cells (PMN). With the liver macroscopic lesions
were found on the surface in some mice. These appeared as small
white foci or streaks of necrosis, usually l-2mm across. They had
slightly depressed surfaces and were often bordered by a thin red
haemorrhagic zone. Microscopically the hepatocytes and the
sinusoidal lining cells within these foci had undergone coagulative
necrosis and at the clearly demarcated interphase with adjacent
normal tissue there was often a clear zone of haemorrhage within
the lesion (Fig 2). There was virtually no inflammatory cell
infiltration within these foci nor was any significant amount of
antigen demonstrable (Fig 3).
A more consistent microscopic finding in the liver was multiple,
small foci of inflammation. The likely development of the lesion
was as follows. The foci commenced in the sinusoids (Fig 4).
Initially Kupffer cells appeared prominent and antigen was seen in
some (Fig 5) , as the reticuloendothelial system was stimulated.
The sinusoids became congested both with aggregates of these cells
as they proliferated, and by blood borne inflammatory cells. By
day 5 the foci were larger and were composed mainly of PMN in the
centre of the focus while the periphery was mainly composed of
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Figure 1A (upper): A section of spleen from an uninfected athymic
mouse from group G, on day 3
(HExl6)
Figure IB (lower): A section of spleen from an infected athymic
mouse from group C, on day 3
(HExl6)
Note the clear increase in size of the infected spleen in the




Figure 2: A section of liver from an infected, athymic mouse from
group C, on day 3. The photograph depicts a large area
of necrosis (N) with a zone of haemorrhage around its
periphery (H). There is also a lack of inflammatory
cell infiltration within the necrotic area.
(HEx4 0)
Figure 3: A section of liver from an infected athymic mouse from
group D, on day 3 treated with an immunoperoxidase
technique to detect the presence of chlamydial antigen.





Figure 4: A section of liver from an infected thymic mouse from
group B, on day 5. The photograph shows a marked
inflammatory cell infiltration (C) within the sinusoids,
adjacent to many normal hepatocytes.
(HExl60)
Figure 5: A section of liver from an infected athymic mouse from
group C, on day 3 treated with an immunoperoxidase
technique to detect the presence of chlamydial antigen.
The Kupffer cell (arrow) lining the sinusoid has




reticulo-endothelial cells. Surrounding hepatocytes did not appear
to be a primary target as only a very few displayed irreversible
degenerative changes (Fig 6). These foci of inflammation should
not be confused with the focal necrosis described above in which
large numbers of hepatocytes become necrotic. Chlamydial antigen
was readily demonstrated in many of these foci by the
immunoperoxidase method, as was chlamydial RNA by an in situ
hybridisation method. Chlamydiae were seen to be both
extracellular and within inflammatory cells. A cellular thickening
of the alveolar septa in the lungs of infected mice was also noted
(Fig 7), and in some cases there appeared to be an increase in the
number of alveolar macrophages.
The five control groups (E-I) showed no significant
abnormalities either macroscopically or on histopathological
examination. No chlamydial antigen was detected following staining
with the immunoperoxidase method. No chlamydia were isolated from
any tissue in these control groups and spleen size remained
constant. Therefore, as an aid to clarity the control groups have




Spleen weights are given both as actual weight in grams and also
as per cent body weight in table 7.2. There was a significant
increase in groups B and D (antibody treated and infected) on day 3
when compared with groups A and C and the control groups E-I
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Figure 6: A section of liver from an infected athymic mouse from
group C, on day 5. The photograph shows a small focus




Figure 7A (upper): A section of lung from an uninfected athymic
mouse from group G, on day 5.
(HExl60)
Figure 7B (lower): A section of lung from an infected athymic mouse
from group D, on day 5.
(HExl6 0)
Note the clear increase in the number of cells in the alveolar
septa in photograph 7B.
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(p<0.002 for actual weight and p<0.01 for percent body weight). On
day 5, groups A to D had all increased in size significantly
(p<0.02 for both actual weight and percent body weight), whereas
the control groups had remained the same (p>0.05). In addition, by
day 5 the weights of the spleens in groups A to D were
significantly greater than the control groups (p<0.01 and p<0.008,
respectively) and those in group B were significantly greater than
those in other infected groups (p<0.01 and p<0.003).
Table 7.2: Mean body weight (g±se), mean weights of spleens (g±se)
and the mean weights of spleens expressed as a
percentage of the mean body weight of the mice from a
given experimental group.
Group Day killed Body weight Weight spleen % Weight
A 3 29.52+1.36 0.120+0.015 0.41+0.04
5 31.29±2.81 0.276+0.050aC 0.85±0.09ac
B 3 30.87±0.60 0.190±0.010b 0.62±0.03b
5 28.65+0.80 0.308+0.008ac 1.01±0.01ac
C 3 22.53±1.35 0.107±0.010 0.46±0.02
5 24.35±1.20 0.167±0.020ac 0.68+0.06ac
D 3 25.37±0.80 0.180+0.007b 0.71±0.03b
5 23.79±1.60 0.210±0.020ac 0.88±0.06ac
E 3 26.29+0.80 0.107+0.007 0.40+0.03
5 25.94±0.70 0.110±0.015 0.43+0.06
F 3 35.34+1.03 0.090±0.005 0.25±0.02
5 36.16±0.70 0.080±0.000 0.22+0.01
G 3 28.31+1.30 0.090+0.010 0.34±0.03
5 29.89±2.10 0.087±0.007 0.32±0.02
H 3 26.44+1.06 0.087±0.007 0.30±0.03
5 26.50±0.50 0.110±0.019 0.38±0.09
I 3 35.56±1.60 0.115+0.005 0.32±0.01
5 37.94±0.10 0.105+0.005 0.28±0.01
P<0.05 when compared with day 3 results of same group
b
P<0.05 when compared with control day 3 results
0
P<0.05 when compared with control day 5 results
194
II) Histopathology.
a) Prominence of Periarteriolar Lymphoid Sheaths (PALS).
In all infected groups PALS were more prominent at days 3 and 5,
than in control groups. There was no recognisable difference
within any single group between day 3 and 5, however, in both
groups B and D the PALS did appear to be more prominent than the
PALS of groups A and C on both day 3 and day 5.
b) Vacuoles and cytolytic debris.
By day 3, in groups A and C (animals which were not treated with
antibody), vacuoles containing pyknotic cells and cytolytic debris
(Fig 8), were frequently scattered throughout the red pulp and to a
much lesser extent, the white pulp of the spleen, but by day 5,
they were very few in number. In group D, similar numbers of
vacuoles were present on both day 3 and 5, while in group B they
were relatively uncommon on both days.
c) Polymorphonuclear cells (PMN).
The degree of PMN infiltration was less on day 5 than on day 3
in groups A and B, although in mice in group B, larger numbers of
PMN were observed on both day 3 and 5. In groups C and D, the
degree of PMN infiltration was greater on day 5 than day 3,
although antibody treated mice did have larger numbers on both
days.
d) Antigen.
Antigen was detected in all groups of infected mice, on both
days. It was mainly associated with the vacuoles (FIG 9) described
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Figure 8: A section of spleen from an infected athymic mouse from
group C, on day 3. Within the tissue there are vacuoles
(arrow) which contain cytolytic debris and pyknotic
cells.
(HExl60)
Figure 9: A section of spleen from an infected athymic mouse from
group C, on day 3 treated with an immunoperoxidase
technique. The photograph demonstrates the presence of




above, although not exclusively so, since there was also a
lesser amount of antigen detected in the red pulp in the form of EB
inclusions. In groups A and B, the amount of antigen.detected was
similar on day 3 and 5, whereas in the athymic groups C and D the
amount of antigen detected in the spleen was greater than that
detected in groups A and B. There was also more antigen detected
on day 5 when compared with day 3 in groups C and D. More
inclusions could also be found in the red pulp of the spleens from
groups C and D.
Ill) Isolation.
The number of viable C.psittaci per gram of tissue, was lower
in group A than in B, C or D at day 3 (significantly lower than
the two antibody treated groups, B and D. p=<0.01). On day 5 the
numbers of viable chlamydiae isolated in group A were significantly
less than on day 3 (p=<0.002) and were also significantly less than
for any other group at day 5 (p=<0.03). In group C the numbers of
chlamydiae isolated at day 3, although higher than group A were
not significantly so (p=>0.05), and there was little change by day
5 (p=>0.05). Mice in group D had more viable chlamydiae in their
spleens than any other group at day 3 (p=<0.001) and day 5
(p=<0.0005) and also had significantly more on day 5 than on day 3
(p=<0.002) .
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Table 7.3: Summary of the findings in the spleens of the infected
groups A to D.
Prominance Isolation
Group Day of PALS Vacuoles PMN Antigen (IFU x 105)
A3 + ++ + + 5 . 6+0. 8
5 + - ± ± 0.1±0.ia
B 3 +(+) + ++ + 9.0±0.6
5 +(+) + + + 13.0+4.0a
C 3 + ++ ± + 8.3+1.1
5 + ± + ++ 13.0+1.la
D 3 + ++ + ++ 19.0±1.6
5 +(+) ++ ++ +++ 46.0+2.5a
a
P<0.05 when compared with day 3 isolation results of same group
Conclusions.
* C.psittaci infection caused an increase in spleen we ight and made
the PALS more prominent.
* Anti-Y -IFN monoclonal antibody treatment further accentuated
this.
* The latter treatment also correlated with a greater detection of
viable chlamydiae in the spleen.
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* Athymic mice harboured greater numbers of viable chlamydiae
than mice with thymuses.
* More antigen was detected in the tissue sections of spleens from
athymic mice than from similarly treated mice with thymuses.
Liver.
I) Necrosis.
In group A, at necropsy macroscopic lesions could be seen on the
surface of the livers of 2 of 5 mice on day 3, however by day 5,
there were no visible signs of necrosis in this group (see table
7.4). In group B, on day 3, 2 of 5 mice had visible hepatic
necrosis, and by day 5 all 5 mice were similarly affected. In
group C, lesions of necrosis were seen in all 6 mice on day 3 and
2 of 6 on day 5 while in group D it was only seen in 2 animals on
day 3, but in all mice on day 5.
Table 7.4: Summary of the presence of macroscopic lesions detected
on the liver tissue of the infected mice on day 3 and
day 5.







a) Foci of inflammation: frequency and size.
There were no significant differences in the frequency of
inflammatory foci in any group A to D on day 3 (P>0.05) (see table
7.5) In all groups, however, the frequency was significantly
higher on day 5 than on day 3 (PcO.OOl). Also on day 5, there
were significantly more foci of inflammation in groups B and D when
compared with the day 5 results of groups A and C (P<0.03). On day
3, groups A and C had significantly fewer inflammatory cells in
each focus when compared with groups B and D (P<0.05). Again, in
all groups the number of cells in each focus was significantly
higher on day 5 than on day 3 (P<0.001). On day 5, groups B and D
had significantly more cells in each focus than any other group
(P<0.04) .
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Table 7.5: Analysis of the inflammation in the livers of mice
infected with C.psittaci: Frequency and size of
inflammatory foci.
Inflammatory foci/ Mean number of cells/
Group Day per field per focus
A 3 0.64 + 0.16 40.24 + LD oo
5 1.84 + 0.2a 112.28 + 19a
B 3 1. + 0.17 57.8 + 6
5 4.24 + 0.35ab 129.5 + 17a
C 3 1. + 0.16 41.5 + 4.4
5 1.43 + 0.14a 88.2 + 11. 9a
D 3 1.23 + 0.19 55.8 + 5.8
5 2.70 + 0.3a 206.0 + 28ab
a
P<0.05 when compared with day 3 results in same group
b
PC0.05 when compared with day 5 results of all groups
b) Antigen.
A small amount of antigen was detected in the livers of mice in
groups A, B, C and D sampled at day 3 (see table 7.6). On day 5,
significantly more antigen was detected in all groups (P<0.04),
with the largest difference in chlamydiae detected being found in
group B. The antigen was generally intracytoplasmic and within the
foci of inflammation (Fig 10), particularly those with large
infiltrates of PMN. Mice given monoclonal antibody (groups B and D)
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Figure 10A (upper): A section of liver from an infected athymic
mouse from group C, on day 5 treated with an
immunoperoxidase technique to detect the
presence of chlamydial antigen.
(IPxl60)
Figure 10B (lower): A section of liver' from an infected athymic
mouse from group C, on day 5 treated with an
in situ hybridisation technique employing
chlamydial RNA.
(ISHX160)
In the upper photograph a brown staining reaction product
demonstrates the presence of chlamydial antigen within the
cytoplasm of inflammatory cells. In the lower photograph the
presence of chlamydial RNA is detected within the cytoplasm of
cells in an inflammatory focus.
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had significantly greater amounts of antigen detected on day 5
when compared with groups A and C (P<0.04), as well as containing
more chlamydial inclusions (Fig 11), which were not associated
with the inflammatory response, than groups A and C, on both days.
Table 7.6: Summary of the presence of chlamydial antigen detected
in the inflammatory foci of the liver tissue from
infected mice on day 3 and day 5.
% cells containing antigen
Group day 3 day 5
A 3.6±1.0 10.8±2.9a
B 7 . 4±2 .1 23.0+2.9a
C 4.0+1. 3 15.0+4.3a
D 8.0±1.6 32.6±6.lab
PC0.05 when compared with day3 results
k
P<0.05 when compared with day5 results
III) Isolation.
More viable C.psittaci were isolated per gram of hepatic tissue
from group C and D, on day 3 and 5, than from mice in group A or
B (day 3 P=<0.005, day 5 P=<0.002) (see table 7.7). At day 3,
while athymic mice in group D contained significantly more
organisms (P=<0.009) than thymic mice in group B, there was no
difference between group B and the untreated athymic group C
(P=>0.05). However, on day 5, significantly more viable chlamydiae
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Figure 11: A section of liver from an infected athymic mouse from
group D, on day 5 treated with an immunoperoxidase
tecnique to detect the presence of chlamydial antigen.
The photograph shows large areas of brown staining
chlamydial antigen as well as chlamydial inclusions





were isolated from mice in group B than from mice in group C
(P=<0.01). Groups B and D both showed a significant increase
between day 3 and day 5 (P=<0.02) while in both groups A and C a
significant decrease was detected in the number of viable organisms
in hepatic tissue (P=<0.0007).
Table 7.7: Summary of the findings in the livers of groups A to D.
Inflammation
Focal % cells Isolation
Group Day Necrosis Frequency Size containing Ag (IFUxlO )
A 3 1/5 + + + 3.3±0.2
5 1/5 ++ ++ ++ 0.2±0.3a
B 3 2/5 + + + 7.4+0.2
5 4/5 +++ +++ +++ 32.0±6.0a
C 3 6/6 + + + 7.3+0.5
5 2/6 ++ ++ ++ 3.7±0.3a
D 3 1/6 + + + 16.0+2.0




compared with day 3 results in same group
* Focal necrosis was more common in athymic mice.
* Anti-Y-IFN monoclonal antibody treatment of both athymic and
thymic mice caused more necrosis on day 5.
* The inflammatory response was similar in thymic mice and in
athymic mice.
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* Antibody treatment of both athymic and thymic mice produced a
greater inflammatory response.
* More viable C.psittaci were isolated from athymic mice.
* More viable C.psittaci were isolated from mice given antibody.
* More antigen was detected in athymic mice when compared with
thymic mice.
* Antibody treatment increased the amount of antigen detected in




All groups infected with C .psittaci showed an increased
cellularity of the alveolar septa when compared with the lungs from
animals in the uninfected control groups E to I (see table
7.8). This was in part due to the presence of PMN, particularly in
groups C and D, In group C, (athymic
mice not treated with antibody) numbers of PMN in the alveolar
septa were minimal on day 3, whereas in group D, at this time,
(athymic mice given antibody) they were more frequent. The presence
of PMN did not appear to be a prominent feature of the increased
cellularity of alveolar septa in groups A and B. PMN were detected
in the lungs of mice in group B on both days but could only be
found on day 5, in group A. Alveolar macrophages were more
frequent in all cases on both days.
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b) Antigen.
No antigen could be detected in the lung sections from group A
or C, on day 3 or 5, by the immunoperoxidase method and little or
no chlamydial RNA could be detected by in situ hybridisation (see
table 7.8). In groups B and D, antigen/RNA was detected by both
methods, but only on day 5 (Fig 12).
II) Isolation.
Viable chlamydiae were isolated from all the lungs of groups A,
B, C and D on both day 3 and 5 (see table 7.8). In group A the
number of chlamydia isolated was less on day 5 than on day 3
(P=<0.007), but in all other groups the numbers were increased
significantly on day 5 (P=<0.02). More chlamydiae were isolated
from mice in groups B or D than from mice in groups A or C mice on
both days (day 3 P=<0.0006; day 5 P=<0.007) and more chlamydiae
were isolated from athymic mice in groups C and D than from thymic
mice in groups A and B, on both days (P=<0.005; P=<0.006).
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Figure 12: A section of lung from an infected athymic mouse from
group D, on day 5 treated with an immunoperoxidase
technique. Note the presence of chlamydial antigen














A 3 + +/" - 1.1±0.2
5 + +/+ - 0.3±0.la
B 3 + +/- - 4.2±0.3
5 + +/- + 14.0+2.4a
C 3 + +/- - 1.6±0.3
5 + +/+ - 3.7±0.5a
D 3 + +/+ - 7.8+0.3
5 + +/+ + 36.0±5.la
a
P<0. 05 when compared with the day 3 results of the same group
Conclusions.
* C.psittaci infection stimulated an increase in cellularity of the
alveolar septa of all mice.
* Chlamydial antigen was only detected in mice treated with
antibody and only on day 5.
* More viable C.psittaci were isolated from mice treated with
antibody.




The sera of all mice were tested for the presence of interferon
in an anti-viral bioassay. Activity was only detected in mice from
groups B and D treated with antibody (see table 7.9). In group B,
5 of 5 mice tested on day 3 were positive with titres ranging from
40 U/ml to 320 U/ml, but only 1 mouse tested on day 5 was positive,
with a titre of 80 U/ml. In group D all 6 mice tested on day 3
were positive for interferon activity and 5/6 tested on day 5 were
also positive. Titres on day 3 ranged from 160-320U/ml in both
cases, but were not significantly higher than those in group B
(p=>0.05).
All positive sera were tested again for the presence of y-IFN
using a y-IFN neutralising bioassay. All IFN positive sera proved
to be negative for y-IFN with the exception of one mouse from group
D, day 5, which had a titre of 160U/ml.
Conclusion.
* Treatment of mice with anti-y-IFN monoclonal antibody stimulated
an interferon-like activity in the serum.
* This activity was not due to the presence of y-IFN (with one
exception)
* Interferon-like activity was detected in both athymic and thymic
mice.
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Table 7.9: Summary and titres of interferon containing sera from
infected groups A-D
Group Day Q/p-IFN U/ml Y-IFN U/ml
A 3 0/5 - - -
5 0/5 - - -
B 3 5/5 120±25 0/5 -
5 1/5 80 0/1 -
C 3 0/6 - - -
5 0/6 - - -
D 3 6/6 140±16 0/6 -
5 5/6 60+10 1/5 160
Discussion.
It has been demonstrated in this chapter that infection with
C.psittaci causes cellular changes in tissues of mice. In the
liver, large foci of necrosis may occur while smaller foci of
inflammation develop. In the spleen the PALS expand and become
prominent and cytolytic vacuoles form, while in the lungs there is
a slight cellular thickening of the alveolar septa. In all tissues
examined from the infected groups (A to D), while the same basic
histopathological changes were seen, treatment with the monoclonal
antibody against murine Y-IFN altered the severity and probably the
rate of change. In both groups B and D, antibody treatment resulted
in the earlier appearance of and the development of greater numbers
of inflammatory foci. The numbers of cells in each focus was also
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greater when compared with their untreated counterparts. In
addition to this the numbers of vacuoles in the spleen, while
decreasing with time in untreated mice, were maintained in
antibody treated groups. The function of these vacuoles is not
clear although it seems likely that they represent sites of
phagocytosis, possible effete single macrophages, since they
contained cell debris and chlamydial antigen. Therefore in both the
liver and the spleen it would appear that in mice not given
monoclonal antibody the initial infection was being resolved,
while in mice treated with anti-y-IFN monoclonal antibody infection
was not being so readily controlled. This resulted in further
tissue damage, allowing the suggestion that y-IFN has an important
role to play in the immune control of chlamydial infection.
Chlamydial infection caused a significant rise in spleen weights
when compared with any of the uninfected control groups. In
addition, antibody treated mice showed the greatest increase
associated with a greater prominence of PALS, suggesting that the
treatment stimulated an increase in blastogenesis. This effect
could be due to the removal of suppressive effects that y-IFN might
exert on proliferation as it has been identified as a potent
suppressor of proliferation in vitro (Richard, Forget and
Turcotte, 1991). In vitro studies have also shown that activated
splenic macrophages can suppress the proliferative response of
lymphocytes to mitogens (Tomioka, Saito and Yamada, 1990). The
results presented above may be an in vivo demonstration of these
experimental phenomena based on the removal of y-IFN and a
consequent reduction in the number of activated macrophages.
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Foci of necrosis, visible with the naked eye, were present in
the livers of all infected animals at day 3 and day 5 and y-IFN,
appeared to be associated with its onset and severity , since the
apparent neutralisation of the cytokine delayed the appearance of
necrotic tissue until day 5 in the majority of mice in groups B and
D mice. These foci of coagulative necrosis, which rarely
contained inflammatory cells or antigen but were often bordered by
a thin, red outer zone of haemorrhage, had the appSSLrance of
infarcts. Whether this was a result of increased numbers of
chlamydiae in the organs of antibody treated mice causing the
release of sufficient cell debris to block hepatic blood vessels
and cause necrosis is not clear.
y-IFN has also been shown to cause cell death in mouse and rat
fibroblasts (Dijkmans et al, 1989) and this action is enhanced by
bacterial LPS (Dijkmans et al, Billiau, 1990). Chlamydial LPS has
been demonstrated on the surface of infected cells (Richmond and
Stirling, 1981) and in small chlamydial infections this cytotoxic
reaction may provide a protective immune response, since infected
cells would be destroyed, releasing immature, non-infectious RBs.
Cell debris from the damaged tissue may also attract phagocytic
cells to the site of infection and aid the clearance of the
organisms. The lack of detectable antigen within the large areas
of necrosis described above, suggests that a direct effect on
chlamydia infected cells as described above is an unlikely
explanation for the widespread necrosis seen. However, it may be
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that tissue damage caused by this mechanism contributes to the
pathogenesis of chronic chlamydial infections. It remains a
possibility that the necrosis described was caused by a combination
of the above factors.
Another major feature of the pathology of the infected animals
was the presence of foci of inflammation within the liver. These
foci increased both in number and in size, as determined by the
number of inflammatory cells they contained on day 5 when compared
with day 3. Groups B and D which had been treated with antibody had
more frequent and larger foci than their group A and C
counterparts. It seems likely that this is linked to the finding
that larger numbers of viable chlamydiae were recovered from the
hepatic tissue of groups B and D. Tissue damage and cell debris
caused by the increased infection would in turn attract more
phagocytic cells and create large foci of inflammation. This
hypothesis is strengthened by the finding that most of the
detectable antigen and chlamydial RNA was associated with these
foci. Thus infection of the Kupffe*"* cells within the hepatic
sinusoids was in some way related to the formation of these foci.
Two methods of detecting chlamydiae in tissue sections were used
in this study. The first was a direct immunoperoxidase method and
the second was by in situ hybridisation using a specific RNA probe.
The two methods were employed initially to determine whether one
was more sensitive than the other. Both proved equally sensitive
and confirmed the results obtained from the other. Thus it seems
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reasonable to conclude that in this experiment chlamydial RNA was
always associated with chlamydial antigen, there being no evidence
to support the suggestion that the organism could remain undetected
in a latent form by not expressing antigen.
The amount of antigen detected in the spleen was greatest in the
athymic mice of group C. It also increased between day 3 and day
5, whereas in thymic mice in group A, the amount of antigen
detected decreased with time. The administration of antibody to
both types of mice led to an increase in the amount of antigen
detected at any time. This pattern was repeated in the other
tissues examined, sometimes with large differences seen between the
different groups and the largest amount of antigen being in mice
given antibody. In the lungs in particular, antigen was only
detected in groups given antibody and then it was only at day 5
that any could be visualised.
The site of the detected antigen varied between those mice which
had been given antibody and those which had not. In the spleen,
for example, while all groups had antigen present in cytolytic
vacuoles in the red pulp, to where it had presumably been carried
by the blood, antibody treated groups also had inclusions present,
indicating that chlamydial replication was taking place at these
sites. A similar picture was seen in the liver where inclusions
were seen in hepatocytes in mice injected with the monoclonal
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antibody. Again the inclusions appeared to be growing unhindered
and free from inflammatory cell infiltration. These findings would
suggest that y-IFN has a role to play in the clearance of
C.psittaci from infected tissue.
The sera of the infected mice were tested for the presence of
interferon and specifically y-IFN, but as in previous reports
there was no detectable interferon in the sera of infected mice not
injected with monoclonal antibody (Williams et al, 1988: Zhong et
al, 1989). Sera from antibody treated mice did contain interferon
and in these animals it was of the a/p type. It is not clear why
a/P IFN was produced in this instance, but it is known that many
intracellular bacteria such as Listeria monocytogenes and Brucella
abortus can induce a/P-IFN after systemic infection of the host
(Nakane and Minegawa, 1981; Youngner and Stinebring, 1964).
Therefore the production of a/P-IFN may be a further indication of
the extent of exacerbation of the pathology caused by injection of
the monoclonal antibody. Another factor to consider is that
bacterial lipopolysaccharide is known to induce a/P-IFN in murine
macrophages (Maehara and Ho, 1977) and it is possible that the
lipopolysaccharide from the increased multiplication of C.psittaci
in antibody treated animals may have induced the production of the
a/P-IFN in the macrophages. Only one mouse had any detectable
y-IFN in its serum, but the reason for this is unknown. This mouse
also had less detectable antigen and fewer viable chlamydia, in
its tissues than other mice in its group.
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Conclusions.
It is clear from this study that y-IFN has a role to play in the
early immune response of mice to C.psittaci. Infected mice,
treated with a y_lFN neutralising antibody, consistently developed
more severe lesions and harboured a greater number of viable
chlamydiae in the spleen, liver and lung, when compared with
untreated, but infected control mice. However, the role of
T-cells at this time is less clear. While there was often a slight
exacerbation of infection in athymic mice, the differences were not
always significantj <3n exception to this being the greater numbers
of viable chlamydiae isolated from the tissues of the athymic mice.
Therefore it would appear that T-cells also have a role to play in
the clearance of a chlamydial infection. While in this experiment
the exact nature of this has yet to be elucidated^ iX may be that
T-cells become more important in immune control as the infection
proceeds beyond the time scale examined in this study, as would





The main aim of this thesis was to examine the ovine immune
response to C.psittaci. Work in other species has shown the
importance of both humoral and cellular response to this organism
(Buzoni-Gatel et al, 1987) and studies carried out previously at
the Moredun Research Institute have examined and characterised the
humoral response of sheep to C.psittaci (Tan, 1989). The
experiments contained within this thesis were therefore designed to
extend our understanding of ovine cell mediated immunity to
C .psittaci, by examining the development of maternal
lymphoproliferative responses during gestation, and determining
which antigens of C.psittaci provoked both proliferative and
cytokine mediated responses after abortion. An attempt was also
made to demonstrate the in vivo importance of one of these
cytokines in the resolution of a chlamydial infection.
As the results of specific experiments were discussed in the
relevant chapters, this final chapter will attempt to bring
together the main findings of the thesis and discuss them in
relation to what is already known about ovine chlamydial
infections.
The route of transmission of C .psittaci is still poorly
understood although recent findings suggest that it is passed on by
the ingestion of contaminated placentas and bedding (Aitken, 1990)
and the tonsil has been implicated as a possible portal of entry
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(Jones and Anderson, 1988). It is clear, however, that once an
infection is established C.psittaci can lie dormant and not cause
abortion until the following year. However, the site of latency is
not known.
Studies in mice have shown that after infection the organisms
spread to many tissues of the body including the spleen, liver and
lungs (Chapter 7). In all the tissues studied the initial response
was invariably by cells of the reticuloendothelial system (Chapter
7). Proliferation of these phagocytic cells was followed by focal
infiltration by PMN, possibly attracted by chemotatic factors and
cell debris (Chapter 7). PMN are also important in human
chlamydial infections (Register et al., 1987) where low molecular
weight fractions of PMN granule proteins have been shown to inhibit
C.psittaci infectivity and fractions containing lysozyme to inhibit
C.trachomatis infectivity. While the reason for this species
difference is unknown, it may be pertinent that C.trachomatis has
been shown not to grow well in "professional" phagocytes which are
lysozyme rich (Register et al., 1987). However, the role of PMN in
chlamydial infection remains unclear, since in earlier work it was
shown that the presence of PMN in infected mice did not correlate
with survival (Heubner and Byrne, 1984).
Research has shown that cytokines are also important during the
early stages of infection (Chapter 7). Gamma interferon has both
an in vivo effect on the severity of the disease (Chapter 7) and in
the resolution of infection (Williams, Bonewald, Roodman, Byrne,
Magee and Schachter, 1989), possibly by virtue of its synergism
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with tumour necrosis factor (TNF-a) (Shemer-Avni, Wallach and
Sarov, 1989) . The mechanisms by which y-IFN works are not known.
A direct effect, potentiated by bacterial LPS, which causes
suicide-like destruction of infected cells has been postulated
(Dijkmans et al. , 1990), as has a microbiostatic effect caused by
y-IFN enhanced degradation of the essential amino acid tryptophan
(Byrne et al., 1986). This latter effect may prove to be the
immunological basis for the persistence or latency which is common
in chlamydial infections, particularly EAE (Chapter 1). It is
clear that after infection, C.psittaci is difficult to isolate
from sheep (Huang et al., 1990) but that it will reappear in the
placenta of an infected sheep after day 90 (Buxton et al., 1990).
It may be that y-IFN forces the C.psittaci to adopt a latent form
(Moulder et al., 1980) until a trigger releases the C.psittaci
from its intracellular site with recrudescence of infection
resulting in abortion or premature birth (Aitken, 1990) .
The intracellular nature of the chlamydiae mean that cytotoxic
cells, important in viral infections, may also be important in
containing the infection during the latent phase and in maintaining
immunity to C.psittaci after abortion. Natural Killer cells (NK
cells) mediate natural resistance against tumours, viruses and
intracellular parasites (Herberman and Ortaldo, 1981) although the
mechanism whereby NK cells recognise foreign antigen and lyse
infected cells is not yet fully understood (Surianni, Tagliaferri
and Arnti, 1990). The ability of NK cells to produce y-IFN also
has a role to play in host defence against bacterial and viral
infections (Dunn and North, 1991) and therefore it is tempting to
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suggest that y-IFN from NK cells and CD4+ cells may help resolve a
chlamydial infection (Chapter 6 and 7) and/or maintain it in a
latent state (Chapter 1). While the importance of NK cells in
chlamydial immunity is unclear, it is known that as well as
producing y-IFN, NK cell activity itself is augmented by this
cytokine (Djeu, Heinbaugh, Holden and Herberman, 1979) . Ovine
y-IFN is produced in response to C.psittaci antigens by peripheral
blood mononuclear cells (Chapter 6) and is also important in
resolving chlamydial infection (Chapter 7) perhaps by aiding
macrophages and NK cells. It is also interesting to note that
during gestation NK cells lose their activity. While y-IFN
augments the activity of NK cells estradiol suppresses their
activity (Seaman, Blackman, Gindhart, Roubinian, Loch and Talal,
1978) as does stress (Shavit, Lewis, Terman, Gale and Liebeskung,
1984), both of which feature during pregnancy. If NK cells were
important in chlamydial immunity this reduction in activity during
gestation could lead to recrudescence of a latent infection and
might explain why placental infection only develops after day 90
(Buxton et al., 1990).
As well as non-specific cytotoxicity by NK cells there is also
the possibility that specific cytotoxicity by CD8+ T cells, is also
important in chlamydial immunity. CD8+ T cells have a receptor
which recognises specific foreign antigen, in association with MHC
Class I molecules on the surface of infected cells (reviewed in
Kaufmann, 1988) . It may be that these CD8+ T cells recognise
chlamydial peptides expressed on the surface of infected cells and
lyse them. This cytotoxicity, both specific and non-specific, may
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prove to be an important mechanism for limiting the intracellular
cycle of a chlamydial infection, (Chapter 1), because lysis of
infected cells would release non-infectious RBs which cannot then
infect other cells. The prematurely released RBs would then be
open to attack from other components of the immune response such as
phagocytes and antibody.
Murine CD8+ cells also release y-IFN in response to purified
protein derivative (PPD) after infection with Mycobacterium bovis
(Sonnenfield, Mandel and Merigan, 1979) and adoptive transfer of
CD8+ cells partially protects mice against malaria, a mechanism
which can be reversed by y-IFN neutralising antibody (Schofield.
Schellekens, Nussenweig and Nussenweig, 1987.)
Villarquiran, Ferreirra, 1987). Tnese findings may suggest an
indirect or a direct role for y-IFN in the protection afforded by
CD8+ T-cells against intracellular bacteria and since y-IFN is
important in chlamydial immunity (Chapter 6 and 7), this may be
further evidence of a putative role for CD8+ T-cells in the ovine
immune response to C.psittaci. However, the importance of
cytotoxicity, in the immune response to C.psittaci in sheep,
remains to be elucidated.
One unanswered question surrounding the period of
latency/persistence between initial infection and abortion (Chapter
1) concerns the trigger which signals both the end of the latent
phase and the reemergence of infection, with the subsequent
colonisation of the placenta. It is possible that the chlamydiae
undergo periodic release from the site(s) of latency, but the
placenta is not colonised until after day 90, because favourable
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conditions do not exist until that time. It is also possible that
the chlamydiae are only reactivated after day 9 0 by a
hormonal/chemical signal, which is either absent or at a low
concentration before this time, and which triggers their release.
Ovine T-cell proliferative responses can be measured following
infection at 90 days gestation (Chapter 4). Similar experiments to
those conducted in chapter 4, but employing sheep infected before
tupping may help answer this question. If during the measurement
of T-cell proliferation to C.psittaci EBs, from infection to
subsequent lambing/abortion, there is little or no response until
after day 90, it would suggest that C.psittaci is released from
the site of latency at this time. If, however, proliferative
responses to EBs could be measured throughout gestation, it may
suggest there is a periodic release of C.psittaci constantly
boosting the immune response. These releases of chlamydiae may be
limited by the immune system until the organisms colonise the
placenta after day 90 when conditions are more favourable. This
latter suggestion is strengthened by the unpublished finding that
sheep infected with C.psittaci show intermittent phases of fever
during gestation (D. Buxton, personal communication). It is
possible that this fever is caused by the release of C.psittaci and
a subsequent activation of macrophages and release of the pyrogen
IL-1.
After abortion sheep are solidly immune and do not abort again
(Chapter 1). Both T-cell proliferative responses (Chapter 5),
cytokine release (Chapter 6) and B-cell antibody production (Tan,
1989) can be measured at this time and all three may be involved in
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long term immunity. It is hoped that the identification of
proteins which caused both proliferation (Chapter 5) and cytokine
release (Chapter 6) will prove useful in the future development of
an improved vaccine against EAE. Further study will be necessary to
determine if individual proteins can be used to produce effective
immunity against bacterial infections such as C.psittaci. It is
encouraging to note that murine immunisation against cutaneous
Leshmaniasis has been obtained using defined membrane surface
antigens reconstituted into liposomes (Russell and Alexander,
1988). Recombinant chlamydial proteins, such as the MOMP, of the
ovine abortion strain S26/3 (Herring et al., 1989), will provide
useful tools for this analysis.
While the T-cell lines used in Chapters 5 and 6 were polyclonal,
future studies may be further advanced by using T-cell clones which
are reactive against single epitopes. These clones could then be
used to map epitopes on synthetic peptides based on the known
sequences of chlamydial proteins in the same manner as has been
used to successfully map epitopes on synthetic peptides from
Plasmodium vivax (George, Law, Rich and Martin, 1990),
Schistosomiasis mansoni (Reynolds, Kunkel, Thomas and Higashi,
1990), Mycobacterium tuberculosis (Barnes, Mehra, Hirschfield,
Fong, Abou-Zeid, Rook, Hunter, Brennan and Modlin, 1989) and
Influenza A virus (Gao, Liew and Tite, 1989).
Finally, a major aspect of ovine chlamydiology which requires
further study is the question of diagnosis of infection. At
present, the most common diagnostic techniques for EAE are based on
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the detection of antibody with either the complement fixation test
(Stamp et al., 1950) or by Western blot analysis (Tan, 1989),
however neither detect high levels of antibody until after abortion
(Chapter 1). Cellular techniques can detect differences between
infected and naive sheep during gestation (Chapter 4), but the
lymphocyte transformation assays described in this thesis (Chapter
3) are currently labour intensive, expensive and require the use of
radioisotopes. Therefore, this test is impractical for the
screening of large numbers of sheep for the presence of a
chlamydial infection. An ELISA for the detection of y-IFN (Chapter
6) has been developed as a diagnostic test for the detection of
Mycobacterium bovis (Wood, Corner and Plackett, 1990) and has
recently undergone extensive field trials in Australia with
documented success (Wood, La Corner, Rothel, Baldock, Jones,
Cousins, McCormick, Francis, Creeper and Tweedale, 1991). The kit
has recently been approved for use in the diagnosis of bovine
tuberculosis by the Australian Animal Health Committee (Wood et
al., 1991). As results in Chapter 6 show, using similar
techniques to the Australian workers, differences between post
abortion ewes and naive sheep could be detected in the limited
number of animals tested. To determine whether or not the test was
specific enough to differentiate between pathogenic abortion
strains of C.psittaci and harmless enteric isolates a larger trial
would have to be initiated. Success may come from the development
of synthetic peptides specific for C.psittaci abortion isolates, as
it has been shown that even small peptides can stimulate the
production of y-IFN from primed T-cells (Chapter 6). A further
question to be answered would be whether there was a correlation
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between detection of y-IFN and protective immunity to abortion
which could allow the development of an assay for vaccine efficacy
in sheep. Again, however, a large scale trial would be necessary to
evaluate the suitability of a y-IFN ELISA for this purpose.
Therefore, there is still much work to be done before the full
role of cell mediated immunity in ovine chlamydial infection has
been elucidated. The results presented in this thesis indicate an
important role for both CD4+ T-cells and y-IFN in the maintenance
of protective immunity. In addition, immunodominant antigens have
been described which may aid future, sub-unit vaccine development.
It is hoped that this thesis will provide the groundwork for future
work which will further define the immunodominant antigens of
C.psittaci and the cellular components of the ovine immune response
to them, and therefore lead to an even greater understanding of
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Chlamydia psittaci, a zoonotic bacterium, is the causal agent of enzootic abortion of ewes, an im¬
portant disease of sheep in many European countries. The major thrust ofcurrent chlamydial research
is directed towards the human pathogen Chlamydia trachomatis. This review attempts to bring to¬
gether relevant information concerning the host immune response to all members of the genus Chla-
mydiae and show how this has led to an increased understanding of the ovine humoral and cell me¬
diated immune responses to C. psittaci while emphasising areas where there is still a lack of knowledge.
Specifically the review looks at the common immuno-accessible antigens of the Chlamydiae and the
antibody responses produced during infection, as well as covering the role of T cells and cytokines in
the protective immune response.
INTRODUCTION
This review discusses what is currently known about the pathogenesis of
and immune response to chlamydial infections in sheep. Members of genus
Chlamydia are Gram-negative bacteria. They are obligate, intracellular path¬
ogens which lack the ability to synthesise high energy compounds such as
adenosine tri-phosphate, leading Moulder (1974) to coin the phrase "energy
parasites". At present two species are recognised Chlamydia trachomatis and
C. psittaci, (Moulder, 1984) although a third species C. pneumoniae has been
proposed (Grayston etal., 1989).
Chlamydial disease has almost as many forms as hosts. Chlamydia infect
arthropods, molluscs, over 130 species of birds and several species of mam-
mels (Ward, 1983). Avian strains can cause acute respiratory infection in
man (Macfarlane and Macrae, 1983) as well as birds and the mammalian
strains are known to cause pneumonia, conjunctivitis, polyarthritis, synovi¬
tis, enteritis, seminal vesiculitis, sporadic encephalomyelitis and abortion
(Storz and Krauss, 1985). Indeed, 20% of ovine abortion reported annually
0378-1 135/90/$03.50 © 1990 — Elsevier Science Publishers B.V.
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in Great Britain is due to C. psittaci (Aitken, 1986). However, the target cells
in all cases are epithelial cells and infiltrating macrophages (Kuo, 1986).
C. trachomatis strains are mainly human pathogens which can be sub-di¬
vided into three biovars; the trachoma strains, which cause oculo-genital dis¬
ease; the lymphogranuloma venereum (LGV) strains, include all other hu¬
man strains; and the mouse pneumonitis strains. C. trachomatis is the most
common causative agent of preventable blindness in man, as well as being the
cause of the most common sexually transmitted infection in the world (Ward,
1983).
The third species, C. pneumoniae, has been proposed to include the TWAR
strains of C. psittaci. These strains, named after the first isolates discovered
TW-183 from Taiwan and AR-39 from Seattle (Grayston et al., 1986), cause
acute respiratory infections, but unlike other species of C. psittaci appear to
be host-specific, specific only to man.
Mammalian strains of C. psittaci have been subgrouped into nine immu-
notypes by Perez-Martinez and Storz (1985), using an indirect microimmu-
nofluorescence technique. These immunotypes show patterns of either dis¬
ease or host specificity and correlate well with the eight bio-types of C. psittaci
earlier defined by Spears and Storz (1979). Of particular importance in sheep
are immunotype 1, causing abortion; and immunotype 2, causing arthritis
and conjunctivitis. Immunotype 9 also has been isolated from sheep faeces
but has not been associated with any disease (Perez-Martinez and Storz,
1985). In the case of immunotype 1 strains, target cells are fetal trophoblast
cells whereas immunotype 2 has a predilection for synovial and corneal cells.
Chlamydial infections are complicated by the organism's intracellular life
cycle first described by Bedson and Bland (1932). This involves two forms,
the infectious, extracellular elementary body (EB) and the non infectious,
intracellular reticulate body (RB). The EB gains access to the cell where it
transforms into an RB and begins to replicate within a cytoplasmic mem¬
brane or inclusion vacuole using the hosts' cells energy. The by now large
numbers of RBs then revert to the EB form again and burst from the cell ready
to infect further healthy cells.
PERSISTENCE OF INFECTION
The disease states caused by C. psittaci fall into two groups; chronic disease
such as conjunctivitis and arthritis, due to immunotype 2, or single episode
diseases such as enzootic abortion of ewes (EAE), caused by immunotype 1.
However, in both cases there is a persistence or latency of infection, both in
vitro (Rodolakis et al., 1989), where virulence affects the frequency at which
persistence occurs, and in vivo. It has been shown that following initial infec¬
tion in young lambs, C. psittaci can persist until the following season when
the animals become pregnant at which time a proportion abort (McEwen et
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al., 1951). Infection can also persist and C. psittaci can be isolated from goats
after abortion, when the animals are considered to be immune (Brown et al.,
1988). In 1980 Moulder and co-workers suggested a cryptic form of the par¬
asite, which did not stain with Giemsa, to explain the persistence of infection
they demonstrated in vitro. These cryptic forms revert to dividing RBs when
triggered by a factor as yet unknown allowing the disease cycle to begin again.
However, persistance is still not fully understood but may be partly due to
the unique interactions between macrophages and C. psittaci. C. psittaci can
exist within the macrophage (Kuo, 1988) which is one of the principal anti¬
gen presenting cells of the immune system. This may have profound impli¬
cations in the generation of immune responses during infection. The chla-
mydiae achieve their survival by inhibiting phagosome-lysosome fusion (Friis,
1972), perhaps in the same manner as other intracellular pathogens such as
Toxoplasma gondii (Jones and Hirsch, 1972) and Mycobacterium tuberculo¬
sis (Lowrie, 1983). Mycobacterium leprae, on the other hand, escapes from
the phagosome into the cytoplasm before fusion (Sibley et al., 1987). The
exact mechanisms by which these effects are achieved have yet to be defined,
but Byrne and Moulder (1978) showed that uptake of chlamydiae was para-
site-induced and that this phagocytosis was inhibited by heating the chlamy¬
diae, suggesting that a heat-labile structure on the surface of the organism was
responsible for their uptake. It was also noted that the addition of large num¬
bers of viable chlamydiae did not induce the uptake of heat-inactivated or¬
ganisms, showing that the unknown component was not a general promoter
of phagocytosis.
Intracellular RBs are incapable of inhibiting phagosome-lysosome fu¬
sion (Brownridge and Moulder, 1979) and cannot induce uptake by the target
cell since, when compared with EBs, fewer RBs are phagocytosed and more
are destroyed upon uptake by macrophages. Phagosome-lysosome fusion in¬
hibition is thus restricted to and is triggered by EBs (Eissenberg and Wyrick,
1981). When yeast and EBs are concomitantly phagocytosed by macrophages
fusion occurs only with yeast laden vacuoles, showing that chlamydial EBs
cause specific and not general suppression of fusion (Eissenberg and Wyrick,
1981). Later it was shown that purified EB envelopes alone could inhibit fu¬
sion and in this case the ability to inhibit fusion was not lost on heating the
envelopes (Eissenberg et al., 1983). However, large numbers of EBs, rather
than causing higher rates of infection, actually cause reduced rates due to a
phenomenon known as immediate cytotoxicity (Moulder et al., 1976). This
is thought to be caused by membrane lesions resulting from the parasite-in¬
duced phagocytosis (Friis, 1972). Therefore, larger numbers of EBs give rise
to more ingestion, causing more lesions, leading to irreparable membrane
damage and cell death, before the invading chlamydiae can replicate.
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ANTIBODY RESPONSES INDUCED BY ANTIGENS OF C. PSITTACI
There are many surface antigens on C. psittaci which may stimulate a hu¬
moral immune response. Sixteen to eighteen bands, separatable by SDS-PAGE
electrophoresis, react in immunoblotting experiments using sera from ewes
recovering from a chlamydial infection (Tan et al., 1988). Two of the most
prominent are a 38-42 kD protein antigen described for two strains of
C. trachomatis and one of C. psittaci (Hatch et al., 1981) and a carbohydrate
antigen, first described by Bedson (1936) and later shown to be lipopolysac-
charide (LPS) (Nurminen et al., 1983). These two antigens are associated
on the surface of chlamydiae (Birkalund et al., 1988).
Due to its prominence on the surface of all strains studied, the 38-42 kD
protein antigen has been called the major outer membrane protein (MOMP)
(Salari and Ward, 1981). In 1982, Caldwell and Schachter showed that
MOMP contained a complex hierarchy of epitopes, including species, sub¬
species, and serotype specific epitopes. Cloning of the MOMP gene of C. tra¬
chomatis (Allan et al., 1984), and recent sequencing of the MOMP gene of
the C. psittaci ovine abortion strain S26/3 (Herring et al., 1989) should in¬
crease knowledge of its role in the immune response as should work by Con-
Ian and his co-workers on the primary amino acid sequence of the epitopes
(1988).
LPS is genus-specific, being found on all strains of chlamydiae, and forms
the basis of the complement fixation test(CF) used in serodiagnosis of dis¬
ease. It has been shown to cross-react immunologically with the mutant Re
determinant of other bacterial LPS (Nurminen et al., 1983). Caldwell and
Hitchcock (1984) subsequently demonstrated that there was also a species-
specific epitope on chlamydial LPS. The chemical nature of this epitope has
been described by Nurminen and colleagues (1985) and recently a trisac-
charide related to chlamydial LPS was synthesised by Kosma and co-workers
(1988).
Other antigens of importance in chlamydial infection are recognised in im-
munoblot experiments using sera from convalescent ewes (Tan et al., 1988)
and man (Newhall et al., 1982) and include three cysteine-rich proteins of
molecular weights 15 kD, 60 kD, 62 kD found on C. psittaci (Hatch et al.,
1984) and C. trachomatis (Batteiger et al., 1985). These are absent from RB's
and the lack of disulphide bridges may explain the less rigid structure of the
RB cell wall. There are also two adhesins of 31 kD and 18 kD which appear
to be eukaryotic cell binding proteins (Hackstadt, 1986). These proteins are
not denatured by heating unlike the envelope proteins described by Byrne
and Moulder (1978). The 18 kD protein has been cloned in E. coli and anti¬
body raised against the expressed product has a neutralising effect on chla¬
mydial infectivity (Kaul et al., 1987). These adhesins take on further signif¬
icance in light of studies by Russel and Alexander (1988) which demonstrated
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prophylaxis in cutaneous leishmaniasis using two antigens known to be in¬
volved in the attachment of another intracellular parasite, Leishmania
mexicana, to its host cell, the macrophage.
Specific IgM and IgG antibodies are induced by these immunoreactive an¬
tigens following infection (Page et al., 1967). Originally, Isa et al. (1968)
claimed that only IgG was produced in monkeys, even in a primary infection.
However this was later shown not to be the case and the earlier lack of IgM
activity was due to either inapparent previous infections or cross-reacting an¬
tigens (Isa, 1973). The ability of the immunofluorescence test used to detect
IgM in primates has also been questioned (Juchau et al., 1972), since high
affinity IgG may effect the ability of low affinity IgM to bind to chlamydial
antigen.
Following infection in ewes, CF antibody is produced against epitopes found
on chlamydial LPS. Titres rise to a peak at about 14 days after abortion and
remain high for several weeks (Stamp et al., 1952). Neutralising antibody
appears later, and titres remain higher for longer (McEwen and Foggie, 1954),
but neither CF nor neutralising antibody titres correlate with immunity (Storz
and Krauss, 1985).
Recent work has concentrated on which subclass of IgG is produced in the
humoral response. This interest was stimulated when Schmeer and co-work¬
ers (1985) showed by ELISA, that IgG2 was the dominant subclass in bovine
chlamydial infections. However, similar work with sheep antibodies showed
that IgGl is dominant (Krauss et al., 1985). The significance of this is un¬
known at present but work on how antigens stimulate different subclasses of
antibody may prove useful, particularly in light of the fact that gamma-inter-
feron enhances murine IgG2 production and decreases IgGl production in
vitro (O'Gara et al., 1988).
However, laboratory animal studies dealing with passive transfer of anti¬
bodies have produced conflicting results. Watson and colleagues (1973) pas¬
sively transferred serum antibody into non-immune guinea pigs which re¬
sulted in titres higher than those associated with natural immunity. However,
on subsequent challenge the disease was neither prevented nor slowed. Bu-
zoni-Gatel and co-workers (1987) found that immune sera transferred to mice
infected with C. psittaci led to eradication of the organism. Whether this is
due to the different animal models used is uncertain, but both authors agree
that cell-mediated immune mechanisms may predominate in resistance to
this disease.
CELL-MEDIATED IMMUNITY
Cell-mediated immunity (CMI) is a function of specific T cell cytotoxicity
and delayed type hypersensitivity (DTH) reactions, and of natural immune
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mechanisms including natural killer cell activity and phagocytosis by cyto-
kine-activated macrophages.
Cytotoxicity attributed to both natural and T cell mediated mechanisms
has been demonstrated in spleen cells from mice infected with C. psittaci Cal
10 strain (Lammert, 1982). In comparison, cytotoxicity could not be found
in lymphocyte preparations taken from the spleen, lymph nodes or peritoneal
cavities of mice infected with the LGV strains of C. trachomatis (Pavia and
Schachter, 1983). Further work with human lymphocytes also failed to dem¬
onstrate cytotoxicity against the LGV strains of C. trachomatis (Qvigstad and
Hirschberg, 1984). The role of T cell cytotoxicity is therefore unresolved, al¬
though the reported differences may be due to the different species used. It
remains to be elucidated whether these mechanisms play a role in ovine C.
psittaci infection.
That T cell mediated immunity to C. psittaci occurs in sheep can be dem¬
onstrated by DTH tests (Wilsmore et al., 1984; Dawson et ah, 1986). After
abortion, ewes develop a positive DTH reaction, however, if primary infec¬
tion occurs outwith pregnancy no immunity is generated. In the latter case it
is possible that the organism may persist at too low a level to stimulate the
DTH response, but may cause abortion of the following pregnancy. Immunity
is then generated, presumably due to the higher levels of replication within
the placenta and substantial challenge of the ewe with antigen as a result of
parturition (Storz, 1971). This explains the earlier findings that after abort¬
ing ewes display immunity (Stamp et ah, 1950). The generation of CMI may
prevent further chlamydaemias and thereby stop subsequent placental infec¬
tion even though ewes may still harbour a low level infection.
Cytokine-activated phagocytosis by macrophages may occur as a result of
DTH responses. In 1983, Murray and colleagues showed that oxygen-inde¬
pendent activity of macrophages against intracellular parasites, including C.
psittaci, was enhanced by a cytokine and IFN-g was later shown to be the
cytokine, originally termed macrophage activating factor (MAF), responsi¬
ble for oxygen dependent activation of macrophages against intracellular par¬
asites (Nathan et al., 1983). However, as early as 1975 Borges and Johnson
had demonstrated that products in the supernatant of activated T cells could
effectively reduce the intracellular replication of T. gondii. IFN-g is released
by activated T cells. Cytokine-activated macrophages have been associated
with restriction of chlamydial replication, possibly leading to persistent infec¬
tions (Moulder et al., 1980). Huebner and Byrne (1988) found that while
not clearing infection, activated macrophages were necessary for survival of
infected mice indicating that their action was bacteriostatic. This effect of
IFN-g had been described previously (Byrne and Faubion, 1982). Recently,
Byrne and colleagues (1989) have also demonstrated a cytotoxic effect on
C. psittaci by infected cells activated by IFN-g.
At the time IFN-g was identified as a macrophage activator it was also im-
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plicated as the factor in crude cytokine preparations which induced inhibi¬
tion of C. psittaci replication in macrophages (Rothermel et al., 1983; Byrne
and Krueger, 1983). It was shown that anti-IFN-g antibodies could remove
this inhibition and precipitate a recrudesence of infection. Recently, catabo-
lism of essential amino acids induced by IFN-g was identified as the mecha¬
nism for this inhibition (Byrne et al., 1986). This is not the first time, how¬
ever, that parasite and host competition for essential amino acids has been
cited as a mechanism for inhibition of replication due to bacteriostasis (Hatch,
1975).
Other phagocytes involved in the response to chlamydial infection are po¬
lymorphonuclear cells or neutrophils (Register et al., 1987). These cells are
attracted to sites of inflammation by the release of arachidonic acid metabo¬
lites from activated macrophages. However, this does not seem to be the case
with other intracellular parasites such as T. gondii (Locksley et al., 1985)
which appear to affect the host cell's arachidonic acid metabolism altering the
concentrations of leucotrienes produced, thereby reducing the inflammatory
response to the infection and lowering the numbers of neutrophils at the site
of infection.
Granules from neutrophils, of patients with chronic granulocytic leukae¬
mia, were fractionated in order to examine which compounds were important
in the response to Chlamydia spp. The heavier fractions, which contained
lysozyme, reduced C. trachomatis infectivity, whereas the lighter fractions,
Mw< 13 kD, had a detrimental effect on C. psittaci. Granules eluted in the
lower molecular weight fractions contain cationic proteins, but the important
individual ones are unknown at present.
Further in vitro techniques also show CMI has a role to play. These include
specific antigen-induced migration inhibition of peritoneal exudate cells from
guinea pigs infected with C. psittaci (Seynk et al., 1981) and the proliferation
of lymphocytes from lymph nodes of sheep (Russo and Giauffret, 1978), and
from guinea pigs with C. psittaci antigens (Seynk et al., 1981), and in human
T cell clones using C. trachomatis antigens (Qvigstad and Hirschberg, 1984).
In each case migration inhibition and lymphocyte proliferation were demon¬
strated, indicating that T cells have been exposed to and have recognised chla¬
mydial antigen. Lammert and Wyrick (1982), using a similar mouse lympho¬
cyte proliferation assay, found that the response to the T cell mitogens
concanavalin A and phytohaemagglutinin was reduced 1-2 weeks after infec¬
tion and that proliferation in response to chlamydial antigen was suppressed.
Chlamydiae-induced proliferation occurred only 4 weeks after infection, by
which time mitogen response had returned to normal.
Treatment with compounds known to be selectively immunosuppressive
has shown that CMI is not the only important immune response to C. psittaci.
When cyclophosphamide is administered at levels which deplete humoral re¬
sponses, but have no effect on CMI, there is no resolution of disease
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(Modabber et al., 1976). There is therefore cooperation between the humoral
and the cell-mediated systems, although the exact mechanism by which this
occurs is not yet known (Buzoni-Gatel et al., 1987; Rank et al., 1989). Two
possibilities are suggested; antibody-dependent cell cytotoxicity and opsoni-
sation. Wyrick and colleagues (1978) demonstrated that opsonised EBs were
taken up and destroyed in macrophages, presumably because they could no
longer prevent phagosome-lysosome fusion, while it has also been shown that
although immune sera can transfer immunity the effect is increased by T cell
transfer (Buzoni-Gatel et al., 1985).
IMMUNOMODULATION BY C. PSITTACI
Of importance in any review on immunity is the consideration of modula¬
tion of the host immune response following invasion by the pathogen. With
relevance to C. psittaci infection this may occur by pathogen-induced cyto¬
kine release, hormonal alterations and direct suppression of the immune
system.
One such example, the restrictive effects of IFN-g, has been discussed above.
However, IFN-g also has profound effects upon the immune system, particu¬
larly leading to the expression of class II major histocompatibility complex
(MHC class II) antigens on a variety of cell types. It is the presence of pro¬
cessed peptides from foreign antigens in association with MHC class II mol¬
ecules on cell surfaces that is recognised by T cells and thus initiates specific
immune responses. In mice infected with C. psittaci increased expression of
MHC II antigens has been described on macrophages (Paulnock et al., 1986).
This may well play a role in the generation of immune responses at sites of
infection.
C. psittaci may also have a direct modulatory effect on the immune system
by inducing immunosuppression through infection of macrophages, which are
important in the presentation of antigen to the T cell and also important
phagocytic cells. Thus, while not killing the macrophages, chlamydial infec¬
tion may alter their ability to perform their normal functions and interfere
with the immune system on many different levels. It has also been shown that
antigen from C. psittaci can directly inhibit lymphocyte proliferation in vitro
(Lammert, 1982). This is similar to the immu osuppressive substance re¬
cently shown to be released by Mycobacterium It rae (Liew, 1988).
In addition, hormones have been shown to en lance C. trachomatis infec¬
tions in many animal models (Kuo, 1988) and ii EAE it seems reasonable to
suggest that hormones may stimulate the infectii n of the placenta which oc¬
curs at or about 90 days into gestation (Buxton et al., 1990). Alteration in
the levels of many hormones affect many functioi s of the immune system and
immunosuppression associated with pregnancy is a well recognised phenom¬
enon. (Tomasi, 1983).
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CONCLUSION
It is obvious that knowledge of the mechanisms involved in the ovine im¬
mune response to C. psittaci is scanty. More work is required on the antigens
protective in the immune response as well as on the cellular interactions in¬
volved in generating a protective immune response. It will also be necessary
to elucidate the nature of the balance between the immune system of the host
and persistent infection, it is anticipated that current studies of these param¬
eters will provide information to allow rational design of an effective vaccine
which may also prevent the establishment of persistent infections in sheep.
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